Improving Access to Influenza Countermeasures for U.S. Jurisdictions Skip to main content Sign In U.S. Department of Health & Human Services It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again. Toggle navigation Improving Access to Influenza Countermeasures for U.S. Jurisdictions Strategic National Stockpile HHS is standing by in case there is an increased demand for certain medicines due in part to multiple illnesses circulating this winter season. Should there be an increased demand for antiviral drugs, HHS is giving U.S. jurisdictions the ability to use their own stockpiles of Tamiflu procured under the HHS Antiviral Subsidy Vendor Contract between 2006-2009 as well as access to additional supplies of Tamiflu from the Strategic National Stockpile, if needed. Jurisdictions may access additional supplies in the following ways: Jurisdictions can dispense certain lots of Tamiflu 30mg, 45mg and 75mg that were procured for pandemic preparedness under the HHS Antiviral Subsidy Vendor Contract between 2006-2009. These supplies may be held in jurisdictional stockpile for pandemic use but are now allowed for use in the current flu season. Jurisdictions that have exhausted their own stockpiled supplies of Tamiflu may request supplemental Tamiflu 75mg from the Strategic National Stockpile (SNS). This product is part of the federal stockpile of antiviral drugs held for pandemic preparedness. The Tamiflu products held in jurisdictional stockpiles and in the SNS for pandemic use include drug lots that have been extended by the Food and Drug Administration for up to 20 years beyond their original manufacture date, provided they have been stored under labeled storage conditions. These lots have not been relabeled with new expirations, and healthcare providers and recipients should be notified of the 20-year extension. Additional information may be found in FDA's Expiration Dating Extension | FDA. Jurisdictions should work with their ASPR Regional Teams to initiate any requests for Tamiflu through the SNS. HHS is committed to ensuring that jurisdictions receive the assistance they need without affecting our nation's preparedness for a potential pandemic flu. To determine the expiration date for extended but not relabeled Tamiflu products, find the lot number on the product label and refer to the table below to identify the corresponding expiration date. Table 1: Summary of Tamiflu Lot Expiration Dates for SNS-provided Product NDC Tamiflu® Description Lot Number Date of Manufacture New Expiration Date (20 years beyond date of manufacture) 0004-0800-85 75mg blister B1079 10/14/04 10/14/2024 0004-0800-85 75mg blister B1080 10/14/04 10/14/2024 0004-0800-85 75mg blister B1081 10/15/04 10/15/2024 0004-0800-85 75mg blister B1082 10/18/04 10/18/2024 0004-0800-85 75mg blister B1082-01 10/18/04 10/18/2024 0004-0800-08 75mg bottle B1090 11/23/04 11/23/2024 0004-0800-08 75mg bottle B1100 12/06/04 12/6/2024 0004-0800-08 75mg bottle B1100-01 12/06/04 12/6/2024 0004-0800-08 75mg bottle B1109 01/27/05 1/27/2025 0004-0800-08 75mg bottle B1118 04/26/05 4/26/2025 0004-0800-85 75mg blister B1120 04/28/05 4/28/2025 0004-0800-08 75mg bottle B1122 05/02/05 5/2/2025 0004-0800-08 75mg bottle B1148 07/13/05 7/13/2025 0004-0800-08 75mg bottle B1149 07/14/05 7/14/2025 0004-0800-08 75mg bottle U2011 10/19/05 10/19/2025 0004-0800-08 75mg bottle U2012 10/20/05 10/20/2025 0004-0800-08 75mg bottle U2013 10/24/05 10/24/2025 0004-0800-08 75mg bottle U2015 01/27/06 1/27/2026 0004-0800-08 75mg bottle U2017 02/28/06 2/28/2026 0004-0800-08 75mg bottle U2018 03/02/06 3/2/2026 0004-0800-08 75mg bottle U2021 04/11/06 4/11/2026 0004-0800-08 75mg bottle U2022 04/28/06 4/28/2026 0004-0800-08 75mg bottle U2025 05/05/06 5/5/2026 0004-0800-08 75mg bottle U4000-50 05/05/06 5/5/2026 0004-0800-08 75mg bottle U2026 05/08/06 5/8/2026 0004-0800-08 75mg bottle U4001-50 05/09/06 5/9/2026 0004-0800-08 75mg bottle U2027 05/11/06 5/11/2026 0004-0800-08 75mg bottle U4002-50 05/11/06 5/11/2026 0004-0800-08 75mg bottle U2030 06/05/06 6/5/2026 0004-0800-08 75mg bottle U2034 06/15/06 6/15/2026 0004-0800-08 75mg bottle U2038 07/12/06 7/12/2026 0004-0800-08 75mg bottle U2039 07/13/06 7/13/2026 0004-0800-08 75mg bottle U2040 07/17/06 7/17/2026 0004-0800-08 75mg bottle U2041 07/18/06 7/18/2026 0004-0800-08 75mg bottle U2042 07/19/06 7/19/2026 0004-0800-08 75mg bottle U2043 07/19/06 7/19/2026 0004-0800-08 75mg bottle U2044 07/21/06 7/21/2026 0004-0800-08 75mg bottle U4004 07/24/06 7/24/2026 0004-0800-08 75mg bottle U2045 07/26/06 7/26/2026 0004-0800-08 75mg bottle U4005 07/27/06 7/27/2026 0004-0800-08 75mg bottle U2046 07/31/06 7/31/2026 0004-0800-08 75mg bottle U2047 08/01/06 8/1/2026 0004-0800-08 75mg bottle U4006 08/01/06 8/1/2026 0004-0800-08 75mg bottle U2048 08/02/06 8/2/2026 0004-0800-08 75mg bottle U2049 08/02/06 8/2/2026 0004-0800-08 75mg bottle U2050 08/03/06 8/3/2026 0004-0800-08 75mg bottle U4007 08/03/06 8/3/2026 0004-0800-08 75mg bottle U2051 08/04/06 8/4/2026 0004-0800-08 75mg bottle U4008-10 08/05/06 8/5/2026 0004-0800-08 75mg bottle U4008-50 08/05/06 8/5/2026 0004-0800-08 75mg bottle U2052 08/07/06 8/7/2026 0004-0800-08 75mg bottle U2053 08/08/06 8/8/2026 0004-0800-08 75mg bottle U4009 08/08/06 8/8/2026 0004-0800-08 75mg bottle U4010 08/10/06 8/10/2026 0004-0800-08 75mg bottle U4011 08/12/06 8/12/2026 0004-0800-08 75mg bottle U4012 08/16/06 8/16/2026 0004-0800-08 75mg bottle U4013 08/18/06 8/18/2026 0004-0800-08 75mg bottle U4014 08/21/06 8/21/2026 0004-0800-08 75mg bottle U4015 08/23/06 8/23/2026 0004-0800-08 75mg bottle U4016-50 08/25/06 8/25/2026 0004-0800-08 75mg bottle U4017 08/29/06 8/29/2026 0004-0800-08 75mg bottle U4030-01 10/03/06 10/3/2026 0004-0800-08 75mg bottle U4030-02 10/03/06 10/3/2026 0004-0800-08 75mg bottle U4031-01 10/08/06 10/8/2026 0004-0800-08 75mg bottle U4032-01 10/10/06 10/10/2026 0004-0800-08 75mg bottle U4033-01 10/16/06 10/16/2026 0004-0800-08 75mg bottle U2088 10/17/06 10/17/2026 0004-0800-08 75mg bottle U2089 10/18/06 10/18/2026 0004-0800-08 75mg bottle U4034-01 10/18/06 10/18/2026 0004-0800-08 75mg bottle U2090-01 10/19/06 10/19/2026 0004-0800-08 75mg bottle U2091 10/20/06 10/20/2026 0004-0800-08 75mg bottle U2092 10/20/06 10/20/2026 0004-0800-08 75mg bottle U4035-01 10/23/06 10/23/2026 0004-0800-08 75mg bottle U2093 10/25/06 10/25/2026 0004-0800-08 75mg bottle U4036-01 10/25/06 10/25/2026 0004-0800-08 75mg bottle U2094 10/26/06 10/26/2026 0004-0800-08 75mg bottle U4037-01 10/30/06 10/30/2026 0004-0800-08 75mg bottle U2105 11/10/06 11/10/2026 0004-0800-08 75mg bottle U4046 01/16/07 1/16/2027 0004-0800-08 75mg bottle U4047 01/22/07 1/22/2027 0004-0800-08 75mg bottle U4048 01/24/07 1/24/2027 0004-0800-08 75mg bottle U4049 01/28/07 1/28/2027 0004-0800-08 75mg bottle U4050 01/30/07 1/30/2027 0004-0800-08 75mg bottle U4051 02/05/07 2/5/2027 0004-0800-08 75mg bottle U4052 02/07/07 2/7/2027 0004-0800-08 75mg bottle U4053 02/11/07 2/11/2027 0004-0800-08 75mg bottle U4055 02/20/07 2/20/2027 0004-0800-08 75mg bottle U3000-50 05/11/07 5/11/2027 0004-0800-08 75mg bottle U3001 05/14/07 5/14/2027 0004-0800-08 75mg bottle U3002 05/16/07 5/16/2027 0004-0800-08 75mg bottle U4067 08/06/07 8/6/2027 0004-0800-08 75mg bottle U4068 08/08/07 8/8/2027 0004-0800-08 75mg bottle U4069 09/10/07 9/10/2027 0004-0800-08 75mg bottle U4070 09/13/07 9/13/2027 0004-0800-08 75mg bottle U4072 09/19/07 9/19/2027 0004-0800-08 75mg bottle U4073 09/24/07 9/24/2027 0004-0800-08 75mg bottle U4075 11/05/07 11/5/2027 0004-0801-08 45mg bottle B1003-50 11/07/07 11/7/2027 0004-0800-08 75mg bottle U4076-01 11/07/07 11/7/2027 0004-0802-08 30mg bottle B1004-50 11/09/07 11/9/2027 0004-0800-08 75mg bottle U4077 11/09/07 11/9/2027 0004-0801-08 45mg bottle B1004 11/12/07 11/12/2027 0004-0802-08 30mg bottle B1006 11/12/07 11/12/2027 0004-0800-08 75mg bottle U4078 11/12/07 11/12/2027 0004-0802-08 30mg bottle B1005 11/13/07 11/13/2027 0004-0800-08 75mg bottle U4097 05/03/09 5/3/2029 0004-0800-08 75mg bottle U4098 05/05/09 5/5/2029 0004-0800-08 75mg bottle U4099 05/07/09 5/7/2029 0004-0800-08 75mg bottle U2121-50 05/11/09 5/11/2029 0004-0800-08 75mg bottle U4100 05/11/09 5/11/2029 0004-0802-08 30mg bottle B1020-02 05/13/09 5/13/2029 0004-0800-08 75mg bottle U2122-50 05/13/09 5/13/2029 0004-0800-08 75mg bottle U4101 05/13/09 5/13/2029 0004-0800-08 75mg bottle U2123 05/14/09 5/14/2029 0004-0800-08 75mg bottle U2124 05/15/09 5/15/2029 0004-0801-08 45mg bottle B1014-02 05/18/09 5/18/2029 0004-0802-08 30mg bottle B1021/01 05/18/09 5/18/2029 0004-0800-08 75mg bottle U2125 05/18/09 5/18/2029 0004-0800-08 75mg bottle U4102 05/18/09 5/18/2029 0004-0800-08 75mg bottle U2126 05/20/09 5/20/2029 0004-0800-08 75mg bottle U4103 05/20/09 5/20/2029 0004-0800-08 75mg bottle U2127 05/21/09 5/21/2029 0004-0800-08 75mg bottle U4104 05/22/09 5/22/2029 0004-0800-08 75mg bottle U2128 05/26/09 5/26/2029 0004-0800-08 75mg bottle U2129 05/27/09 5/27/2029 0004-0800-08 75mg bottle U4105 05/27/09 5/27/2029 0004-0800-08 75mg bottle U2130 05/28/09 5/28/2029 0004-0800-08 75mg bottle U2131 05/28/09 5/28/2029 0004-0800-08 75mg bottle U4106 05/29/09 5/29/2029 0004-0800-08 75mg bottle U4107 06/02/09 6/2/2029 0004-0800-08 75mg bottle U4108 06/05/09 6/5/2029 0004-0800-08 75mg bottle U4109 06/09/09 6/9/2029 0004-0800-08 75mg bottle U4065 04/22/07 4/22/2027 0004-0801-08 45mg bottle U6000-50 09/02/09 9/2/2029 0004-0801-08 45mg bottle U6001-50 09/03/09 9/3/2029 0004-0801-08 45mg bottle U6002-50 09/04/09 9/4/2029 0004-0802-08 30mg bottle U5004 09/10/09 9/10/2029 0004-0802-08 30mg bottle U5000-50 09/11/09 9/11/2029 0004-0802-08 30mg bottle U5000-51 09/11/09 9/11/2029 0004-0802-08 30mg bottle U5000-53 09/11/09 9/11/2029 0004-0802-08 30mg bottle U5001-50 09/11/09 9/11/2029 0004-0802-08 30mg bottle U5002-50 09/22/09 9/22/2029 0004-0802-08 30mg bottle U5002-51 09/22/09 9/22/2029 0004-0802-08 30mg bottle U5003 10/21/09 10/21/2029 0004-0802-08 30mg bottle B1022/01 10/22/09 10/22/2029 0004-0802-08 30mg bottle B1023/01 10/22/09 10/22/2029 0004-0802-08 30mg bottle B1024/01 10/23/09 10/23/2029 0004-0801-08 45mg bottle U6003-01 10/26/09 10/26/2029 0004-0802-08 30mg bottle U5005 12/02/09 12/2/2029 0004-0802-08 30mg bottle U5006 12/04/09 12/4/2029 Table 2: Summary of Tamiflu Lot Expiration Dates for Jurisdictional Purchases NDC Tamiflu® Description Lot Number Date of Manufacture New Expiration Date (20 years beyond date of manufacture) 0004-0800-85 75mg 650509 7/18/2011 7/18/2031 0004-0800-85 75mg 633178 6/9/2014 6/9/2034 0004-0800-06 75mg U2063 8/10/2006 8/10/2026 0004-0800-06 75mg U2064 8/15/2006 8/15/2026 0004-0800-06 75mg U2061 8/25/2006 8/25/2026 0004-0800-06 75mg U2062 8/30/2006 8/30/2026 0004-0800-06 75mg U2065 9/5/2006 9/5/2026 0004-0800-06 75mg U4019-01 9/5/2006 9/5/2026 0004-0800-06 75mg U4020 9/6/2006 9/6/2026 0004-0800-06 75mg U2066 9/6/2006 9/6/2026 0004-0800-06 75mg U4024 9/18/2006 9/18/2026 0004-0800-06 75mg U4025 9/18/2006 9/18/2026 0004-0800-06 75mg U4027 9/26/2006 9/26/2026 0004-0800-06 75mg U4029-01 10/2/2006 10/2/2026 0004-0800-06 75mg U4029-02 10/2/2006 10/2/2026 0004-0800-06 75mg U4038 11/1/2006 11/1/2026 0004-0800-06 75mg U2103 11/3/2006 11/3/2026 0004-0800-06 75mg U4039 11/6/2006 11/6/2026 0004-0800-06 75mg U4040 11/8/2006 11/8/2026 0004-0800-06 75mg U2104 11/9/2006 11/9/2026 0004-0800-06 75mg U4041 11/12/2006 11/12/2026 0004-0800-06 75mg U2106 11/13/2006 11/13/2026 0004-0800-06 75mg U4042 11/14/2006 11/14/2026 0004-0800-06 75mg B1304 11/15/2006 11/15/2026 0004-0800-06 75mg U4043 1/8/2007 1/8/2027 0004-0800-06 75mg U4044 1/10/2007 1/10/2027 0004-0800-06 75mg U4045 1/15/2007 1/15/2027 0004-0800-06 75mg U4056 2/25/2007 2/25/2027 0004-0800-06 75mg U4057 2/27/2007 2/27/2027 0004-0800-06 75mg U4058 3/5/2007 3/5/2027 0004-0800-06 75mg U2113 3/6/2007 3/6/2027 0004-0800-06 75mg U2114 3/7/2007 3/7/2027 0004-0800-06 75mg U2117 3/7/2007 3/7/2027 0004-0800-06 75mg U2115 3/13/2007 3/13/2027 0004-0800-06 75mg U2111 3/14/2007 3/14/2027 0004-0800-06 75mg U2116 4/2/2007 4/2/2027 0004-0800-06 75mg U2118 4/4/2007 4/4/2027 0004-0801-06 45mg B1004-51 11/12/2007 11/12/2027 0004-0800-06 75mg U4079 11/14/2007 11/14/2027 0004-0800-06 75mg U4080 11/15/2007 11/15/2027 0004-0800-06 75mg U4081 11/18/2007 11/18/2027 0004-0802-06 30mg B1008 1/14/2008 1/14/2028 0004-0802-06 30mg B1008-01 1/14/2008 1/14/2028 0004-0802-06 30mg B1008-02 1/14/2008 1/14/2028 0004-0800-06 75mg U4083 3/16/2008 3/16/2028 0004-0800-06 75mg U4084 3/18/2008 3/18/2028 0004-0800-06 75mg U4085 5/27/2008 5/27/2028 0004-0800-06 75mg U4086-01 5/29/2008 5/29/2028 0004-0800-06 75mg U4087-01 6/9/2008 6/9/2028 0004-0802-06 30mg B1009-50 7/15/2008 7/15/2028 0004-0800-06 75mg U4094-01 10/20/2008 10/20/2028 0004-0800-06 75mg U2119 4/5/2007 4/5/2027 0004-0800-06 75mg U409501 12/1/2008 12/1/2028 0004-0802-06 30mg B1011-01 12/8/2008 12/8/2028 0004-0800-06 75mg U4096 5/1/2009 5/1/2029 0004-0802-06 30mg B1020/01 5/13/2009 5/13/2029 0004-0801-06 45mg B1014/01 5/19/2009 5/19/2029 0004-0802-06 30mg U5000-52 9/11/2009 9/11/2029 0004-0801-06 45mg U6003 10/26/2009 10/26/2029 0004-0800-06 75mg U4132-01 11/9/2009 11/9/2029 0004-0800-06 75mg U2102 11/9/2006 11/9/2026 0004-0800-85 75mg B1181 1/2/2006 1/2/2026 0004-0800-85 75mg B1086 11/30/2004 11/30/2024 0004-0800-85 75mg B1093 11/26/2004 11/26/2024 0004-0800-85 75mg B1094 11/29/2004 11/29/2024 0004-0800-06 75mg U4029-09 10/2/2006 10/2/2026 0004-0800-06 75mg U2062 8/30/2006 8/30/2026 0004-0800-06 75mg U4082 1/31/2008 1/31/2028 0004-0802-06 30mg B1009-01 7/15/2008 7/15/2028 0004-0800-85 75mg U2058-01 8/16/2006 8/16/2026 0004-0800-85 75mg U2067-03 9/7/2006 9/7/2026 0004-0800-85 75mg U2076-01 9/25/2006 9/25/2026 0004-0800-85 75mg U2080-01 9/20/2006 9/20/2026 0004-0800-85 75mg U2085-02 10/10/2006 10/10/2026 0004-0800-85 75mg U2087-01 10/12/2006 10/12/2026 0004-0800-85 75mg U2098-01 11/1/2006 11/1/2026 0004-0800-85 75mg U2120-01 4/6/2007 4/6/2027 0004-0802-85 30mg B1000-50 7/27/2006 7/27/2026 0004-0802-85 30mg B3003-02 7/14/2009 7/14/2029 0004-0802-85 30mg B3003-02U1 7/14/2009 7/14/2029 0004-0801-85 45mg B3000-01U1 5/26/2009 5/26/2029 0004-0800-85 75mg U4060-01 4/3/2007 4/3/2027 0004-0800-85 75mg U4064-01 4/17/2007 4/17/2027 0004-0800-85 75mg U4114 6/25/2009 6/25/2029 0004-0800-85 75mg U4110-01 6/16/2009 6/16/2029 0004-0800-85 75mg U2134 7/8/2009 7/8/2029 0004-0800-85 75mg U2136-10 7/10/2009 7/10/2029 0004-0800-85 75mg U2133 7/7/2009 7/7/2029 0004-0800-85 75mg U2132 7/6/2009 7/6/2029 0004-0800-85 75mg U2135 7/9/2009 7/9/2029 0004-0800-85 75mg U2141 7/23/2009 7/23/2029 0004-0800-85 75mg U4116 8/26/2009 8/26/2029 0004-0800-85 75mg U2143-U1 11/10/2009 11/10/2029 0004-0800-08 75mg U4089-03 6/18/2008 6/18/2028 0004-00802-85 30mg 3037836 2/5/2011 2/5/2031 0004-00802-85 30mg 690003 11/14/2007 11/14/2027 0004-00800-85 75mg 3088657 9/13/2013 9/13/2033 0004-00800-85 75mg 633177 5/5/2014 5/5/2034 0004-00800-85 75mg 633184 7/22/2014 7/22/2034 0004-00800-85 75mg 636096 5/22/2012 5/22/2032 0004-00800-85 75mg 636095 5/22/2012 5/22/2032 0004-0801-85 45mg 634433 1/31/2011 1/31/2031 0004-0800-06 75mg U4021 9/7/2006 9/7/2026 0004-0800-06 75mg U4022 9/10/2006 9/10/2026 0004-0800-06 75mg U4023 9/12/2006 9/12/2026 0004-0800-06 75mg U4026 9/25/2006 9/25/2026 0004-0800-07 75mg U4019 9/5/2006 9/5/2026 0004-0800-07 75mg U4066 4/24/2007 4/24/2027 0004-0800-85 75mg U4064 4/17/2007 4/17/2027 0004-0800-06 75mg U4022C 9/10/2006 9/10/2026 00004-0801-08 45mg B1004-50 11/12/2007 11/12/2027 00004-0801-06 45mg B1008-01 7/16/2008 7/16/2028 0004-00800-85 75mg 589654U1 9/9/2013 9/9/2033 0004-00800-85 75mg 531741 11/3/2010 11/3/2030 0004-00800-06 75mg U2059 8/17/2006 8/17/2026 Table 3: Summary of Tamiflu Lot Expiration Dates for SNS-held Inventory NDC Tamiflu® Description Lot Number Date of Manufacture New Expiration Date (20 years beyond date of manufacture) 0004-0802-08 Tamiflu 30mg Capsules B1003-50 11/7/2007 11/7/2027 0004-0802-08 Tamiflu 30mg Capsules B1004-50 11/9/2007 11/9/2027 0004-0802-08 Tamiflu 30mg Capsules B1005 11/13/2007 11/13/2027 0004-0802-08 Tamiflu 30mg Capsules B1006 11/12/2007 11/12/2027 0004-0802-08 Tamiflu 30mg Capsules B1020-02 5/13/2009 5/13/2029 0004-0802-08 Tamiflu 30mg Capsules B1021/01 5/18/2009 5/18/2029 0004-0802-08 Tamiflu 30mg Capsules B1021-01 5/18/2009 5/18/2029 0004-0802-08 Tamiflu 30mg Capsules B1022/01 10/22/2009 10/22/2029 0004-0802-08 Tamiflu 30mg Capsules B1023/01 10/22/2009 10/22/2029 0004-0802-08 Tamiflu 30mg Capsules B1024/01 10/23/2009 10/23/2029 0004-0802-08 Tamiflu 30mg Capsules U5000-50 9/11/2009 9/11/2029 0004-0802-08 Tamiflu 30mg Capsules U5000-51 9/11/2009 9/11/2029 0004-0802-08 Tamiflu 30mg Capsules U5000-53 9/11/2009 9/11/2029 0004-0802-08 Tamiflu 30mg Capsules U5001-50 9/11/2009 9/11/2029 0004-0802-08 Tamiflu 30mg Capsules U5002-50 9/22/2009 9/22/2029 0004-0802-08 Tamiflu 30mg Capsules U5002-51 9/22/2009 9/22/2029 0004-0802-08 Tamiflu 30mg Capsules U5003 10/21/2009 10/21/2029 0004-0802-08 Tamiflu 30mg Capsules U5004 9/10/2009 9/10/2029 0004-0802-08 Tamiflu 30mg Capsules U5005 12/2/2009 12/2/2029 0004-0802-08 Tamiflu 30mg Capsules U5006 12/4/2009 12/4/2029 0004-0801-08 Tamiflu 45mg Capsules B1003-50 11/7/2007 11/7/2027 0004-0801-08 Tamiflu 45mg Capsules B1004 11/12/2007 11/12/2027 0004-0801-08 Tamiflu 45mg Capsules B1014-02 5/18/2009 5/18/2029 0004-0801-08 Tamiflu 45mg Capsules U6000-50 9/2/2009 9/2/2029 0004-0801-08 Tamiflu 45mg Capsules U6001-50 9/3/2009 9/3/2029 0004-0801-08 Tamiflu 45mg Capsules U6002-50 9/4/2009 9/4/2029 0004-0801-08 Tamiflu 45mg Capsules U6003-01 10/26/2009 10/26/2029 0004-0800-08 Tamiflu 75mg Capsules B110001 12/6/2004 12/6/2024 0004-0800-08 Tamiflu 75mg Capsules B1118 4/26/2005 4/26/2025 0004-0800-08 Tamiflu 75mg Capsules B1122 5/2/2005 5/2/2025 0004-0800-08 Tamiflu 75mg Capsules B1148 7/13/2005 7/13/2025 0004-0800-08 Tamiflu 75mg Capsules B1149 7/14/2005 7/14/2025 0004-0800-08 Tamiflu 75mg Capsules U2013 10/24/2005 10/24/2025 0004-0800-08 Tamiflu 75mg Capsules U2015 1/27/2006 1/27/2026 0004-0800-08 Tamiflu 75mg Capsules U2017 2/28/2006 2/28/2026 0004-0800-08 Tamiflu 75mg Capsules U2018 3/2/2006 3/2/2026 0004-0800-08 Tamiflu 75mg Capsules U2021 4/11/2006 4/11/2026 0004-0800-08 Tamiflu 75mg Capsules U2022 4/28/2006 4/28/2026 0004-0800-08 Tamiflu 75mg Capsules U2025 5/5/2006 5/5/2026 0004-0800-08 Tamiflu 75mg Capsules U2026 5/8/2006 5/8/2026 0004-0800-08 Tamiflu 75mg Capsules U2027 5/11/2006 5/11/2026 0004-0800-08 Tamiflu 75mg Capsules U2030 6/5/2006 6/5/2026 0004-0800-08 Tamiflu 75mg Capsules U2034 6/15/2006 6/15/2026 0004-0800-08 Tamiflu 75mg Capsules U2038 6/15/2006 6/15/2026 0004-0800-08 Tamiflu 75mg Capsules U2039 7/13/2006 7/13/2026 0004-0800-08 Tamiflu 75mg Capsules U2040 7/17/2006 7/17/2026 0004-0800-08 Tamiflu 75mg Capsules U2041 7/18/2006 7/18/2026 0004-0800-08 Tamiflu 75mg Capsules U2042 7/19/2006 7/19/2026 0004-0800-08 Tamiflu 75mg Capsules U2043 7/19/2006 7/19/2026 0004-0800-08 Tamiflu 75mg Capsules U2044 7/21/2006 7/21/2026 0004-0800-08 Tamiflu 75mg Capsules U2045 7/26/2006 7/26/2026 0004-0800-08 Tamiflu 75mg Capsules U2046 7/31/2006 7/31/2026 0004-0800-08 Tamiflu 75mg Capsules U2047 8/1/2006 8/1/2026 0004-0800-08 Tamiflu 75mg Capsules U2048 8/2/2006 8/2/2026 0004-0800-08 Tamiflu 75mg Capsules U2049 8/2/2006 8/2/2026 0004-0800-08 Tamiflu 75mg Capsules U2050 8/3/2006 8/3/2026 0004-0800-08 Tamiflu 75mg Capsules U2051 8/4/2006 8/4/2026 0004-0800-08 Tamiflu 75mg Capsules U2052 8/7/2006 8/7/2026 0004-0800-08 Tamiflu 75mg Capsules U2053 8/8/2006 8/8/2026 0004-0800-08 Tamiflu 75mg Capsules U2088 10/17/2006 10/17/2026 0004-0800-08 Tamiflu 75mg Capsules U2089 10/18/2006 10/18/2026 0004-0800-08 Tamiflu 75mg Capsules U2090-01 10/19/2006 10/19/2026 0004-0800-08 Tamiflu 75mg Capsules U2091 10/20/2006 10/20/2026 0004-0800-08 Tamiflu 75mg Capsules U2092 10/20/2006 10/20/2026 0004-0800-08 Tamiflu 75mg Capsules U2093 10/25/2006 10/25/2026 0004-0800-08 Tamiflu 75mg Capsules U2094 10/26/2006 10/26/2026 0004-0800-08 Tamiflu 75mg Capsules U2121-50 5/11/2009 5/11/2029 0004-0800-08 Tamiflu 75mg Capsules U2122-50 5/13/2009 5/13/2029 0004-0800-08 Tamiflu 75mg Capsules U2123 5/14/2009 5/14/2029 0004-0800-08 Tamiflu 75mg Capsules U2124 5/15/2009 5/15/2029 0004-0800-08 Tamiflu 75mg Capsules U2125 5/18/2009 5/18/2029 0004-0800-08 Tamiflu 75mg Capsules U2126 5/20/2009 5/20/2029 0004-0800-08 Tamiflu 75mg Capsules U2127 5/21/2009 5/21/2029 0004-0800-08 Tamiflu 75mg Capsules U2128 5/26/2009 5/26/2029 0004-0800-08 Tamiflu 75mg Capsules U2129 5/27/2009 5/27/2029 0004-0800-08 Tamiflu 75mg Capsules U2130 5/28/2009 5/28/2029 0004-0800-08 Tamiflu 75mg Capsules U2131 5/28/2009 5/28/2029 0004-0800-08 Tamiflu 75mg Capsules U300050 5/11/2007 5/11/2027 0004-0800-08 Tamiflu 75mg Capsules U3001 5/14/2007 5/14/2027 0004-0800-08 Tamiflu 75mg Capsules U3002 5/16/2007 5/16/2027 0004-0800-08 Tamiflu 75mg Capsules U400150 5/9/2006 5/9/2026 0004-0800-08 Tamiflu 75mg Capsules U400250 5/11/2006 5/11/2026 0004-0800-08 Tamiflu 75mg Capsules U4004 7/24/2006 7/24/2026 0004-0800-08 Tamiflu 75mg Capsules U4005 7/27/2006 7/27/2026 0004-0800-08 Tamiflu 75mg Capsules U4006 8/1/2006 8/1/2026 0004-0800-08 Tamiflu 75mg Capsules U4007 8/3/2006 8/3/2026 0004-0800-08 Tamiflu 75mg Capsules U400810 8/5/2006 8/5/2026 0004-0800-08 Tamiflu 75mg Capsules U400850 8/5/2006 8/5/2026 0004-0800-08 Tamiflu 75mg Capsules U4009 8/8/2006 8/8/2026 0004-0800-08 Tamiflu 75mg Capsules U4010 8/10/2006 8/10/2026 0004-0800-08 Tamiflu 75mg Capsules U4011 8/12/2006 8/12/2026 0004-0800-08 Tamiflu 75mg Capsules U4012 8/16/2006 8/16/2026 0004-0800-08 Tamiflu 75mg Capsules U4013 8/18/2006 8/18/2026 0004-0800-08 Tamiflu 75mg Capsules U4014 8/21/2006 8/21/2026 0004-0800-08 Tamiflu 75mg Capsules U4015 8/23/2006 8/23/2026 0004-0800-08 Tamiflu 75mg Capsules U401650 8/25/2006 8/25/2026 0004-0800-08 Tamiflu 75mg Capsules U4017 8/29/2006 8/29/2026 0004-0800-08 Tamiflu 75mg Capsules U403001 10/3/2006 10/3/2026 0004-0800-08 Tamiflu 75mg Capsules U4031-01 10/8/2006 10/8/2026 0004-0800-08 Tamiflu 75mg Capsules U4032-01 10/10/2006 10/10/2026 0004-0800-08 Tamiflu 75mg Capsules U4033-01 10/16/2006 10/16/2026 0004-0800-08 Tamiflu 75mg Capsules U4034-01 10/18/2006 10/18/2026 0004-0800-08 Tamiflu 75mg Capsules U4035-01 10/23/2006 10/23/2026 0004-0800-08 Tamiflu 75mg Capsules U4036-01 10/25/2006 10/25/2026 0004-0800-08 Tamiflu 75mg Capsules U4037-01 10/30/2006 10/30/2026 0004-0800-08 Tamiflu 75mg Capsules U4046 1/16/2007 1/16/2027 0004-0800-08 Tamiflu 75mg Capsules U4047 1/22/2007 1/22/2027 0004-0800-08 Tamiflu 75mg Capsules U4048 1/24/2007 1/24/2027 0004-0800-08 Tamiflu 75mg Capsules U4049 1/28/2007 1/28/2027 0004-0800-08 Tamiflu 75mg Capsules U4050 1/28/2007 1/28/2027 0004-0800-08 Tamiflu 75mg Capsules U4051 2/5/2007 2/5/2027 0004-0800-08 Tamiflu 75mg Capsules U4052 2/7/2007 2/7/2027 0004-0800-08 Tamiflu 75mg Capsules U4053 2/11/2007 2/11/2027 0004-0800-08 Tamiflu 75mg Capsules U4055 2/20/2007 2/20/2027 0004-0800-08 Tamiflu 75mg Capsules U4067 8/6/2007 8/6/2027 0004-0800-08 Tamiflu 75mg Capsules U4068 8/8/2007 8/8/2027 0004-0800-08 Tamiflu 75mg Capsules U4069 9/10/2007 9/10/2027 0004-0800-08 Tamiflu 75mg Capsules U4070 9/13/2007 9/13/2027 0004-0800-08 Tamiflu 75mg Capsules U4072 9/19/2007 9/19/2027 0004-0800-08 Tamiflu 75mg Capsules U4073 9/24/2007 9/24/2027 0004-0800-08 Tamiflu 75mg Capsules U4075 11/5/2007 11/5/2027 0004-0800-08 Tamiflu 75mg Capsules U407601 11/7/2007 11/7/2027 0004-0800-08 Tamiflu 75mg Capsules U4077 11/9/2007 11/9/2027 0004-0800-08 Tamiflu 75mg Capsules U4078 11/12/2007 11/12/2027 0004-0800-08 Tamiflu 75mg Capsules U4097 5/3/2009 5/3/2029 0004-0800-08 Tamiflu 75mg Capsules U4098 5/5/2009 5/5/2029 0004-0800-08 Tamiflu 75mg Capsules U4099 5/7/2009 5/7/2029 0004-0800-08 Tamiflu 75mg Capsules U4100 5/11/2009 5/11/2029 0004-0800-08 Tamiflu 75mg Capsules U4101 5/13/2009 5/13/2029 0004-0800-08 Tamiflu 75mg Capsules U4102 5/18/2009 5/18/2029 0004-0800-08 Tamiflu 75mg Capsules U4103 5/20/2009 5/20/2029 0004-0800-08 Tamiflu 75mg Capsules U4104 5/22/2009 5/22/2029 0004-0800-08 Tamiflu 75mg Capsules U4105 5/27/2009 5/27/2029 0004-0800-08 Tamiflu 75mg Capsules U4106 5/29/2009 5/29/2029 0004-0800-08 Tamiflu 75mg Capsules U4107 6/2/2009 6/2/2029 0004-0800-08 Tamiflu 75mg Capsules U4108 6/5/2009 6/5/2029 0004-0800-08 Tamiflu 75mg Capsules U4109 6/9/2009 6/9/2029 0004-0800-85 Tamiflu 75mg Capsules (Blister Pack) U2133 7/7/2009 7/7/2029 0004-0800-85 Tamiflu 75mg Capsules (Blister Pack) U2134 7/8/2009 7/8/2029 0004-0800-85 Tamiflu 75mg Capsules (Blister Pack) U2135 7/9/2009 7/9/2029 Note: Certain lots in this spreadsheet have undergone SLEP testing. For such lots, the SNS has applied the dating that provides the longer use period (i.e., the later new use date). SNS Right-Nav Strategic National Stockpile About the SNS Who We Are Steve Adams, MPH Lisa Dillard Stockpile Products CHEMPACK Federal Medical Stations Personal Protective Equipment (PPE) Ventilators Sustaining the Stockpile Emergency Preparedness and Response Mpox COVID-19 Influenza Requesting SNS Assets Response History Inventory Management and Tracking System Training and Exercise Support SNS Course Listing Federal Medical Stations Preparing Global Responders Watch Us in Action Watch SNS Videos SNS in Pictures Home Contact Us ASPR Archive Accessibility Privacy Policies Disclaimer HHS Viewers & Players HHS Plain Language FOIA Vulnerability Disclosure Policy HHS, Administration for Strategic Preparedness and Response (ASPR) 200 Independence Ave., Washington, DC 20201Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site | Nature Communications Skip to main content Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement View all journals Search Log in Explore content About the journal Publish with us Sign up for alerts RSS feed nature nature communications articles article Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site Download PDF Download PDF Article Open access Published: 21 December 2022 Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site Daniel Stadlbauer ORCID: orcid.org/0000-0001-6792-76501, Meagan McMahon ORCID: orcid.org/0000-0002-7450-66241, Hannah L. Turner2, Xueyong Zhu ORCID: orcid.org/0000-0002-6021-37402, Hongquan Wan ORCID: orcid.org/0000-0002-6374-03433, Juan Manuel Carreño1, George O’Dell1, Shirin Strohmeier1,4, Zain Khalil5, Marta Luksza5,6, Harm van Bakel ORCID: orcid.org/0000-0002-1376-69165,7, Viviana Simon ORCID: orcid.org/0000-0002-6416-50961,8,9,10,11, Ali H. Ellebedy ORCID: orcid.org/0000-0002-6129-253212, Ian A. Wilson ORCID: orcid.org/0000-0002-6469-24192,13, Andrew B. Ward ORCID: orcid.org/0000-0001-7153-37692 & …Florian Krammer ORCID: orcid.org/0000-0003-4121-776X1,9,10 Show authors Nature Communications volume 13, Article number: 7864 (2022) Cite this article 4348 Accesses 8 Citations 10 Altmetric Metrics details Subjects AntibodiesInfluenza virus AbstractContemporary influenza A H3N2 viruses circulating since 2016 have acquired a glycosylation site in the neuraminidase in close proximity to the enzymatic active site. Here, we investigate if this S245N glycosylation site, as a result of antigenic evolution, can impact binding and function of human monoclonal antibodies that target the conserved active site. While we find that a reduction in the inhibitory ability of neuraminidase active site binders is measurable, this class of broadly reactive monoclonal antibodies maintains protective efficacy in vivo. Similar content being viewed by others A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases Article Open access 03 November 2022 A pan-influenza antibody inhibiting neuraminidase via receptor mimicry Article Open access 31 May 2023 Antigenic comparison of the neuraminidases from recent influenza A vaccine viruses and 2019–2020 circulating strains Article Open access 14 July 2022 IntroductionH1N1, H3N2, and type B seasonal influenza viruses cause a large number of infections and deaths annually1. Typically, influenza seasons that are dominated by H3N2 viruses are worse in terms of disease outcome, number of hospitalizations, and are especially concerning for at-risk populations such as the elderly or younger children2. In recent years, matching the H3N2 vaccine component to actual circulating H3N2 viruses has been particularly challenging due to the occurrence of mutations in the hemagglutinin (HA) during the vaccine production process in eggs3,4 and the emergence of genetically different co-circulating H3N2 clades5. In addition, the introduction of an N-linked glycosylation site at residue 245 of the neuraminidase (NA) contributed to antigenic drift6 and resulted in the blocking of monoclonal and human serum NA-specific antibodies7. Therefore, broadly protective, universal influenza vaccines8 or improved classical seasonal vaccine formulations are urgently needed9. Such efforts are informed by the structural and functional characterization of antibodies that target broadly neutralizing epitopes on the influenza virus NA. A double mutation in the NA of influenza A H3N2 viruses, which leads to changes in amino acids at positions 245 and 247, was first detected in 2014 and, by 2016/17, almost all circulating H3N2 viruses in humans carried these mutations that introduced an N-glycosylation site at Asn245, as mentioned above6. These mutations have become fixed in circulating H3N2 viruses and the introduced glycan might then contribute to the shielding of certain epitopes.Here, we test three previously described broadly protective influenza virus NA monoclonal antibodies (mAbs)10 against a panel of H3N2 viruses, including influenza virus vaccine strains and clinical H3N2 isolates (Fig. 1A and Supplementary Fig. 1). We show, that a reduction in the inhibitory ability of these mAb active site binders is measurable against viruses harboring the Asn245 glycosylation site but that this class of broadly reactive antibodies maintains protective efficacy in vivo.Fig. 1: Phylogenetic tree of N2 NA of H3N2 viruses and functional characterization of NA-specific antibodies.A Phylogenetic tree of N2 NAs. The scale bar represents a 1% change in nucleotides. The tree was built using nucleotide sequences in ClustalOmega and visualized in FigTree. Vaccine virus strains and other strains tested in this study are indicated. The H3N2 clade (based on HA), the amino acid residues at position 245–247, and all predicted potential glycosylation sites are shown. B Scale bar for the IC50 in μg/ml of viruses tested as shown in the heatmap. C Heatmap of IC50 of three NA antibodies and irrelevant IgG control mAb. IC50 values shown were measured in ELLAs except for viruses A/New York City/PV00033/2017 and A/New York City/PV00077/2017, were the inhibitory concentrations were determined in an NA-Star assay because of low NA activity in the ELLA. The antibodies were tested against the viruses in duplicate and the average of the two measurements was used to calculate the IC50 values depicted. D Weight loss curves of DBA/2 J mice challenged with reassortant H6N2 viruses. The data are presented as the mean of the group (n = 5 per group, except for the middle panel where the n in the irrelevant control IgG group was 4) with error bars indicating the standard error of the mean. Percent survival upon virus challenge is indicated in parenthesis and the dashed line represents 75% of the initial body weight, which was defined as the humane endpoint. The experiment was performed once. Source data are provided as a Source Data file.Full size imageResultsEnzymatic-site targeting mAbs recognize and inhibit drifted N2 NAWe found that the three NA mAbs could bind to recombinant N2 NAs (produced in the baculovirus system) of three recent influenza virus vaccine strains that harbor the S245N glycosylation site in enzyme-linked immunosorbent assays (ELISAs) (Supplementary Fig. 2) and that the antibodies can inhibit the NA enzymatic activity of vaccine strain viruses (grown in eggs) as measured in enzyme-linked lectin assays (ELLAs) (Fig. 1C, Supplementary Fig. 2, and Source Data file). Further, the three antibodies inhibited, to different extents, the NA activity of various clinical H3N2 virus isolates (grown in cell culture) that were cultured from nasopharyngeal swab specimen obtained from patients seeking care at the Mount Sinai Hospital in the years 2017 to 2019 (Fig. 1C). Here we selected antigenically distinct clinical virus isolates based on the N2 neuraminidase sequence for testing to cover a broad range of circulating H3N2 viruses. The 50% inhibitory concentration (IC50) values of the antibodies tested against viruses without the glycan [A/Hong Kong/4801/2014 (Hong Kong14) and A/New York City/PV00077/2017] were lower (0.01-0.69 ug/mL)) compared to viruses that harbor the glycan (0.60–35.62 ug/mL). Antibody 1E01 had the lowest IC50 across the viruses tested, followed by 1G01, which was previously shown to be the most cross-reactive of the three antibodies, and 1G04 (Fig. 1C). Interestingly, in some cases, differences between mAbs become apparent only in the NI assay but not in the ELISA. This could be due to differences in glycan size between recombinant proteins produced in insect cells and viruses grown in cells or embryonated eggs11.1G01-like mAbs maintain in vivo protection against drifted N2 NANext, we investigated the protective efficacy of the antibodies in passive transfer and viral challenge experiments in DBA/2 J mice using reassortant viruses that all contain the same avian H6 HA but different N2 NAs. The first virus carried the wild-type N2 NA of the Hong Kong14 virus (no glycan at position 245). The second virus expressed the Hong Kong14 N2 NA but with amino acid changes at positions 245 (S245N) and 247 (S247T) that introduce a glycosylation site and a change at some distance from the catalytic active site at position 267 (T267K) that is also present in the N2 NA of A/Singapore/INFIMH-16-0019/2016 (Singapore16). The third virus was an H6 reassortant virus with the N2 NA of Singapore16 that harbors the glycosylation site naturally6. To confirm the presence of the additional glycan on the Singapore16 N2 NA expressing virus grown in eggs or cell culture, peptide:N-glycosidase F (PNGaseF) treatment followed by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting was performed (Supplementary Fig. 3). The SDS-PAGE indicates the presence of an additional glycosylation site on the Singapore16 N2 NA when compared to the Hong Kong14 N2 NA, and PNGaseG treatment removes glycans allowing the NA proteins to run at the same size on the SDS-PAGE. These differences in glycosylation sites are similar to those previously shown by others6,12.The three antibodies were given intraperitoneally at a concentration of 5 mg/kg 2 h prior to challenge and conferred full protection against morbidity (Hong Kong14 virus without or with artificially introduced 245 glycosylation site) or mortality (Singapore16 virus with glycosylation site) (Fig. 1D) compared to the control groups. Interestingly, the functional capacity of the antibodies in vitro in ELLAs displayed stark differences between the viruses with or without the glycan (Supplementary Fig. 4) that were not recapitulated in the mouse model. This finding could be explained by the contribution of Fc-effector functions, such as antibody-dependent cellular cytotoxicity (ADCC) or antibody-dependent cellular phagocytosis (ADCP), to protective efficacy in vivo, by differences in how the epitope is displayed in the respective test system, or could indicate that only very low neuraminidase inhibition (NI) activity is needed for protection in vivo. Furthermore, the glycan at NA Asn245 has been shown to reduce NA enzymatic activity7. The reduced activity is controlled for in the in vitro experiments to measure IC50s; however, reduced NA activity in the in vivo experiments might be another reason for the discordance of measured IC50s and in vivo protective effects.Structural characterization of the mAb-drifted N2 interactionTo illustrate the location of the glycan in the context of the antigen–antibody interaction, we modeled the complex of the Singapore16 N2 NA with the antibody binding fragment (Fab) of 1G01. Based on the modeling results in combination with the binding, NI and protection data, we concluded that 1G01 is still able to bind to Singapore16 N2 NA with the additional Asn245 glycosylation (Fig. 2A), although the glycan attached at NA Asn245 could potentially form transient interactions with 1G01. As a control, we also modeled the complex of the Hong Kong14 N2 NA with 1G01 Fab (Fig. 2A), where the only difference in the 1G01 epitope was at N245 and T247 that encodes the 245 glycosylation site in Singapore16 N2 NA as compared to S245 and S247 in Hong Kong14 N2 NA. Similarly, antibodies 1E01 and 1G04 also appear able to bind Singapore16 N2 NA with the additional Asn245 glycosylation (Supplementary Fig. 5). Further, we confirmed the modeling results by performing negative-stain electron microscopy (nsEM) studies (Fig. 2B and Supplementary Fig. 6). Examination of 2D class averages from the nsEM images for complexes of Singapore16 N2 NA with Fabs 1G01, 1G04, or 1E01 showed that one Fab bound to the active site of each N2 NA protomer (i.e., four Fabs per NA tetramer) (Fig. 2B). In 3D reconstructions, antibodies 1G01, 1G04, and 1E01 were found to bind to Singapore16 N2 NA in a similar manner to binding to N1 NA from A/California/04/2009 (H1N1) (Cali04), Hunan16 N9 NA from A/Hunan/02650/2016 (H7N9) (Hunan16), and N2 NA from A/Japan/305/1957 (H2N2) (Japan57)10, respectively, in which the 1G01, 1G04, and 1E01 epitopes consisted mostly of conserved active site residues of the NAs (Fig. 2B). Sequence comparison of the 1E01 epitope in Japan57 N2 NA, as well as the 1G01 epitope in Cali04 N1 NA and the 1G04 epitope in Hunan16 N9 NA, with Hong Kong14 N2 NA and Singapore16 N2 NA indicated that the their epitopes are quite conserved in these N2 NAs (Supplementary Figs. 7, 8, 9). Notwithstanding, the epitope differences between these three antibodies to N2 NA (Supplementary Figs. 7, 8, 9), the potential different angles of the approach of these antibodies to N2 NA (Supplementary Fig. 10), as well as the sequence differences between these antibodies10, may contribute to the differences in their binding to NA and NA inhibition efficacy (Fig. 1 and Supplementary Figs. 1, 2, 4).Fig. 2: Model of the complex of Singapore16 and Hong Kong14 N2 NAs with 1G01 Fab and negative-stain electron microscopy of antibodies 1G01, 1G04, and 1E01 bound to Singapore16 N2 NA.A The Singapore16 N2 NA was modeled with a mannose-9 glycan at Asn245. The 1G01 Fab is able to interact with the N2 NA (left). The glycan can be accommodated without steric clash with the 1G01 Fab. A model of the interaction of 1G01 Fab to Hong Kong14 N2 NA is also shown (right). NA protomers are colored green. Asn245 and attached glycans, as well as the ten residues that are not conserved between these two N2 NAs in their ectodomain (82–469) are shown in sticks and colored with yellow carbon, red oxygen and blue nitrogen atoms. The 1G01 Fab is colored brown (heavy chain) and gray (light chain). B Two-dimensional class averages of Singapore16 N2 NA in complex with 1G01, 1G04, and 1E01 Fabs (Top). Standard view (middle) and side view (bottom) of three-dimensional reconstruction of negative-stain EM maps of Singapore16 N2 NA tetramer (center, in green) in complex with four 1G01 Fabs (in orange), four 1G04 Fabs (in yellow), and 1E01 Fabs (in cyan), respectively (densities with a dimple on the periphery). The crystal structures of 1G01 Fab (PDB code 6Q23), 1G04 Fab (PDB code 6Q1Z), and 1E01 Fab (PDB code 6Q20) and the Singapore16 N2 NA tetramer model were docked into the reconstruction, respectively, and the Fabs were adjusted individually to best fit the EM density.Full size imageDiscussionIn summary, we demonstrate that broadly protective human antibodies that target the active site of the influenza virus NA can maintain binding, functionality, and protective efficacy against contemporary H3N2 viruses with an S245N glycosylation site. In previous studies, antigenic drift was observed in the NAs of recent viruses with a reduction in NI titers of human sera against these NAs and a loss of in vivo protection in passive transfer studies; substantially reduced binding of NA-specific mAbs was also demonstrated6. However, the introduction of the S245N glycan into the N2 NA did not prevent the binding of 1G01 and 1G01-like mAbs that directly target the NA active site, as confirmed by electron microscopy. Of note, NI activity of human polyclonal serum was also not completely abrogated, although significantly reduced, in earlier studies, perhaps suggesting the presence of 1G01-like antibodies in serum that maintain activity. Of course, the inhibiting antibody response to NA is not restricted to the active site and antibodies to other epitopes may contribute to this residual activity. Our findings showing the continued activity of 1G01-like antibodies against drifted N2 NA, in combination with the exclusive breadth across NA subtypes, further highlight the value of these particular antibodies as possible prophylactic or therapeutic agents. In addition, developing vaccines that can elicit 1G01-like antibodies would allow for protection against drifted viruses and broad protection in general.MethodsOur research conforms to all ethical regulations. Specifically, animal experiments were conducted in compliance with protocols approved by the Icahn School of Medicine at Mount Sinai’s Institutional Animal Care and Use Committee.Cells, proteins, and virusesMadin Darby canine kidney (MDCK, source ATCC) cells were grown in Dulbecco’s modified Eagle’s medium (DMEM; Gibco) containing FBS (fetal bovine serum, 10%; Corning) and penicillin–streptomycin antibiotics mix (pen-strep antibiotics mix, 100 μg/mL streptomycin, 100 U/mL of penicillin; Gibco) resulting in complete DMEM (cDMEM). Human embryonic kidney (HEK) cells (293 T, source ATCC) were grown and maintained in cDMEM. HEK 293 F cells (Thermo Fisher) were grown in Expi293 Expression medium (Gibco). BTI-TN−5B1- 4 cells (Trichoplusia ni, source Vienna Institute of Biotechnology, University of Natural Resources and Life Sciences) were grown in serum-free SFX medium (HyClone) supplemented with pen-strep antibiotics mix . Sf9 cells (Spodoptera frugiperda, source Vienna Institute of Biotechnology, University of Natural Resources and Life Sciences) were maintained in TNM-FH medium (Gemini Bio-Products) in the presence of pen-strep antibiotics mix and 10% FBS. Vaccine strains and reassortant viruses were grown in 8–10-day-old embryonated chicken eggs (Charles River Laboratories) at 37 °C (influenza A viruses) for 2 days. Virus reassortants used in this study were rescued by plasmid-based reverse genetic techniques as previously described in refs. 6, 13. All reassortant viruses bear the internal genes from A/Puerto Rico/8/1934 H1N1. Primary virus isolates were obtained from discarded nasopharyngeal specimens that tested positive for influenza virus infection. Briefly, specimens were pre-diluted in infection media consisting of Minimum Essential Media (Gibco) supplemented with 1 µg/ml of tosylsulfonyl phenylalanyl chloromethyl ketone (TPCK)-treated trypsin (Gibco) and added to 90% confluent MDCK cell-monolayers. Infections were let to proceed for 1 h with intermittent shaking. The inoculum was removed and infection media was added. Plates were incubated at 37 °C with 5% CO2 and supernatants were collected at 24–48 hpi when a cytopathic effect was detected. Samples were cleared by centrifugation at 4300 × g for 5 min and aliquoted through 0.22 µm pore size membrane filters (Millipore). Supernatants were stored at −80 °C until further use and viruses were sequenced after culture. To purify viruses for binding assays, viruses were grown in eggs or in cell culture and purified over a 30% sucrose cushion.Recombinant proteins were expressed in the baculovirus expression system as previously described in detail in ref. 14. All NAs were expressed as ectodomains with an N-terminal vasodilator-stimulated phosphoprotein (VASP) tetramerization domain and a hexahistidine tag for purification.Monoclonal antibody generation and purificationHeavy and light chain plasmids were co-transfected into Expi293F cells for expression and antibodies were purified via sepharose G columns (GE Healthcare)10. The antibody sequences have been uploaded on GenBank (accession numbers: MN013068 (1G01 VH), MN013072 (1G01 Vκ), MN013070 (1E01 VH) MN013070 (1E01 Vκ), MN013069 (1G04 VH), and MN013073 (1G04 Vκ). The heavy and light chain plasmids of an irrelevant human IgG control monoclonal antibody were co-transfected and purified similarly.Enzyme-linked immunosorbent assayMicrotiter 96-well plates (Thermo Fisher) were coated with 50 μL recombinant NA at a concentration of 2 μg/mL in phosphate-buffered saline (PBS; Gibco) at 4 °C overnight. The following day, 220 μL blocking solution (PBS (Gibco) supplemented with 0.1% Tween 20 (Fisher Scientific), 3% goat serum (Life Technologies), and 0.5% milk powder (American-Bio)) was added to all wells and the plates were incubated for 1 h at room temperature. The antibodies were diluted to a starting concentration of 30 μg/mL, serially diluted 1:3 in blocking solution, and incubated for 2 h in a room temperature incubator. The microtiter plates were washed three times with T-PBS (PBS (Gibco) supplemented with 0.1% Tween 20 (Fisher Scientific)) and 50 μL goat anti-human IgG (Fab specific) horseradish peroxidase antibody (HRP; Sigma, #A0293) diluted 1:3000 in blocking solution was added to all wells and incubated for 1 h at room temperature. The plates were washed four times with shaking and 100 μL SigmaFast o-phenylenediamine dihydrochloride (OPD; Sigma) was added to all wells. After 10 min, the reaction was stopped with 50 μL 3 M hydrochloric acid (Thermo Fisher) and the plates were read at a wavelength of 490 nm with a plate reader (BioTek). The data were analyzed in Microsoft Excel and GraphPad Prism 7. The data were visualized as binding curves by applying a nonlinear fit.Enzyme-linked lectin assayNinety-six-well microtiter plates (Thermo Fisher) were coated with 100 μL/well fetuin (Sigma) at a concentration of 25 μg/mL in PBS at 4 °C overnight. To determine the amount of virus to use in the assay, the viruses were serially diluted twofold in sample diluent (PBS (Gibco) with 0.9 mM CaCl2 and 0.5 mM MgCl2 supplemented with 1% bovine serum albumin (MP Biomedicals) and 0.5% Tween 20 (Fisher Scientific)) in cell culture 96-well plates. The fetuin plates were washed three times with T-PBS and 100 ul of the diluted viruses transferred into the fetuin plates. The plates were incubated for 18 h at 37 °C and washed three times with T-PBS and HRP-conjugated peanut agglutinin (PNA) in PBS was added (100 ul/well) to the plates. The plates were incubated at RT for 2 h and washed four times with shaking and developed with SigmaFast OPD. Absorbance was read at 490 nm on a microplate reader. The data were analyzed using GraphPad Prism 8 and the 50% effective concentration (EC50) was calculated based on four-parameter nonlinear regression. The dilution of the virus that resulted in 2x the EC50 was chosen for the subsequent NA inhibition assay.To measure the inhibitory concentration of the antibodies, the antibodies were serially diluted in sample diluent (starting concentration 30 ug/ml) and incubated for 18 h at 37 °C with an equal volume (50 ul) of the selected virus dilution in the fetuin-coated plates. The remainder of the assay was performed as described above. One column on the plate contained sample diluent without antibodies and served as a positive (virus-only) control. Another column contained sample diluent only (no virus) and served as negative (background) control. Data were analyzed in GraphPad Prism 8 and the 50% inhibitory concentration (IC50) was calculated based on nonlinear regression using a four-parameter curve fit.NA-Star assayThe NA-Star assay was performed for viruses that had low NA activity in the ELLA. The NA-Star can measure NA activity with higher sensitivity. The antibodies tested in the present study target the NA active site directly, which makes it possible to use the NA-Star assay for the determination of NAI. Typically, the NA-Star kit is used to detect resistance to neuraminidase inhibitors (e.g. small molecules). The NA-Star Influenza Neuraminidase Inhibitor Resistance Detection Kit (Applied Biosystems) was used according to the manufacturer’s protocol. In brief, the antibodies were diluted to a concentration of 30 ug/ml, serially diluted twofold in assay buffer, and 25 ul transferred to a white 96-well cell culture plate. Twenty-five ul of virus diluted to 2xEC50 (as determined in prior assays testing the respective viruses in the absence of antibodies) was added to each well and the plates were incubated for 20 min at 37 °C with shaking. The NA-Star substrate was prepared immediately before use and 10 ul/well was added to all wells. The plates were incubated for 30 min at RT and 60 ul/well of NA-Star accelerator solution was added shortly before reading the plates using a microtiter plate reader (BioTek). The data were analyzed in GraphPad Prism 8 and the inhibition curves were plotted.PNGaseF treatment, SDS-PAGE, and Western blotPurified viruses were treated using the PNGaseF kit (NEB) according to the manufacturer’s instructions. The samples were then treated with 4X-Laemli buffer (Bio-Rad) containing beta-mercaptoethanol (BME) and heated at 100 °C for 5 min. Approximately 1 ug purified virus was added to each lane on a 7.5% Mini-PROTEAN® TGX™ precast protein gel (Bio-Rad) and run for 5.5 h at 25 V. After electrophoresis, the proteins were transferred to a nitrocellulose membrane using the iBlot transfer and stack device (Invitrogen) at 20 V for 7 min. The membranes were blocked in 5% nonfat dry milk (Bio-Rad) in PBS-T (0.5%) for 1 h at room temperature with shaking. The blocking solution was removed and anti-N2 guinea pig antisera (generated in-house by vaccinating guinea pigs intramuscularly with Hong Kong14 N2 recombinant protein) diluted 1:2000 in PBS supplemented with 1% (w/v) BSA was added. The membranes were incubated overnight and washed three times with PBS-T. The following day, a donkey anti-guinea pig IgG-horseradish peroxidase conjugate (IgG-HRP; EMD Millipore, AP193P) was added for 1 h at room temperature and the membranes were washed. The membranes were developed by adding ECL prime and incubated for 5 min. The developed blot membranes were visualized by scanning using an ImageScanner III imager with accompanying LabScan software (GE Healthcare).Passive transfer experiments in miceAnimal experiments were conducted in compliance with protocols approved by the Icahn School of Medicine at Mount Sinai’s Institutional Animal Care and Use Committee. Mice were housed in a facility with a 12 h light/dark cycle, room temperature, relative humidity between 20 and 30% and access to food ad libitum. Passive transfer experiments to test the prophylactic efficacy of the mAbs were performed as described earlier10. In brief, 6–8 weeks-old female DBA/2 J mice (n = 5 mice/group except for Fig. 1D in the middle panel in the irrelevant IgG control where n = 4; mice were sourced from The Jackson Laboratory) were given antibody 1G01, 1E01, and 1G04 at a concentration of 5 mg/kg or an irrelevant human IgG control antibody at the same dose intraperitoneally in a volume of 100 ul. Two hours post transfer, the mice were anesthetized with a ketamine-xylazine-water mixture (0.15 mg ketamine/kg and 0.03 mg/kg xylazine of body weight; 100 μl intraperitoneally) and challenged intranasally with 10 × the 50% mouse lethal dose (mLD50) of the respective challenge virus. H6N2 reassortant viruses were used in this study because of their ability to cause disease in the DBA/2 J mouse model. Weight loss was monitored daily for 14 days and the humane endpoint was defined as a loss of 25% of the initial day 0 body weight. The data were recorded in Microsoft Excel and the weight loss and survival graphs were visualized in GraphPad Prism 8.Modeling of Singapore16 and Hong Kong14 N2 NAs in complex with 1G01 FabThe head domains of N2 NAs (residues 82–469) from A/Singapore/INFIMH-16-0019/2016 (H3N2) (Singapore16 N2, GISAID14 accession number EPI810155) and A/Hong Kong/4801/2014 (H3N2) (Hong Kong14 N2, GISAID accession number EPI675797) were modeled by MODELER15 using a crystal structure of the N2 NA from A/Tanzania/205/2010 (H3N2) (PDB ID 4GZO, 2.6 Å resolution16) as a template, with which Singapore16 N2 NA and Hong Kong14 N2 NA share 97.4 and 98.5% amino acid identity, respectively. A model of the complex between Singapore N2 NA and 1G01 Fab was constructed in Coot17 using the crystal structure of the N1 NA from A/California/04/2009 (H1N1) (Cali04 N1) in complex with 1G01 (PDB ID 6Q23, 3.27 Å resolution10) as a template by superimposing the model of Singapore N2 NA to the Cali04 N1 NA; a mannose-9 glycan was modeled at Asn245 for illustration, although the glycosylation type (high mannose or complex) is not known. A model of the complex between Hong Kong14 N2 NA and 1G01 Fab was also constructed in Coot17 as above by superimposing the model of Hong Kong14 N2 NA to the Cali04 N1 NA. Furthermore, models of the complexes between Singapore16 N2 NA and 1E01 or 1G04 Fabs were also constructed in Coot17 as above using the crystal structures of 1E01 Fab with N2 NA from A/Japan/305/1957 (H2N2) (Japan57, PDB ID 6Q20, 2.45 Å resolution10) and 1G04 Fab with N9 NA from A/Hunan/02650/2016 (H7N9) (Hunan16, PDB ID 6Q1Z, 3.45 Å resolution10), respectively.Negative stain electron microscopy studies of Singapore16 N2 in complex with broadly-protective anti-NA antibodies 1G01, 1G04, and 1E01The head domain of the N2 NA (residues 82–469) from Singapore16 with a VASP tetramerization domain was cloned and expressed using the baculovirus system in Sf9 cells essentially as previously described in ref. 18. Singapore16 N2 NA without VASP tetramerization domain was obtained by thrombin cleavage of the purified Singapore16 N2 NA with the VASP tetramerization domain. Broadly protective anti-NA antibody Fabs 1G01, 1G04, and 1E10 were expressed in mammalian ExpiCHO cells as previously reported10.Antibody 1G01 and 1E01 Fabs were added in 4 M excess to Singapore16 N2 NA without the VASP tetramerization domain, and 1G04 Fab was added in 4 molar excess to Singapore16 N2 NA with the VASP tetramerization domain. The N2-Fab complexes were incubated overnight at 4 °C and directly added to 400 mesh carbon-covered copper grids and stained with 2% uranyl formate. The grids were imaged on a Tecnai TF20 equipped with a TVIPS 4k × 4k camera or a Talos Arctica single tilt equipped with a 4k × 4k Ceta camera. Micrographs were collected using Leginon19 and uploaded to Appion20 for processing. Particles were picked using DoGpicker21 and stacked particles were put into Relion22 for 2D classification and 3D classification. Chimera23 was used to dock the individual crystal structures of Fabs 1G01 (PDB code 6Q23), 1G04 (PDB code 6Q1Z), and 1E10 (PDB code 6Q20) and the Singapore16 N2 NA tetramer model into 3D EM maps.NA sequencesThe sequences for the generation of the phylogenetic tree were downloaded from the Influenza Resource Database (www.fludb.org) or the Global Initiative on Sharing Avian Influenza Data (www.gisaid.org). The primary H3N2 virus isolates were sequenced in-house and the sequences were provided by the Mount Sinai Pathogen Surveillance Program. These were then uploaded to GISAID and Genbank (see below).Reporting summaryFurther information on research design is available in the Nature Portfolio Reporting Summary linked to this article. Data availability Data supporting our work are available in the paper and Supplementary Figs. 1–10. Source data are provided with this paper. Virus sequences used are available the Global Initiative on Sharing Avian Influenza Data (www.gisaid.org and/or at Genbank): A/New York City/PV00077/2017 (EPI_ISL_4073021, NA:MW651812,NP:MW651813,NS:MW651814,PB2:MW651815,HA:MW651816,PA:MW651817,M:MW651818,PB1:MW651819), A/New York City/PV00012/2017 (EPI_ISL_4062122, PB2:OP872033,PB1:OP872034,PA:OP872035,HA:OP872036,NP:OP872037,NA:OP872038,M:OP872039,NS:OP872040), A/New York City/PV00034/2017 (EPI_ISL_15842142, PB2:OP871889,PB1:OP871890,PA:OP871891,HA:OP871892,NP:OP871893,NA:OP871894,M:OP871895,NS:OP871896), A/New York City/PV00109/2017 (EPI_ISL_15842162, PB2:OP871905,PB1:OP871906,PA:OP871907,HA:OP871908,NP:OP871909,NA:OP871910,M:OP871911,NS:OP871912), A/New York City/PV00088/2017 (EPI_ISL_15842180, PB2:OP871913,PB1:OP871914,PA:OP871915,HA:OP871916,NP:OP871917,NA:OP871918,M:OP871919,NS:OP871920), A/New York City/PV00100/2017 (EPI_ISL_15842199, PB2:OP871977,PB1:OP871978,PA:OP871979,HA:OP871980,NP:OP871981,NA:OP871982,M:OP871983,NS:OP871984), A/New York City/PV00033/2017 (EPI_ISL_4073067, NA:MW651820,M:MW651821,PB2:MW651822,NS:MW651823,PA:MW651824,PB1:MW651825,NP:MW651826,HA:MW651827), A/New York City/PV00068/2017 (EPI_ISL_15842216, PB2:OP871921,PB1:OP871922,PA:OP871923,HA:OP871924,NP:OP871925,NA:OP871926,M:OP871927,NS:OP871928), A/New York City/PV00306/2017 (EPI_ISL_15842235, PB2:OP872025,PB1:OP872026,PA:OP872027,HA:OP872028,NP:OP872029,NA:OP872030,M:OP872031,NS:OP872032), A/New York City/PV00328/2017 (EPI_ISL_15842254, PB2:OP871985,PB1:OP871986,PA:OP871987,HA:OP871988,NP:OP871989,NA:OP871990,M:OP871991,NS:OP871992), A/New York City/PV01148/2018 (EPI_ISL_326910, PB2:OP872017,PB1:OP872018,PA:OP872019,HA:OP872020,NP:OP872021,NA:OP872022,M:OP872023,NS:OP872024), A/New York City/PV00528/2018 (EPI_ISL_326929, PB2:OP871969,PB1:OP871970,PA:OP871971,HA:OP871972,NP:OP871973,NA:OP871974,M:OP871975,NS:OP871976), A/New York City/PV00058/2017 (EPI_ISL_15842270, PB2:OP871937,PB1:OP871938,PA:OP871939,HA:OP871940,NP:OP871941,NA:OP871942,M:OP871943,NS:OP871944), A/New York City/PV00073/2017 (EPI_ISL_15842280, PB2:OP871961,PB1:OP871962,PA:OP871963,HA:OP871964,NP:OP871965,NA:OP871966,M:OP871967,NS:OP871968), A/New York City/PV00190/2017 (EPI_ISL_15842288, PB2:OP871945,PB1:OP871946,PA:OP871947,HA:OP871948,NP:OP871949,NA:OP871950,M:OP871951,NS:OP871952), A/New York City/PV02895/2019 (EPI_ISL_15842298, PB1:MW650793,HA:MW650794,PB2:MW650795,M:MW650796,NP:MW650797,PA:MW650798,NA:MW650799,NS:MW650800), A/New York City/PV01536/2018 (EPI_ISL_4072967, PB2:MW651804,NS:MW651805,PB1:MW651806,PA:MW651807,NP:MW651808,HA:MW651809,M:MW651810,NA:MW651811), A/New York City/PV00072/2017 (EPI_ISL_15842308, PB2:OP872041,PB1:OP872042,PA:OP872043,HA:OP872044,NP:OP872045,NA:OP872046,M:OP872047,NS:OP872048), A/New York City/PV00009/2017 (EPI_ISL_15842318, PB2:OP872001,PB1:OP872002,PA:OP872003,HA:OP872004,NP:OP872005,NA:OP872006,M:OP872007,NS:OP872008), A/New York City/PV00098/2017 (EPI_ISL_15842329, PB2:OP871929,PB1:OP871930,PA:OP871931,HA:OP871932,NP:OP871933,NA:OP871934,M:OP871935,NS:OP871936), A/New York City/PV00046/2017 (EPI_ISL_15842341, PB2:OP872049,PB1:OP872050,PA:OP872051,HA:OP872052,NP:OP872053,NA:OP872054,M:OP872055,NS:OP872056), A/New York City/PV01296/2018 (EPI_ISL_326915, PB2:OP913191,PB1:OP913192,PA:OP913193,HA:OP913194,NP:OP913195,NA:OP913196,M:OP913197), A/New York City/PV02516/2019 (EPI_ISL_15842351, NA:MW650801,NS:MW650802,PB1:MW650803,PB2:MW650804,HA:MW650805,PA:MW650806,M:MW650807,NP:MW650808), A/New York City/PV03878/2019 (EPI_ISL_15842352, PB2:OP871897,PB1:OP871898,PA:OP871899,HA:OP871900,NP:OP871901,NA:OP871902,M:OP871903,NS:OP871904), A/New York City/PV00099/2017 (EPI_ISL_4072918, PA:MW651788,PB2:MW651789,HA:MW651790,PB1:MW651791,NS:MW651792,NA:MW651793,NP:MW651794,M:MW651795), A/New York City/PV00105/2017 (EPI_ISL_15842353, PB2:OP871953,PB1:OP871954,PA:OP871955,HA:OP871956,NP:OP871957,NA:OP871958,M:OP871959,NS:OP871960), A/Kansas/14/2017 (EPI_ISL_403059), A/Singapore/INFIMH-16-0019/2016 (EPI_ISL_13046488), A/Switzerland/8060/2017 (EPI_ISL_332305), A/Switzerland/9715293/2013 (EPI_ISL_230377), A/Hong Kong/4801/2014 (EPI_ISL_389028) and A/Aichi/2/1968 (EPI_ISL_123225). Source data are provided with this paper. ReferencesWHO. (World Health Organisation, 2018) https://www.who.intews/item/13-12-2017-up-to-650-000-people-die-of-respiratory-diseases-linked-to-seasonal-flu-each-year.Jester, B., Uyeki, T. & Jernigan, D. Fifty years of influenza A(H3N2) following the pandemic of 1968. Am. J. Public Health 110, 669–676 (2020).Article Google Scholar Zost, S. et al. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc. Natl Acad. Sci. USA 114, 12578–12583 (2017).Article ADS CAS Google Scholar Wu, N.C. et al. A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. PLoS Pathog. 13, e1006682 (2017).Article Google Scholar Jorquera, P. A. et al. Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011–2018. Sci. Rep. 9, 1–16 (2019).Article CAS Google Scholar Wan, H. et al. The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain. Nat. Microbiol. 4, 2216–2225 (2019).Article Google Scholar Powell, H. & Pekosz A. Neuraminidase antigenic drift of H3N2 clade 3c.2a viruses alters virus replication, enzymatic activity and inhibitory antibody binding. PLoS Pathog. 16, e1008411 (2020).Article CAS Google Scholar Erbelding, E. et al. A universal influenza vaccine: the strategic plan for the National Institute of Allergy and Infectious Diseases. J. Infect. Dis. 218, 347–354 (2018).Article CAS Google Scholar Krammer, F. et al. NAction! How can neuraminidase-based immunity contribute to better influenza virus vaccines? mBio 9, e02332–02317 (2018).Article CAS Google Scholar Stadlbauer, D. et al. Broadly protective human antibodies that target the active site of influenza virus neuraminidase. Science 366, 499–504 (2019).Article ADS CAS Google Scholar An, Y. et al. Comparative glycomics analysis of influenza Hemagglutinin (H5N1) produced in vaccine relevant cell platforms. J. Proteome Res. 12, 3707–3720 (2013).Article CAS Google Scholar Neumann, G. et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl Acad. Sci. USA 96, 9345–9350 (1999).Article ADS CAS Google Scholar Margine, I., Palese, P. & Krammer, F. Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system. J. Vis. Exp. 81, e51112 (2013).Article Google Scholar Shu, Y. & McCauley, J. GISAID: Global initiative on sharing all influenza data - from vision to reality. Euro Surveill. 22, 30494 (2017).Article Google Scholar Webb, B. & Sali, A. Comparative protein structure modeling using MODELLER. Curr. Protoc. Bioinformatics 54, 5.6.1–5.6.37 (2016).Zhu, X. et al. Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic acid receptors. J. Virol. 86, 13371–13383 (2012).Article CAS Google Scholar Emsley, P., Lohkamp, B., Scott, W. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D. Biol. Crystallogr. 66, 486–501 (2010).Article CAS Google Scholar Xu, X., Zhu, X., Dwek, R., Stevens, J. & Wilson, I. Structural characterization of the 1918 influenza virus H1N1 neuraminidase. J. Virol. 82, 10493–10501 (2008).Article CAS Google Scholar Potter, C. et al. Leginon: a system for fully automated acquisition of 1000 electron micrographs a day. Ultramicroscopy 77, 153–161 (1999).Article CAS Google Scholar Lander, G. et al. Appion: an integrated, database-driven pipeline to facilitate EM image processing. J. Struct. Biol. 166, 95–102 (2009).Article CAS Google Scholar Voss, N., Yoshioka, C., Radermacher, M., Potter, C. & Carragher, B. DoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopy. J. Struct. Biol. 166, 205–213 (2009).Article CAS Google Scholar Scheres, S. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519–530 (2012).Article CAS Google Scholar Pettersen, E. et al. UCSF Chimera–a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).Article CAS Google Scholar Download referencesAcknowledgementsThis work was partially supported by the NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) contract HHSN272201400008C (F.K. and A.H.E.), NIAID Centers of Excellence for Influenza Research and Response (CEIRR) contract 75N93021C00014 (F.K.) and NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC, 75N93019C00051) (F.K., I.A.W., A.B.W., and A.H.E.). We thank the Mount Sinai Pathogen Surveillance Program for providing access to discard nasopharyngeal swab specimens. We gratefully acknowledge all data contributors, i.e., the authors and their originating laboratories responsible for obtaining the specimens, and their submitting laboratories for generating the genetic sequence and metadata and sharing via the GISAID initiative on which this research is partially based.Author informationAuthors and AffiliationsDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USADaniel Stadlbauer, Meagan McMahon, Juan Manuel Carreño, George O’Dell, Shirin Strohmeier, Viviana Simon & Florian KrammerDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USAHannah L. Turner, Xueyong Zhu, Ian A. Wilson & Andrew B. WardDivision of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USAHongquan WanDepartment of Biotechnology, University of Natural Resources and Life Sciences, Vienna, AustriaShirin StrohmeierDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USAZain Khalil, Marta Luksza & Harm van BakelDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USAMarta LukszaIcahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USAHarm van BakelGlobal Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USAViviana SimonDepartment of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USAViviana Simon & Florian KrammerCenter for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, NY, USAViviana Simon & Florian KrammerDivision of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USAViviana SimonDivision of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USAAli H. EllebedyThe Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA, USAIan A. WilsonAuthorsDaniel StadlbauerView author publicationsYou can also search for this author in PubMed Google ScholarMeagan McMahonView author publicationsYou can also search for this author in PubMed Google ScholarHannah L. TurnerView author publicationsYou can also search for this author in PubMed Google ScholarXueyong ZhuView author publicationsYou can also search for this author in PubMed Google ScholarHongquan WanView author publicationsYou can also search for this author in PubMed Google ScholarJuan Manuel CarreñoView author publicationsYou can also search for this author in PubMed Google ScholarGeorge O’DellView author publicationsYou can also search for this author in PubMed Google ScholarShirin StrohmeierView author publicationsYou can also search for this author in PubMed Google ScholarZain KhalilView author publicationsYou can also search for this author in PubMed Google ScholarMarta LukszaView author publicationsYou can also search for this author in PubMed Google ScholarHarm van BakelView author publicationsYou can also search for this author in PubMed Google ScholarViviana SimonView author publicationsYou can also search for this author in PubMed Google ScholarAli H. EllebedyView author publicationsYou can also search for this author in PubMed Google ScholarIan A. WilsonView author publicationsYou can also search for this author in PubMed Google ScholarAndrew B. WardView author publicationsYou can also search for this author in PubMed Google ScholarFlorian KrammerView author publicationsYou can also search for this author in PubMed Google ScholarContributionsD.S., M.M., H.L.T., X.Z., and H.W. performed experiments and analyzed data. J.M.C. grew primary virus isolates. S.S. produced recombinant proteins. G.O. purified viruses. Z.K., H.v.B., M.L. and V.S. provided primary virus isolates and corresponding sequence information. D.S., I.A.W., A.H.E., A.B.W., and F.K. conceptualized the study and wrote the manuscript.Corresponding authorsCorrespondence to Ali H. Ellebedy, Ian A. Wilson, Andrew B. Ward or Florian Krammer.Ethics declarations Competing interests Washington University has filed a patent application for antibodies 1G01, 1E01, and 1G04 with A.H.E., F.K., and I.A.W. named as inventors and A.H.E., F.K., and I.A.W. have received royalties from licensing 1G01 for clinical development. F.K. is currently consulting for Avimex, GSK, Third Rock Ventures, and Pfizer and is receiving research support from Dynavax. Research support was provided in the past by GSK and Pfizer to the Krammer laboratory. The Ellebedy laboratory received funding from Emergent BioSolutions, Moderna, and AbbVie in the form of scientific research agreements that are unrelated to the data presented in the current study. The remaining authors declare no competing interests. Peer review Peer review information Nature Communications thanks Smriti Sangwan and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Additional informationPublisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Supplementary informationSupplementary InformationReporting SummarySource dataSource DataRights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Reprints and permissionsAbout this articleCite this articleStadlbauer, D., McMahon, M., Turner, H.L. et al. Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site. Nat Commun 13, 7864 (2022). https://doi.org/10.1038/s41467-022-35586-7Download citationReceived: 26 June 2021Accepted: 12 December 2022Published: 21 December 2022DOI: https://doi.org/10.1038/s41467-022-35586-7Share this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative This article is cited by A pan-influenza antibody inhibiting neuraminidase via receptor mimicry Corey MomontHa V. DangMatteo Samuele Pizzuto Nature (2023) Download PDF Advertisement Explore content Research articles Reviews & Analysis News & Comment Videos Collections Subjects Follow us on Facebook Follow us on Twitter Sign up for alerts RSS feed About the journal Aims & Scope Editors Journal Information Open Access Fees and Funding Calls for Papers Editorial Values Statement Journal Metrics Editors' Highlights Contact Editorial policies Top Articles Publish with us For authors For Reviewers Language editing services Submit manuscript Search Search articles by subject, keyword or author Show results from All journals This journal Search Advanced search Quick links Explore articles by subject Find a job Guide to authors Editorial policies Nature Communications (Nat Commun) ISSN 2041-1723 (online) nature.com sitemap About Nature Portfolio About us Press releases Press office Contact us Discover content Journals A-Z Articles by subject protocols.io Nature Index Publishing policies Nature portfolio policies Open access Author & Researcher services Reprints & permissions Research data Language editing Scientific editing Nature Masterclasses Research Solutions Libraries & institutions Librarian service & tools Librarian portal Open research Recommend to library Advertising & partnerships Advertising Partnerships & Services Media kits Branded content Professional development Nature Careers Nature Conferences Regional websites Nature Africa Nature China Nature India Nature Italy Nature Japan Nature Middle East Privacy Policy Use of cookies Your privacy choices/Manage cookies Legal notice Accessibility statement Terms & Conditions Your US state privacy rights © 2024 Springer Nature Limited Close banner Close Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily. Email address Sign up I agree my information will be processed in accordance with the Nature and Springer Nature Limited Privacy Policy. Close banner Close Get the most important science stories of the day, free in your inbox. Sign up for Nature BriefingTackling the Tripledemic: Influenza | Abbott Newsroom INVESTORS OVERVIEW FINANCIALS STOCK INFO RESOURCES NEWS & EVENTS GOVERNANCE NEWSROOM NEWS PRESS RELEASES PRESS CONTACTS HONORS EXPERTS EXECUTIVE TEAM RESPONSIBILITY OVERVIEW SOCIAL IMPACT SUSTAINABILITY ABBOTT FUND SUBSCRIBE Consumers Consumers Healthcare Professionals Healthcare Professionals Careers Overview Working With Us Professionals Students Diversity & Inclusion Benefits FAQS Conferences & Events Search Jobs Careers Overview Working With Us Professionals Students Diversity & Inclusion Benefits FAQS Conferences & Events Search Jobs About Abbott Overview Who We Are Our Heritage Abbott at a Glance Abbott FAQS Contact Us Responsibility Subscribe About Abbott Overview Who We Are Our Heritage Abbott at a Glance Abbott FAQS Contact Us Responsibility Subscribe CONSUMERS HEALTHCARE PROFESSIONALS CAREERS ABOUT ABBOTT CAREERS INVESTORS NEWSROOM Responsibility Partners Contact SITE MAP POLICIES privacy policy Terms & Conditions Home Newsroom Diagnostics Testing Tackling the Tripledemic: Influenza Tackling the Tripledemic: Influenza A series looking at how rapid testing can help quickly identify respiratory viruses, including the flu. Diagnostics Testing|Jan.18, 2023 NOTE TO READERS: As flu, RSV and COVID-19 coincide this virus season, we are presenting a series on the role of rapid testing to give both healthcare professionals and consumers quick results. The first story in the series looks at the role of testing for RSV, or respiratory syncytial virus. Colleen's 11-year-old son woke up with signs of a viral infection. What started with feeling a little run down and a sore throat slowly turned into chills, a fever and body aches. In speaking to her mom circle, Colleen learned that half of her son's basketball team was out sick, with two players testing positive for the flu, specifically influenza A. As an Abbott employee, Colleen understood the importance of immediate answers and she took her son to get a rapid test when he started feeling very lethargic. A couple of hours later, she had the answers she needed: a positive test result for the flu from Abbott’s ID NOW device and a prescription to help alleviate symptoms. "I was able to get quick answers and make informed decisions versus waiting at home to see if he got better. Knowing what I was dealing with allowed me to help my son feel better, faster and also keep our other children away so the virus didn’t spread," Colleen said. Colleen's story is one many families across the U.S. are facing right now with the convergence of respiratory viruses — particularly with rising cases of influenza and RSV — and determining what sickness they or their children may have. Particularly among the flu, the Centers for Disease Control and Prevention's (CDC) latest statistics reported that millions of people across the U.S. have the flu and cases are expected to rise with the holiday season and family gatherings. It's important to understand the risk that flu poses and how to best prepare yourself and your family for the coming season. Flu can be a dangerous disease for the oldest among us, but there are important preventative measures we can take to ensure we stay safe as we celebrate the holidays together. Getting Vaccinated The flu vaccine is the first step toward protecting yourself. It is an effective tool at preventing death and disease. The CDC recommends everyone six months and older should get a flu vaccine every season with rare exception. You can find a location to get a flu shot at vaccines.gov. Getting Tested and Treated If you suspect that you or a loved one has the flu, it’s important to know your status. Medications like Tamiflu are effective at lessening the severity of symptoms such as coughing and sore throat, and lowering the amount of time you experience symptoms by up to two days. Tamiflu is only effective if taken within the first 48 hours of symptom onset, meaning that it’s important to be able to quickly know if you have the flu. That’s where testing at the pharmacy comes in. Pharmacists have played a critical role during the pandemic. Now they're stepping up to help tackle the flu. Throughout the pandemic, Walgreens has used Abbott’s ID NOW rapid molecular tests to give quick and reliable results to help people determine if they had COVID-19. This cold and flu season, Walgreens is expanding its pharmacies’ testing services to help communities manage the highly transmissible viruses circulating this holiday season. People will now be able to schedule both a rapid flu test and rapid COVID-19 test through Abbott’s ID NOW devices at nearly half of Walgreens locations. Individuals can visit Walgreens.com or schedule via the Walgreens app where COVID-19 and flu testing locations can be chosen from the list of stores with availability of these services. Learn more about symptoms, potential complications and the importance of testing and treatment for the flu here. This story originally published on Dec. 19, 2022, and was updated on Jan. 18, 2023. Related Article Tackling the Tripledemic: RSV Like this article IMPORTANT SAFETY INFORMATION ID NOW™ COVID-19 test has not been FDA cleared or approved. They have been authorized by the FDA under an emergency use authorization for use by authorized laboratories. The tests have been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens, and are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. MOST READ READ MORE Healthy Heart Nov. 20, 2023 Smallest Mechanical Heart Valve Saved her Life Baby Sadie received the world's smallest mechanical heart valve, and her life instantly changed. Today, she's a spunky 9-year-old. READ MORE Nutrition, Health and Wellness Dec. 06, 2017 Gentle Stretches to Help Lower Back Pain These gentle stretches can temporarily relieve pain and stiffness from too much sitting. Make them a part of your routine for a healthy and strong back. READ MORE DIABETES CARE Aug. 11, 2017 5 Sugar Substitute Ideas for People With Diabetes A sugar substitute allows diabetics to have their cake and eat it, too. Here are five options. READ MORE Strategy and Strength June 24, 2024 Abbott Enters U.S. Consumer Biowearables Market With Lingo and Libre Rio Recent FDA clearance of two new over-the-counter continuous glucose monitoring systems broadens Abbott’s leading position in biowearables. GET MORE Diagnostics CONSUMERS HEALTHCARE PROFESSIONALS CAREERS ABOUT ABBOTT SUBSCRIBE INVESTORS NEWSROOM RESPONSIBILITY PARTNERS CONTACTS SITE MAP GLOBAL WEBSITES POLICIES TERMS & CONDITIONS PRIVACY POLICY CONSUMER HEALTH DATA PRIVACY POLICY myAbbott Privacy Preferences ADVERTISING PREFERENCES pageURL eventType Submit FOLLOW ABBOTT © 2024 Abbott. All Rights Reserved. Please read the Legal Notice for further details. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. YOU ARE ABOUT TO EXIT FOR ANOTHER ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions. The website you have requested also may not be optimized for your specific screen size. DO YOU WISH TO CONTINUE AND EXIT THIS WEBSITE? YES NOResearchers make important progress toward a possible universal flu vaccine | CNN CNN values your feedback 1. How relevant is this ad to you? 2. Did you encounter any technical issues? Video player was slow to load content Video content never loaded Ad froze or did not finish loading Video content did not start after ad Audio on ad was too loud Other issues Ad never loaded Ad prevented/slowed the page from loading Content moved around while ad loaded Ad was repetitive to ads I've seen previously Other issues Cancel Submit Thank You! Your effort and contribution in providing this feedback is much appreciated. Close Ad Feedback Close icon Health Life, But Better Fitness Food Sleep Mindfulness Relationships More Life, But Better Fitness Food Sleep Mindfulness Relationships Watch Listen Live TV Subscribe Sign in My Account Settings Topics You Follow Sign Out Your CNN account Sign in to your CNN account Sign in My Account Settings Topics You Follow Sign Out Your CNN account Sign in to your CNN account Live TV Listen Watch Edition US International Arabic Español Edition US International Arabic Español Life, But Better Fitness Food Sleep Mindfulness Relationships Follow CNN World Africa Americas Asia Australia China Europe India Middle East United Kingdom US Politics SCOTUS Congress Facts First 2024 Elections Business Tech Media Calculators Videos Markets Pre-markets After-Hours Fear & Greed Investing Markets Now Nightcap Health Life, But Better Fitness Food Sleep Mindfulness Relationships Entertainment Movies Television Celebrity Tech Innovate Foreseeable Future Mission: Ahead Work Transformed Innovative Cities Style Arts Design Fashion Architecture Luxury Beauty Video Travel Destinations Food & Drink Stay News Videos Sports Football Tennis Golf Motorsport US Sports Olympics Climbing Esports Hockey Watch Live TV CNN Fast Shows A-Z CNN10 CNN Max CNN TV Schedules Listen CNN 5 Things Chasing Life with Dr. Sanjay Gupta The Assignment with Audie Cornish One Thing Tug of War CNN Political Briefing The Axe Files All There Is with Anderson Cooper All CNN Audio podcasts Science Space Life Unearthed Climate Solutions Weather Features As Equals Call to Earth Freedom Project Impact Your World Inside Africa CNN Heroes Weather Video Climate Ukraine-Russia War Israel-Hamas War About CNN Photos Investigations CNN Profiles CNN Leadership CNN Newsletters Work for CNN Ad Feedback Researchers make important progress toward a possible universal flu vaccine By Brenda Goodman, CNN 6 minute read Published 7:43 AM EST, Thu December 22, 2022 Link Copied! Video Ad Feedback Seasonal flu: What you need to know 01:46 - Source: CNN CNN — Influenza is continuing its early and severe rampage through the United States, but there’s some hopeful news for flu seasons of the future. In a significant step, researchers recently said they’ve been able to immunize animals against all 20 known influenza A and B virus strains, marking an important step toward the goal of a single vaccine against all types of the flu. Our current flu vaccines prime the body to protect against four strains: two influenza A strains and two B strains. The composition of these vaccines is changed each year in anticipation of which strains will make most people sick during the coming season. Dr. Drew Weissman and Katalin Karikó of the University of Pennsylvania Courtesy Penn Medicine Opinion: Thought mRNA vaccines would end with the pandemic? Think again Certain strains are known to circulate among humans, but many more circulate in animals and scientists worry that these viruses could jump to humans – suddenly exposing us to viruses our immune systems have never seen. That’s where a universal flu vaccine would help. The idea is that these multivalent shots could prep the body to recognize these viruses, should any of them take off in humans, helping prevent severe illness and death. Several universal flu vaccines are in various stages of development and testing, including one at the National Institutes of Health. For the current study, the experimental shot was used only in mice and ferrets, and the results were reported last month in the journal Science. The researchers say they’re working through the process of making the vaccine to human quality standards and aim to try it in people in 2023. They’re hopeful that, if those tests succeed, the vaccine could protect people in the event of another pandemic strain of flu. Another application for mRNA technology To make the vaccine, the researchers relied on the same mRNA technology that’s used in Covid-19 vaccines. But scientists actually started on these experiments in 2017, years before the first Covid-19 shots were given. In fact, it was that research that helped lay the groundwork for the Covid-19 vaccines. In the quest for a universal flu vaccine, scientists have been carefully studying flu viruses, looking for structural regions that are similar among strains. The thinking was that if they could find one or two areas that don’t change much from strain to strain, they could train the immune system to make antibodies against these regions and protect people from many viruses at the same time. (Photo by Mario Tama/Getty Images) Mario Tama/Getty Images Flu activity remains high but shows signs of slowing in parts of the US, CDC says This approach had proved tricky, said Dr. Jennifer Nayak, a pediatric infectious disease specialist who studies immune responses to influenza at the University of Rochester Medical Center. She was not involved in the new research. Among the 20 known flu strains, “there’s some shared pieces between them all, but they’re few and far between,” Nayak said. These regions aren’t what we would call immunodominant, she said. Sometimes, the immune system ends up responding to the thing that differs among viruses, not the thing that’s the same. The team working on the new vaccine, led by researchers at the University of Pennsylvania’s Institute for Immunology, tried something different. The vaccine includes genetic instructions for making the hemagglutinin, or HA, proteins of each of the 20 strains. “Instead of trying to find something that’s shared, let’s just put all of the 20 different HA proteins – let’s put the mRNAs from all of them into this vaccine,” Nayak said. Proof of concept Hemagglutinin is a protein that that sticks up from the surface of flu viruses, very much like the spike proteins on the SARS-CoV-2 virus, says Scott Hensley, senior author of the new study and a microbiologist at the Penn Institute for Immunology. The HA proteins look a little bit like matches sticking up out of an apple, with a globular head that sits on a longer stalk. “What we found is that these vaccines elicit very high levels of antibodies against all 20 subtypes. And we found that the antibodies react to both the globular head the very top of HA as well as the hemagglutinin stalk, which is a little bit lower down,” Hensley said. Before the researchers tried that, though, they vaccinated groups of mice with every antigen they wanted to include in the vaccine to make sure that, individually, each created an immune response. Then, they took those genetic instructions and combined them in a single shot. Each strain was delivered in a 2.5-microgram dose. All together, the shot included a 50-microgram dose of mRNA. Everyone should have a plan for what happens if they develop a viral illness while traveling, says Dr. Leana Wen. Yelizaveta Tomashevska/Adobe Stock Which prevention measures will help keep viruses at bay this Christmas? Our medical analyst explains The researchers tested the shots in animals that had never been exposed to influenza and in animals that had previously been infected with H1N1 flu viruses similar to or different from the ones included in the shot. This was intended to show whether the shot selectively boosted antibodies to flu strains the mice had in their immune memories, a phenomenon called imprinting. The shots boosted antibodies to flu strains that the mice had been exposed to before, the scientists say, but it didn’t come at the expense of generating new antibodies to viral proteins that were unfamiliar to the animals’ immune systems. The scientists also challenged the mice with flu strains that were very similar to the ones included in the vaccine, and those that were less similar. The mice made antibodies that bound to both types of flu, but these antibodies neutralized only the very similar virus. Mice that were challenged with the less similar virus got sick, but they began to recover seven or eight days after infection. Mice that had been given a placebo vaccine, which carried mRNA instructions to make an unrelated enzyme, died after exposure to the flu. Seeking protection against future pandemics “Our vaccine is expected to induce sort of a baseline level of immunity that would prevent severe infections, death and hospitalizations,” Hensley said. It wouldn’t necessarily keep people from getting sick with the flu. Scientists who weren’t involved in the work praised the idea, but cautioned that the results need to be repeated in humans. “I think this is a scientific proof of concept, and it’s really innovative and really intriguing,” said Dr. Kathy Neuzil, director of the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine. “This is only mice and ferrets. Humans are obviously much more complex, genetic and immunologic beings.” Get CNN Health's weekly newsletter Sign up here to get The Results Are In with Dr. Sanjay Gupta every Friday from the CNN Health team. At this point, the jury is still out on how such a vaccine would best be used, she said. If it works as well for adults as it did for mice, would they need to be boosted each year? Or would it best be used in children to create baseline immunity that they would hopefully retain for years? Neuzil said she feels skeptical about that. “Certainly, it’s unlikely to last. The durability of mRNA vaccines hasn’t been shown for Covid, for example, to be significantly longer than other vaccines.” she said. So I think this would have to be a vaccine that would be used in a more limited fashion and perhaps more temporally related to when you needed protection.” Ad Feedback Ad Feedback Ad Feedback Ad Feedback Ad Feedback Ad Feedback Ad Feedback Sign in My Account Settings Topics You Follow Sign Out Your CNN account Sign in to your CNN account Live TV Listen Watch World Africa Americas Asia Australia China Europe India Middle East United Kingdom US Politics SCOTUS Congress Facts First 2024 Elections Business Tech Media Calculators Videos Markets Pre-markets After-Hours Fear & Greed Investing Markets Now Nightcap Health Life, But Better Fitness Food Sleep Mindfulness Relationships Entertainment Movies Television Celebrity Tech Innovate Foreseeable Future Mission: Ahead Work Transformed Innovative Cities Style Arts Design Fashion Architecture Luxury Beauty Video Travel Destinations Food & Drink Stay News Videos Sports Football Tennis Golf Motorsport US Sports Olympics Climbing Esports Hockey Watch Live TV CNN Fast Shows A-Z CNN10 CNN Max CNN TV Schedules Listen CNN 5 Things Chasing Life with Dr. Sanjay Gupta The Assignment with Audie Cornish One Thing Tug of War CNN Political Briefing The Axe Files All There Is with Anderson Cooper All CNN Audio podcasts Science Space Life Unearthed Climate Solutions Weather Features As Equals Call to Earth Freedom Project Impact Your World Inside Africa CNN Heroes Weather Video Climate Ukraine-Russia War Israel-Hamas War About CNN Photos Investigations CNN Profiles CNN Leadership CNN Newsletters Work for CNN Health Watch Listen Live TV Follow CNN Sign in My Account Settings Topics You Follow Sign Out Your CNN account Sign in to your CNN account Terms of Use Privacy Policy Ad Choices Accessibility & CC About Newsletters Transcripts © 2024 Cable News Network. A Warner Bros. Discovery Company. All Rights Reserved. CNN Sans ™ & © 2016 Cable News Network.Avian influenza cases in poultry and water birds on the rise | EFSA Skip to main content An official EU websiteAn official website of the European Union How do you know? All official European Union website addresses are in the <b>europa.eu</b> domain Other sites EFSA Open EFSA EFSA Journal Connect European Food Safety Authority en English Select your language българскиespañolčeštinadanskDeutscheestiελληνικάEnglishfrançaisGaeilgehrvatskiitalianolatviešulietuviųmagyarMaltiNederlandspolskiportuguêsromânăslovenčinaslovenščinasuomisvenska Calendar Menu About About us Mission and values Transparency Working practices Trusted science External experts Governance Management Board members Executive Director Operational Management Documents Corporate publications Partners EU Member States EU institutions and agencies Competent organisations in Member States International Stakeholder engagement Newsroom All contents News Data visualization Videos Podcast Infographics Factsheets Campaigns Safe2Eat PlantHealth4Life Topics All topics Animal health Animal welfare Antimicrobial resistance Chemical contaminants in food and feed Foodborne zoonotic diseases Nutrition Pesticides Qualified presumption of safety (QPS) Glossary Resources Data reports Data standardisation Food tracing Data collection Methodology Guidance Evidence Tools and resources Dietary Exposure (DietEx) tool Publications Applications Application procedures Biological hazards and animal welfare Feed additives Food contact materials Food improvement agents GMO Novel foods and traditional foods Nutrition Pesticides Services for applicants Services for SMEs Ask a question Toolkit QPS assessment Confidentiality and sanitisation Engage Procurement Closed tenders below €143k Instructions and forms Grants ISA scheme Fellowship Programme Calls for data Consultations Observers Research Platform Stakeholders Engagement platforms Engagement in risk assessment Calls for stakeholders Stakeholder registration Careers Working at EFSA Benefits Scientists Experts Staff members Traineeships How to apply Open positions Calendar Other sites Open EFSA EFSA Journal Connect Search Main navigationAboutAbout usMission and valuesTransparencyWorking practicesTrusted scienceExternal expertsGovernanceManagement Board membersExecutive DirectorOperational ManagementDocumentsCorporate publicationsPartnersEU Member StatesEU institutions and agenciesCompetent organisations in Member StatesInternationalStakeholder engagementNewsroomAll contentsNewsData visualizationVideosPodcastInfographicsFactsheetsCampaignsSafe2EatPlantHealth4LifeTopicsAll topicsAnimal healthAnimal welfareAntimicrobial resistanceChemical contaminants in food and feedFoodborne zoonotic diseasesNutritionPesticidesQualified presumption of safety (QPS)GlossaryResourcesData reportsData standardisationFood tracingData collectionMethodologyGuidanceEvidenceTools and resourcesDietary Exposure (DietEx) toolPublicationsApplicationsApplication proceduresBiological hazards and animal welfareFeed additivesFood contact materialsFood improvement agentsGMONovel foods and traditional foodsNutritionPesticidesServices for applicantsToolkitQPS assessmentConfidentiality and sanitisationEngageProcurementClosed tenders below €143kInstructions and formsGrantsISA schemeFellowship ProgrammeCalls for dataConsultationsObserversResearch PlatformStakeholdersEngagement platformsEngagement in risk assessmentCalls for stakeholdersStakeholder registrationCareersWorking at EFSABenefitsScientistsExpertsStaff membersTraineeshipsHow to applyOpen positions HomeNewsroom Avian influenza cases in poultry and water birds on the rise Published:20 December 2022 2 minutes read Share: Share via Twitter Share via Facebook Share via Linkedin Highly pathogenic avian influenza (HPAI) cases recorded in Europe among poultry and water birds have risen since the summer according to the latest report by EFSA, the European Centre for Disease Prevention and Control (ECDC), and the EU reference laboratory (EURL). While the number of HPAI virus detections in sea bird breeding colonies came down since the previous reporting period (June to September 2022), the number of cases in water birds and poultry has increased. The rise in the number of outbreaks in poultry since the summer is suspected to be linked to the spread of the virus via water birds. Detailed information on the number and evolution of cases can be found in a new interactive dashboard published by EFSA today.The ongoing HPAI epidemic A widespread occurrence of an infectious disease in a community at a particular time is the largest ever observed in Europe. In the first year of the epidemic, which ran from October 2021 to September 2022, a total of 2,520 outbreaks in poultry, 227 in captive birds, and 3,867 detections in wild birds were notified in 37 European countries. Some 50 million birds were culled in affected farms. The unusual persistence Persistence refers to the ability of harmful organisms like bacteria to survive and thrive despite regular cleaning and disinfection efforts, potentially lingering in hidden places for months or even years of HPAI in wild birds and poultry throughout the summer of 2022 means that for the first time there was no clear separation between the end of the first year of the epidemic and the beginning of this year’s HPAI season, which began in October 2022.ECDC, which also contributed to the report, concluded that the risk of infection is low for the general human population Community of humans, animals or plants from the same species in the EU/EEA, and low to medium for occupationally exposed people.Following a request by the European Commission, EFSA is currently assessing the availability of vaccines against HPAI for poultry and considering potential vaccination strategies. The outcome of this work, to which the European Medicines Agency (EMA) and EURL are also contributing, will be available in the second half of 2023.Links to scienceAvian influenza overview September – December 2022How to contact usEFSA Media Relations OfficeTel. +39 0521 036 149E-mail: press [at] efsa.europa.eu (Press[at]efsa[dot]europa[dot]eu)(Only if you are a member of the press)Ask a Question ServiceYou have a question about EFSA’s work? Contact our Ask a Question service!Ask a Question Service Related topics Animal health Avian influenza Contents Contents Page contents Did this page meet your expectations ? Yes No Thank you! Any more feedback? I have found the information I was looking for The content was easy to understand There was the right amount of information Other (please specify below) Can you help us make it better for you — Why didn’t it meet your expectations? I did not find the information I was looking for The content was difficult to understand There was too much or too little information Technical problem (please specify below) Other (please specify below) Please specify below: What else positively affected your experience? What could be improved to make your experience better? We value your anonymous feedback and use it to continually improve your experience. If you require an individual response, please visit our Contact us page. About Executive Director Management Board Transparency Regulation Corporate documents Engage Careers Consultations Procurement Grants Connect Newsletters & email alerts Press Centre Contact us Access OpenEFSA EFSA Journal on Wiley Connect EFSA extranet (DMS) Follow us on RSSXInstagramLinkedinYoutubeSpotifyScience, safe food, sustainabilityLegal noticePersonal Data ProtectionMultilingual practiceAccessibilityWebsite release notesThe infection potential of influenza A viruses H3 subtype of avian, equine, and swine origin in humans Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About COVID-19 News Health A-Z Drugs Medical Devices Interviews White Papers More... MediKnowledge Newsletters Health & Personal Care eBooks Contact Meet the Team Advertise Search Become a Member Top Health Categories Coronavirus Disease COVID-19 Diet & Nutrition Artificial Intelligence Allergies Alzheimer's & Dementia Arthritis & Rheumatology Breast Cancer Cold, Flu & Cough Eating Disorders Eye Health Gastrointestinal Health Heart Disease High Blood Pressure Lung Cancer Mental Health Mpox Pregnancy Type 1 Diabetes Type 2 Diabetes Sexual Health Sleep View Health A-Z ×Top Health Categories Coronavirus Disease COVID-19 Heart Disease Diet & Nutrition High Blood Pressure Artificial Intelligence Lung Cancer Allergies Mental Health Alzheimer's & Dementia Mpox Arthritis & Rheumatology Pregnancy Breast Cancer Type 1 Diabetes Cold, Flu & Cough Type 2 Diabetes Eating Disorders Sexual Health Eye Health Sleep Gastrointestinal Health View Health A-Z Medical Home Life Sciences Home About News Life Sciences A-Z White Papers Lab Equipment Interviews Newsletters Webinars More... eBooks Contact Meet the Team Advertise Search Become a Member White Papers MediKnowledge Newsletters Health & Personal Care eBooks Contact Meet the Team Advertise Search Become a Member Webinars eBooks Contact Meet the Team Advertise Search Become a Member The infection potential of influenza A viruses H3 subtype of avian, equine, and swine origin in humans Download PDF Copy By Pooja Toshniwal PahariaReviewed by Danielle Ellis, B.Sc.Dec 20 2022 In a recent study published in Emerging Infectious Diseases, researchers determined the zoonotic transmission potential of influenza A viruses (IAVs) H3 subtype of avian, equine, and swine origin. Study: Human Immunity and Susceptibility to Influenza A(H3) Viruses of Avian, Equine, and Swine Origin. Image Credit: pinkeyes/Shutterstock Background H3 subtype IAVs that infect human beings are antigenically different from those of horses, swine, and birds. Transmission of hemagglutinin (HA)-comprising H3 IAVs from animals to human beings could give rise to a pandemic since humans lack serological humoral immunity against such viruses, which can, therefore, rapidly replicate and spread in human tissues. About the study In the present study, researchers estimated the infection potential of bird-origin, horse-origin, and swine-origin H3 IAVs in humans. Sera were obtained between August 2017 and January 2018 from 286 individuals residing in Belgium to evaluate the anti-HA1 antibody titers using VN and HI assays against avian-origin (mlBE18, mlOH18), swine-origin (swIN16, swMO15, swG17), and equine-origin (eqCH18) H3 IAVs. In addition, human infectivity of avian-origin chG19 (that caused outbreaks in poultry in Belgium in 2019), HK68 (the 1968 human pandemic virus), and dkUK63 (the presumed avian ancestor IAV of HK68) were determined. Epidemiological-type data were analyzed to determine the zoonotic transmission risks. The team assessed the proliferative ability of IAVs in human airway epithelium cells reconstituted from primary cells of biopsy samples from six donor individuals (BD1, BD2, BD3, ND1, ND2, ND3). The study participants were born between 1921 and 2017 and did not have any history of known influenza vaccination or infections. The IAVs were selected based on HA1 amino acid (aa) sequence homology and antigenic relatedness to IAV sequences downloaded from the GenBank database. Maximum-likelihood trees were constructed based on Jones-Taylor-Thornton modeling and the nearest-neighbour-interchange heuristic approach. The viruses were cultured in MDCK cells, and the team propagated only equine and avian viruses for HI assays in embryonated chicken eggs’ allantoic cavities, and all of them underwent ≤4.0 passages. Results Seroprevalence rates for swine-origin IAVs from North America were >51.0%, swine-origin IAVs from Europe ranged between 7.0% and 37%, and for bird-origin IAVs and equids were below or equal to 12.0%. Proliferation was efficient for swine IAVs from North America and those from Europe, intermediate for equine and poultry IAVs, and absent for avian IAVs. Zoonotic transmission risks were the greatest from swine-origin H3 IAVs. HK68 was found to be related closely to avian IAVs and showed 32 to 34/40 similar aa in antigenic sites and 93.0% to 96.0% homology. Avian IAVs and HK68 showed <83% homology with horse-origin and swine-origin IAVs. IAVs of swine-origin shared 24 to 26 amino acids in the antigenic regions with the HK68 virus and shared 17 to 23 amino acids with bird-origin IAVs. Swine and equine IAVs were related most distantly with <78.0% homology and 18 to 21 aa in antigenic regions, whereas all bird-origin IAVs were related closely, and swine-origin IAVs showed considerable antigenic distances among one other. Fifty-one percent and 40.0% of sera showed HK68 seropositivity in HI assays and VN assays, respectively. Seroprevalence and geometric mean titers (GMTs) were greater for individuals born prior to 1977 (71.0% and 65.0% in HI and VN assays, respectively, with GMTs >51) compared to those born between 1977 and 2017 (25.0% and 6.0% in HI and VN assays, respectively, with GMTs <18). The greatest seroreactivity was observed for individuals born between 1947 and 1966. For mlOH18, mlBE18 and dkUK63, <10.0% and <12.0% seropositivity was observed in HI assays and VN assays, respectively. Differences in VN seroprevalence rates were significant for mlBE18 among individuals born between 1947 and 1956 (9.0%) and individuals born between 2007 and 2017 (0%), with GMTs <20 across ages. Seropositivity for chG19 was 2.0% and 1.0% in HI, and VN assays, respectively, with GMTs below the limit of detection across ages, and no anti-chG19 antibodies were detectable among individuals born between 1987 and 2017. Related StoriesWastewater surveillance detects influenza and H5 viruses from human and animal sourcesStem cell therapy advances: MSCs show potential in managing COVID-19 and influenza infectionsUS study uncovers antiviral resistance in swine-origin influenza, urging enhanced pandemic surveillanceOnly 1.0% and 3.0% of all sera showed eqCH18 seropositivity in HI assays and VN assays, respectively, and GMT values were under the limit of detection across ages. Of all individuals, 37.0% and 7.0% showed swG17 positivity in HI assays and VN assays, respectively. Seropositivity and GMT values were greater for individuals born prior to 1997 (46% and 9.0% in HI and VN assays with GMTs >28, compared to those born between 1997 and 2017 (2.0% and 0.0% in HI and VN assays, respectively, with GMTs ≤11.0) with peaks for those born between 1967 and 1976. Seropositivity of 51.0% and 54% were noted for swIN16 in HI assays and VN assays, respectively. Seropositivity and GMT values were greater for individuals born prior to 1997 (61% and 65% in HI and VN assays, GMTs exceeding 46) compared to for persons born between 1997 and 2017 (13.0% and 16.0% in HI and VN assays, respectively, with GMTs <14.0). For swMO15, 76.0% and 72.0% seropositivity was observed in HI assays and VN assays, respectively. Half or more percent of individuals across ages showed seropositivity in HI assays and VN assays with GMTs ≥35, with the greatest seroreactivity among persons born between 1987 and 1996. Seroprevalence rate differences were significant among individuals born between 1987 and 1996, persons born between 2006 and 2017 in the HI assays (97.0% versus 59.0%) and persons born between 1947 and 1956 in the VN assays (93.0% versus 53.0%). HK68 proliferated to titers ≤10.0 log10 median tissue culture infectious dose (TCID50) per mL in the airway cells except those of ND2. Comparable titers were observed for swIN16 and swG17 in nasal and BD1 tissues. The eqCH18 virus proliferated efficiently in BD3, ND1, and BD1 tissues, and peak titers were 2.0 to 3.0 log10 TCID50 per mL lesser than titers for swG17, swIN16, and HK68. ChG19 proliferated with titers ≤4.0 log10 TCID50 per mL in bronchi cells of BD3 and was detected in BD1 and ND1 tissues at 4.0 dpi. The mlOH18, mlB18, and dkUK63 viruses had titers <2.2 log10 TCID50 per mL at four dpi in BD1 and ND1 tissues, and titers of 3.0 log10 TCID50 per mL were observed for swMO15 at 2.0 dpi in ND2 tissues. Overall, the study findings showed a higher potential for swine IAVs to infect humans. Journal reference: Vandoorn E, Stadejek W, Leroux-Roels I, Leroux-Roels G, Parys A, Van Reeth K. Human immunity and susceptibility to influenza A(H3) viruses of avian, equine, and swine origin. Emerg Infect Dis. 2023 Jan. doi: https://doi.org/10.3201/eid2901.220943 https://wwwnc.cdc.gov/eid/article/29/1/22-0943_article Posted in: Medical Science News | Medical Research News | Disease/Infection News Tags: Amino Acid, Antibodies, Antibody, Biopsy, Bronchi, Horse, immunity, Infectious Diseases, Influenza, Pandemic, Proliferation, Tissue Culture, Virus Comments (0) Written byPooja Toshniwal PahariaPooja Toshniwal Paharia is an oral and maxillofacial physician and radiologist based in Pune, India. Her academic background is in Oral Medicine and Radiology. She has extensive experience in research and evidence-based clinical-radiological diagnosis and management of oral lesions and conditions and associated maxillofacial disorders. Download PDF Copy Citations Please use one of the following formats to cite this article in your essay, paper or report:APAToshniwal Paharia, Pooja Toshniwal Paharia. (2022, December 20). The infection potential of influenza A viruses H3 subtype of avian, equine, and swine origin in humans. News-Medical. Retrieved on November 11, 2024 from https://www.news-medical.netews/20221220/The-infection-potential-of-influenza-A-viruses-H3-subtype-of-avian-equine-and-swine-origin-in-humans.aspx.MLAToshniwal Paharia, Pooja Toshniwal Paharia. "The infection potential of influenza A viruses H3 subtype of avian, equine, and swine origin in humans". News-Medical. 11 November 2024. <https://www.news-medical.netews/20221220/The-infection-potential-of-influenza-A-viruses-H3-subtype-of-avian-equine-and-swine-origin-in-humans.aspx>.ChicagoToshniwal Paharia, Pooja Toshniwal Paharia. "The infection potential of influenza A viruses H3 subtype of avian, equine, and swine origin in humans". News-Medical. https://www.news-medical.netews/20221220/The-infection-potential-of-influenza-A-viruses-H3-subtype-of-avian-equine-and-swine-origin-in-humans.aspx. (accessed November 11, 2024).HarvardToshniwal Paharia, Pooja Toshniwal Paharia. 2022. The infection potential of influenza A viruses H3 subtype of avian, equine, and swine origin in humans. News-Medical, viewed 11 November 2024, https://www.news-medical.netews/20221220/The-infection-potential-of-influenza-A-viruses-H3-subtype-of-avian-equine-and-swine-origin-in-humans.aspx. Suggested Reading WHO announces recommended viral composition for 2025 influenza vaccinesUnraveling the mechanism of Shufeng Jiedu Capsules in influenza treatmentNew project launched to accelerate development and accessibility of H5N1 mRNA vaccine candidatesStudy confirms flu vaccine effectiveness against A H1N1 in young childrenA call for robust H5N1 influenza preparedness and responseSeasonal influenza adapted and evolved during the COVID-19 pandemicStudy reveals distinct genetic risk factors for influenza and COVID-19Study reveals a promising approach to developing universal influenza vaccine Comments The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical. Cancel reply to comment Post a new comment Login (Logout) Quirky Comment Title Post TrendingStories LatestInterviews Top HealthArticles Traditional Chinese herb shows promise against Alzheimer’s and Parkinson’sAncient herb shows promise in fighting dementiaBreakthrough research reveals how to target malignant DNA in aggressive cancersLink between COVID-19 and long-term risk of autoimmune and autoinflammatory connective tissue disordersHow calcium and magnesium deficiencies impact cognitive health Exploring the G:Box and for high-quality imaging Dr Martin Biggs In this interview, News Medical speaks with Dr Martin Biggs from Synoptics about Syngene's G:Box, a high-quality imaging and gel documentation system. Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024 Carolyn Marks and Joel Svensson In this interview, conducted at SfN 2024 in Chicago, News Medical speaks with Joel Svensson and Carolyn Marks of Atlas Antibodies, about their new launch, the MolBoolean™, as well as how conferences like SfN are helping shape the future of neuroscience research. How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics Susan Magsamen The intersection of arts and neuroscience reveals transformative effects on health and learning, as discussed by Susan Magsamen in her neuroaesthetics research. Why You Might Feel Tired After Drinking CoffeeMythbusting: The 10,000 Steps Per Day TrendCan Magnesium Supplements Help You Sleep Better?Challenges in the Global ADHD Medication Supply ChainHow Does Semaglutide Work to Lose Weight? Latest NewsNew discovery reveals how mutant RAS genes drive tumor growthTargeted degradation of Pin1 shows promise for pancreatic cancer treatmentFrailty increases a person's risk of dementia, study findsDiscrimination may drive postpartum weight retention in Black womenResearchers develop new antibody with potential to treat several types of cancer Newsletters you may be interested in Infectious Diseases (Subscribe or Preview) Gastroenterology (Subscribe or Preview) Respiratory Diseases (Subscribe or Preview) See all Newsletters » High Credibility: This website adheres to all nine standards of credibility and transparency. Medical Links Medical Home COVID-19 News Health A-Z White Papers Thought Leaders Insights MediKnowledge Series Health & Personal Care Medical Devices Drugs eBooks Life Sciences Links Life Sciences Home News Lab Instruments & Equipment Life Sciences A-Z White Papers Thought Leaders Insights Webinars eBooks Other Useful Links About Meet the Team Search Newsletters Sitemap Advertise Contact Terms & Conditions Privacy & Cookie Policy Content Policy Ownership & Funding Information Other AZoNetwork Sites AZoM AZoNano AZoCleantech AZoOptics AZoRobotics AZoSensors AZoMining AZoQuantum AZoBuild AZoLifeSciences AZoAi Facebook Twitter LinkedIn News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide. Update Your Privacy Preferences Last Updated: Monday 11 Nov 2024 News-Medical.net - An AZoNetwork Site Owned and operated by AZoNetwork, © 2000-2024 Azthena logo with the word Azthena Maximise chat window Hide chat window Your AI Powered Scientific Assistant Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net. To start a conversation, please log into your AZoProfile account first, or create a new account. Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content. Log in A few things you need to know before we start. Please read and accept to continue. Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI. Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy. Large Language Models can make mistakes. Consider checking important information. I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements. Please check the box above to proceed. Start Chat Great. Ask your question. Clear Chat Clear Chat Brief Moderate Detailed Azthena may occasionally provide inaccurate responses. Read the full terms. Terms While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided. Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles. Please do not ask questions that use sensitive or confidential information. Read the full Terms & Conditions. Provide Feedback Submit Cancel You might also like... × Research identifies respiratory transmission potential of H5N1 virusHighly pathogenic avian influenza continues to spread in Missouri Search Query Show Search Home News Health Education Business & Economy Local Government State Government Arts Science Culture Environment Health Education Business & Economy Local Government State Government Arts Science Culture Environment Programs Schedule Local News and Arts Shows Local Music Shows Hosts/Staff Sense of Community Schedule Local News and Arts Shows Local Music Shows Hosts/Staff Sense of Community Support Donate Now Update Payment Method Increase Monthly Gift Become a Volunteer Planned Giving Corporate Support Vehicle Donation More Ways to Give Donate Now Update Payment Method Increase Monthly Gift Become a Volunteer Planned Giving Corporate Support Vehicle Donation More Ways to Give Community Calendar Submit an Event Submit an Event Tune In KSMU - Over the Air & Streaming KSMU - Over the Air & Streaming © 2024 KSMU Radio Menu Show Search Search Query DONATE Play Live Radio Next Up: 0:00 0:00 0:00 0:00 Available On Air Stations On Air Now Playing KSMU HD1 On Air Now Playing KSMU HD2 All Streams Home News Health Education Business & Economy Local Government State Government Arts Science Culture Environment Health Education Business & Economy Local Government State Government Arts Science Culture Environment Programs Schedule Local News and Arts Shows Local Music Shows Hosts/Staff Sense of Community Schedule Local News and Arts Shows Local Music Shows Hosts/Staff Sense of Community Support Donate Now Update Payment Method Increase Monthly Gift Become a Volunteer Planned Giving Corporate Support Vehicle Donation More Ways to Give Donate Now Update Payment Method Increase Monthly Gift Become a Volunteer Planned Giving Corporate Support Vehicle Donation More Ways to Give Community Calendar Submit an Event Submit an Event Tune In KSMU - Over the Air & Streaming KSMU - Over the Air & Streaming News Highly pathogenic avian influenza continues to spread in Missouri KSMU | By Michele Skalicky Published December 21, 2022 at 5:00 AM CST Facebook Twitter LinkedIn Email klimkin / Pixabay A rooster and hens A total of 478,820 birds have been affected in the state so far. The Highly Pathogenic Avian Influenza A (H5N1) continues to infect domesticated birds in Missouri and across the United States.According to the U.S. Department of Agriculture, so far eight commercial flocks have been affected and eight backyard flocks have been impacted by the virus. The total number of birds affected in Missouri to date is 478,820. That includes commercial turkey, domesticated waterfowl and chickens. "It's not concentrated necessarily in one area. It's across the state, so it's important that we continue to stay vigilant as this virus has not left with the birds that are migrating to the south," said Christi Miller, spokesperson for the Missouri Department of Agriculture. She said anyone with backyard chickens, geese and ducks should keep them away from wild waterfowl."Don't let them co-mingle," said Miller. "Don't let them drink at the same stream the same pond, the same creek, Keep them away from the same food sources."She urged those with domesticated chickens, geese, ducks or turkeys to keep them contained during this time of virus spread.The virus appears to spread through droppings, so she suggested having shoes that are worn only in a coop and nowhere else. If you share farm equipment, disinfect it between uses. And watch for sickness, a quieter than usual flock and a higher than usual mortality rate.If you suspect HPAI, contact your veterinarian or the Missouri Department of Agriculture.Miller said, compared to previous avian influenza outbreaks, this one has had a much greater impact.HPAI has impacted 47 states so far, including 301 commercial flocks and 401 backyard flocks.While it has spread to humans, the risk remains low. “Human infections with bird flu viruses have occurred most often after unprotected contact with infected birds or surfaces contaminated with bird flu viruses,” according to the Centers for Disease Control and Prevention. The CDC said monitoring for human infection and person-to-person spread is “extremely important for public health” because of the possibility that bird flu viruses could change and gain the ability to spread easily between people.Christi Miller said the food supply is safe and that you should not stop buying egg, meat and poultry products. Tags News Missouri Department of AgricultureHighly pathogenic avian influenza Facebook Twitter LinkedIn Email Michele Skalicky Michele Skalicky has worked at KSMU since the station occupied the old white house at National and Grand. She enjoys working on both the announcing side and in news and has been the recipient of statewide and national awards for news reporting. She likes to tell stories that make a difference. Michele enjoys outdoor activities, including hiking, camping and leisurely kayaking. See stories by Michele Skalicky © 2024 KSMU Radio Contact Public Inspection Files Support KSMU Schedule About Us Employment Refund PolicyWhy are children catching so many illnesses like flu, RSV and strep A this winter? | New Scientist Close Advertisement Skip to content Sign in Search the website Events Tours Shop Courses Jobs Subscribe now Explore by section News Features Newsletters Podcasts Video Comment Culture Crosswords | This week's magazine Explore by subject Health Space Physics Technology Environment Mind Humans Life Mathematics Chemistry Earth Society Explore our products and services Events Tours Shop Courses Jobs Subscribe now Subscribe now Insight and Health Why are children catching so many illnesses this winter? Many countries in the northern hemisphere are seeing surges of childhood respiratory infections like influenza and RSV. While this is partly because child infections fell during covid-19 restrictions, that isn’t the whole story By Michael Marshall 20 December 2022 Facebook / Meta Twitter / X icon Linkedin Reddit Email Hospitalisations among children for some respiratory infections have been higher than usual in multiple countries this year.Yanukit Raiva/EyeEm/Getty Images After two long winters of covid-19, now the northern hemisphere is enduring a difficult season of multiple infectious illnesses. Other respiratory infections, like influenza and those caused by respiratory syncytial virus (RSV), are running rampant, particularly in children – leading to waves of hospitalisations and a number of deaths. While it is normal for respiratory infections to spike in the coldest months, the timing of the waves and the number of hospitalisations both in children and the wider population… Advertisement Sign up to our weekly newsletter Receive a weekly dose of discovery in your inbox! We'll also keep you up to date with New Scientist events and special offers. Sign up To continue reading, subscribe today with our introductory offersUnlock this articleNo commitment, cancel anytime*Offer ends 15 January 2025.*Cancel anytime within 14 days of payment to receive a refund on unserved issues.Inclusive of applicable taxes (VAT)orExisting subscribersSign in to your account Advertisement More from New Scientist Explore the latest news, articles and features Health Strep A kills 500,000 people a year, so why isn’t there a vaccine? AnalysisSubscriber-only Health Flu, RSV and cost of living will all harm UK child health this winter NewsSubscriber-only Health The covid-19 pandemic’s third year saw countries adopt new approaches NewsSubscriber-only Health Promising universal flu vaccine could protect against 20 strains NewsFree Popular articles Trending New Scientist articles 1 Lights on surfboards and wetsuits could deter shark attacks 2 How a single gopher restored a landscape devastated by a volcano 3 DNA analysis rewrites the stories of people buried in Pompeii 4 Humanity has warmed the planet by 1.5°C since 1700 5 Quantum batteries could give off more energy than they store 6 The best new science fiction books of November 2024 7 The complete guide to cooking oils and how they affect your health 8 Quantum holograms can send messages that disappear 9 Quantum Rubik's cube has infinite patterns but is still solvable 10 Is the climate change food crisis even worse than we imagined? Advertisement Download the app Find us on social media Instagram Facebook X / Twitter Tiktok LinkedIn WhatsApp Subscriptions Subscriber benefits Gift Student & graduate Educational Corporate Support Contact us Help About us Press room Advertise Write for us Tools Events Science Jobs CoLab Syndication RSS feeds Legal and privacy Complaint policy Privacy policy Cookie policy Terms & conditions Cookie Settings © Copyright New Scientist Ltd. Back to the topChildren are dying from flu. Some provinces are slow to report it — and these experts say that's dangerous | CBC News ContentSkip to Main ContentAccessibility HelphamburgerMenuWhen search suggestions are available use up and down arrows to review and enter to select.SearchSearchSign InQuick LinksNewsSportsRadioMusicListen LiveTVWatchnewsTop StoriesLocalClimateWorldCanadaPoliticsIndigenousBusinessThe NationalHealthEntertainmentScienceCBC News InvestigatesGo PublicAbout CBC NewsBeing Black in CanadaMore Children are dying from flu. Some provinces are slow to report it — and these experts say that's dangerous | CBC News LoadedHealthChildren are dying from flu. Some provinces are slow to report it — and these experts say that's dangerousWith influenza sending Canadian children to hospital at rates far above normal for this time of year, there are calls for provincial health systems to be more transparent about pediatric flu deaths and the severity of communicable diseases because it can help people protect themselves and in this case, their kids.Influenza deaths among Canadian kids running higher this year than in typical flu seasonMike Crawley · CBC News · Posted: Dec 18, 2022 4:00 AM EST | Last Updated: December 18, 2022Health-care workers are shown in the intensive care unit at Toronto's Hospital for Sick Children on Wednesday, Nov. 30. Only a few weeks into this flu season, 11 deaths have already been reported among children and teens across the country, according to research by CBC News. (Chris Young/Canadian Press)Social SharingWith influenza sending Canadian children to hospital at rates far above normal for this time of year, there are calls for provincial health systems to be more transparent about pediatric flu deaths. Influenza rarely kills children in Canada. Over the past decade, there have never been more than 13 deaths in a year from the flu among those age 19 or younger, and the pre-pandemic yearly average was nine, according to Public Health Agency of Canada figures. Yet only a few weeks into this flu season, 11 deaths have already been reported among children and teens across the country, according to research by CBC News.Health officials urge parents to have children vaccinated amid 'dramatic increase' in flu casesQ&AHow to protect yourself from a triple-threat of viruses this holiday seasonFlu death numbers not easily availableThe provinces have not made it easy to find out how many kids have died from flu this year. Earlier this month, British Columbia announced publicly that the flu had killed at least five children in November, but only after the details of an internal conversation involving hospital officials was leaked to a media outlet earlier this month. A child receives her influenza vaccine with her family at a Fraser Health vaccination clinic in Surrey, B.C., on Dec. 7. Experts say the transparent reporting of child flu deaths makes it clear that people should treat the illness seriously. (Ben Nelms/CBC)At the same time, when CBC News asked other provinces about pediatric flu deaths, officials in Ontario declined to provide any statistics. Only Alberta provided information right away: two children in that province have died of flu so far this fall. Manitoba reported one death this week, and British Columbia has now confirmed six pediatric deaths linked to flu. Some experts say providing timely information about the severity of a communicable disease like the flu can help people protect themselves and in this case, their kids.The Dose2 Montreal children have died from group A strep complications. Here's what parents need to knowQ&AThe difference between a strep A infection and strep throat"Not being transparent about the number of children dying due to the flu is dangerous for our children," said Irwin Elman, Ontario's former child advocate. (There is no current child advocate in the province because the position was eliminated by Premier Doug Ford's government early in its first term.)"I see no reason why releasing the numbers would be an affront to anybody's privacy," said Elman in an interview. Reporting B.C. deaths triggered surge in flu shotsDr. Rod Lim, head of pediatric emergency at the London, Ont., Health Sciences Centre, said the take away for people from transparent reporting of child flu deaths is to treat the illness seriously. "We know that this is an extremely difficult influenza season across Canada," said Lim during a virtual news conference organized by the Ontario Medical Association this week.WATCH | B.C. children's hospital double bunking flu patients: Flu surge has B.C. kids' hospital double-bunking patients2 years agoDuration 4:13The surge in influenza cases has B.C. Children's Hospital getting ready to double-bunk patients in single rooms. At least six children have died in B.C. after contracting the flu this fall."If the numbers are accurate and reliable, that kind of information can help inform the public and can be useful to encourage people to seek and listen to public health advice," he said. B.C.'s revelation of its pediatric flu deaths provides a concrete example of how this can work: it triggered a surge in parents bringing their kids to get vaccinated against the flu. Why doctors recommend you get a flu shot this weekB.C. launches flu vaccination blitz after deaths of 6 children and youthA spokesperson for the B.C. Coroners Service, which released the statistics, said in an email: "Part of our role is to improve public safety, and we wanted to ensure the public was aware."Transparency key, health officials sayDr. Theresa Tam, Canada's chief public health officer, was asked whether there's a benefit to public reporting of child flu deaths. "Information is extremely important for informing the population about measures to take to protect themselves, that is a fundamental aspect of public health," said Tam in a news conference this week.In October 2020, doctors at the South Hill Family Health Centre in Vancouver provided flu shots to their patients in their underground parking lot. (Ben Nelms/CBC)The Public Health Agency of Canada's weekly flu watch report issued Friday tallies only five pediatric deaths so far this season. That is due to a lag after provinces confirm the deaths before they are added to the federal report."We've gained some capacity from the COVID experience to show that we are capable of monitoring specific health information in real-time in an urgent situation, so I think we can build on that," said Tam.CHEO flu admissions still soaring after near-record monthNon-urgent pediatric surgeries postponed at Winnipeg children's hospital amid unprecedented flu seasonWhen CBC News tried to establish how many children had died from flu in Ontario, three different provincial agencies refused to provide figures. The office of the chief coroner said the information should come from Public Health Ontario (PHO), but PHO said to ask the Ministry of Health. A spokesperson for the ministry referred a CBC producer back to the public health agency. WATCH | How masks and flu vaccines can help children's hopsitals: Masks, flu vaccines could help reduce pressure on children’s hospitals2 years agoDuration 2:34Children’s hospitals are being forced to take drastic measures to cope with an intense respiratory virus season, including one pediatric hospice that discharged its respite patients. Experts are calling for concrete solutions immediately.Separately, a spokesperson for the Ministry of Health told the Ottawa Citizen that information about flu deaths in Ontario is not made public. Dr. Kieran Moore, Ontario's chief medical officer of health, later contradicted that in an interview with CBC News this week and confirmed two pediatric flu deaths.N.B. breaks record for flu cases and hospitalizations, as RSV and COVID-19 cases climbDr. Strang urges caution during holiday season as flu season hits early"We don't cover up any of those facts," Moore said on Thursday. "In Ontario, a sudden death of a child is investigated by a coroner and sometimes it takes time to do all of the investigation and aggregate that data," Moore said. "But you have a commitment from us, we want to be transparent with all of this data to Ontarians."ABOUT THE AUTHORMike CrawleySenior reporterMike Crawley covers health for CBC News. He began his career as a newspaper reporter in B.C., filed stories from 19 countries in Africa as a freelance journalist, then joined the CBC in 2005. Mike was born and raised in Saint John, N.B.Follow Mike Crawley on TwitterCBC's Journalistic Standards and Practices|About CBC NewsCorrections and clarifications|Submit a news tip|Report errorRelated Stories How Canada's largest pediatric hospital's ICU was saved from near collapse Inside an Ontario hospital bracing for a surge in adult patients — while overflowing with sick kidsFooter LinksMy AccountProfileCBC GemNewslettersAbout CBC AccountsConnect with CBCFacebookXYouTubeInstagramMobileRSSPodcastsContact CBCSubmit FeedbackHelp CentreAudience Relations, CBC P.O. Box 500 Station A Toronto, ON Canada, M5W 1E6 Toll-free (Canada only): 1-866-306-4636About CBCCorporate InfoSitemapReuse & PermissionTerms of UsePrivacyPrivacy PreferencesJobsOur UnionsIndependent ProducersPolitical Ads RegistryAdChoicesServicesOmbudsmanCorrections and ClarificationsPublic AppearancesCommercial ServicesCBC ShopDoing Business with UsRenting FacilitiesRadio Canada InternationalCBC LiteAccessibilityIt is a priority for CBC to create products that are accessible to all in Canada including people with visual, hearing, motor and cognitive challenges.Closed Captioning and Described Video is available for many CBC shows offered on CBC Gem.About CBC AccessibilityAccessibility Feedback©2024 CBC/Radio-Canada. All rights reserved. Visitez Radio-Canada.canowBay Port student dies from complications caused by flu and strep B Skip to contentSmall Towns3 Brilliant MinutesWisconsin Adventures2 Your HealthAsk The ExpertAllergyTrackNewsWatch LiveWeather2025 NFL DraftSportsSafety DeskConsumer First AlertFirst Alert TrafficHomepageWBAY HistoryNewsAction 2 News This Morning LIVESTREAMCommunityCrimeHealthHigh SchoolInternationalNationalPoliticsSmall TownsStateVideosLive NewscastsBreaking News VideoWeatherWeather AlertsClosingsFirstAlert Weather 24/7Pinpoint Digital DopplerMap RoomSkyCam NetworkAllergyTrackSevere Weather SafetyGet Our Weather AppGet a Weather Radio2025 NFL DraftSportsScoreboardPackersOperation FootballNationalFirst Alert TrafficContact Us2 Your HealthAsk The ExpertBirthday ClubCircle CountryCommunity CalendarConsumer First AlertFeatured LinksGas TrackerGray DC BureauInvestigateTVWatching Your WalletInvestigationLotteryMeet the TeamPowerNationRecallsSafety DeskSubmit a TipSubmit Photos and VideosSnow & Ski ReportNEXTGEN TVWBAY JobsZeam - News StreamsWBAY MarketingWhat's on TVDigital MarketingBay Port student dies from complications caused by flu and strep BAva Schmidt(GoFundMe)By WBAY news staffPublished: Dec. 23, 2022 at 10:42 AM CST|Updated: Dec. 23, 2022 at 11:59 AM CSTEmail This LinkShare on FacebookShare on X (formerly Twitter)Share on PinterestShare on LinkedInHOWARD, Wis. (WBAY) - A Bay Port High School student died from complications caused by a mix of Influenza A and Strep B.According to the Howard-Suamico School DistrictAva Schmidt died Wednesday. She was a freshman at Bay Port High School.The district sent the following letter to the school community:“Dear HSSD Families and Staff,It is with deep sadness that we are sharing with you news of the death of a Bay Port High School student.Ava Schmidt, a freshman at Bay Port High School, died today, Wednesday, December 21, due to complications caused by Influenza A. Ava is the daughter of Mike and Katerina Schmidt and the sister of Gabby, a seventh grader at Bay View Middle School. Katerina is a teacher at Forest Glen Elementary School.The District respects the family’s request for privacy during this difficult time and is focused on providing support for those impacted by Ava’s passing.School counselors and school social workers are available to help our students and staff cope with this loss. To support student needs we will have staff available at Bay Port or by phone at 920-662-7000 Thursday morning (regardless of potential weather impact on the school day). Classroom teachers at Bay Port, Bay View, and Forest Glen will share an age-appropriate message with students Thursday morning regarding this news. We encourage you to discuss this message with your child at home this evening.We have some suggestions (linked here) that may prove helpful to you as you discuss grief and death with your child. Additionally, Unity Hospice is a non-profit grief counseling organization that will be supporting Ava’s classmates and our students as needed in the coming days, including during winter break.If you have any concerns about your child’s reaction to this loss, please contact us.Our thoughts and prayers are with Ava’s family.”A GoFundMe has been set up for Ava’s family.Ava was the second pediatric influenza patient to die in Wisconsin this season.DHS announced the first pediatric flu death earlier this week. They said the child lived on the western side of Wisconsin.A pediatric death is defined as anyone under the age of 18.DHS encourages everyone six months and older to get vaccinated against the flu. Early data shows the vaccine is a match to current strains. Vaccines can prevent or reduce the severity of flu symptoms, protecting not only yourself but the people around you, and that’s especially a concern with more holiday gatherings coming up. Two out of 3 people in Wisconsin have not received a flu shot.“Those numbers are several percentage points lower than what we had last year, and it’s very disappointing to be honest with you. And this again is one of our meetings, going through media outlets, is really pushing the fact that we need to get people vaccinated. We need to do what we can to stop the spread of influenza. And we, unfortunately, have seen what the complications can lead to during because of this particular case, in this particular child,” DHS influenza surveillance coordinator Tom Haupt said.You can find information on flu vaccines by calling 877-947-2211 or visiting the https://www.vaccines.gov/ website.Local health officials say people should also try to avoid the spread of COVID-19 and RSV.All three illnesses have the potential to be severe for young children, people who are immunocompromised, and older adults.CLICK HERE for Wisconsin respiratory virus reports.DHS recommends these additional steps to stay healthy this season:Wash your hands often with soap and water for 20 seconds.Avoid touching your nose, eyes, and mouth.Stay home and away from others if you feel sick.Avoid being around others who are sick or have flu symptoms.Cover your nose and mouth when you cough or sneeze and encourage children to do the same.Wear a high-quality mask around others to prevent the spread of respiratory illnesses.Copyright 2022 WBAY. All rights reserved.Most Read Kayaker reported missing in Green Lake faked his disappearance, authorities believeVeterans Day 2024 freebies, discounts and donationsAppleton police looking for armed robber Companies prepare to hike prices to offset Trump's tariff plans 49 years later, Edmund Fitzgerald crew remembered in memorial ceremony1 arrested, 1 injured in Forest County shooting Trump on Day 1: Begin deportation push, pardon Jan. 6 rioters and make his criminal cases vanish Veterans Day 2024 eventsLatest News ‘Awesome way to thank our veterans’: Brandon School celebrates 25th, last Veterans Day ceremony‘Awesome way to thank our veterans’: Brandon School celebrates 25th, last Veterans Day ceremony Wisconsin Supreme Court grapples with whether state’s 175-year-old abortion ban is validWisconsin Supreme Court grapples with whether state's 175-year-old abortion ban is validJack Del Rio leaving Wisconsin’s staff after arrest on charge of operating vehicle while intoxicated Veterans Day ceremony at Green Bay Neville Public MuseumVeterans Day ceremony at Green Bay Neville Public Museum$1 million bond set for man charged in fatal hit-and-run in Oconto CountyNewsWeatherSportsBirthday ClubGas TrackerSubmit Photos and VideosTV ProgrammingRecallsSmall Towns3 Brilliant Minutes2 Your Healthnews@wbay.comWBAY115 S. Jefferson St.Green Bay, WI 54301(920) 432-3331Public Inspection FilePublic File Assistance Contact - (920) 432-3331Terms of ServicePrivacy PolicyEEO StatementFCC ApplicationsAdvertisingClosed Captioning/Audio DescriptionDigital MarketingAt Gray, our journalists report, write, edit and produce the news content that informs the communities we serve. Click here to learn more about our approach to artificial intelligence.A Gray Local Media Station © 2002-2024Towards a universal flu vaccine | Nature Materials Skip to main content Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement View all journals Search Log in Explore content About the journal Publish with us Sign up for alerts RSS feed nature nature materials news & views article Towards a universal flu vaccine Download PDF Download PDF News & Views Published: 20 December 2022 mRNA vaccinesTowards a universal flu vaccine Cristina Lo Giudice1 Nature Materials volume 22, page 407 (2023)Cite this article 2233 Accesses 1 Citations 11 Altmetric Metrics details Subjects Biomaterials – vaccinesRNA vaccines Licensed influenza vaccines contain three or four strains of either inactivated or live attenuated influenza viruses and need to be reformulated annually for the Northern and Southern Hemispheres due to the continuous virus evolution that enables escape from natural immunity. Annually, global monitoring of the genetic drift of circulating strains guides the vaccine formulation. The approach has proved useful in preserving public health, but it is not ideal since the vaccine efficacy varies yearly and typically lies below 60%. Credit: reprinted with permission from AAASNow, Arevalo et al. report on a multivalent mRNA lipid nanoparticle vaccine that elicits antibodies against all known influenza virus subtypes (Science 378, 899–904; 2022). There are currently at least 18 influenza A and 2 influenza B subtypes in nature, all containing the viral protein hemagglutinin (HA) (top panel). Most attempts at generating universal influenza vaccines focus on generating cross-reactive antibodies against HA epitopes that are conserved across several virus subtypes. A variety of such formulations is currently undergoing clinical trials. However, none of the reported ones are effective against all 20 subtypes. Arevalo et al. took a radically different yet conceptually simple approach based on incorporating 20 different antigens derived from every known influenza virus subtype into a single vaccine formulation so that a variety of distinct antibodies could be generated after a single injection. Notably, this is only practically achievable thanks to mRNA vaccine technology.The researchers had previously observed that substituting the nucleoside uridine with a modified pseudouridine led to mRNA with a higher translational capacity, and used this approach to develop an mRNA lipid nanoparticle vaccine capable of eliciting antibodies against both HA head and stalk of a single influenza virus subtype. Now, by first optimizing 20 HA-encoding mRNA lipid nanoparticle vaccines for each influenza A and B subtype individually and subsequently combining them in a single cocktail formulation, the researchers were able to generate a nucleoside-modified mRNA lipid nanoparticle vaccine protecting against all the subtypes, with antibody levels remaining stable up to 118 days after the first injection in mice (top panel). The vaccine offers different levels of protection to matched and mismatched viral challenges in mice and ferrets, ranging from effective virus neutralization for matched viruses to largely reduced infection severity and duration via non-neutralizing mechanisms for mismatched viruses (bottom panel). While the approach is still in its infancy, it is broad-spectrum, potentially increasing vaccine efficacy and eliminating the need for annual vaccine reformulation. Moreover, its principles can be easily translated to other viruses, including coronaviruses, offering new directions for vaccine development via mRNA lipid nanoparticle technology. Author informationAuthors and AffiliationsNature Materials https://www.nature.comaturematerialsCristina Lo GiudiceAuthorsCristina Lo GiudiceView author publicationsYou can also search for this author in PubMed Google ScholarCorresponding authorCorrespondence to Cristina Lo Giudice.Rights and permissionsReprints and permissionsAbout this articleCite this articleLo Giudice, C. Towards a universal flu vaccine. Nat. Mater. 22, 407 (2023). https://doi.org/10.1038/s41563-022-01452-6Download citationPublished: 20 December 2022Issue Date: April 2023DOI: https://doi.org/10.1038/s41563-022-01452-6Share this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative This article is cited by Engineered probiotic Escherichia coli elicits immediate and long-term protection against influenza A virus in mice Ling HuangWei TangYangbo Hu Nature Communications (2024) Download PDF Advertisement Explore content Research articles Reviews & Analysis News & Comment Current issue Collections Subjects Follow us on Facebook Follow us on Twitter Sign up for alerts RSS feed About the journal Aims & Scope Our publishing models Journal Information Journal Metrics About the Editors Research Cross-Journal Editorial Team Reviews Cross-Journal Editorial Team Editorial Values Statement Editorial Policies Content Types Web Feeds Contact Publish with us Submission Guidelines For Reviewers Language editing services Submit manuscript Search Search articles by subject, keyword or author Show results from All journals This journal Search Advanced search Quick links Explore articles by subject Find a job Guide to authors Editorial policies Nature Materials (Nat. Mater.) ISSN 1476-4660 (online) ISSN 1476-1122 (print) nature.com sitemap About Nature Portfolio About us Press releases Press office Contact us Discover content Journals A-Z Articles by subject protocols.io Nature Index Publishing policies Nature portfolio policies Open access Author & Researcher services Reprints & permissions Research data Language editing Scientific editing Nature Masterclasses Research Solutions Libraries & institutions Librarian service & tools Librarian portal Open research Recommend to library Advertising & partnerships Advertising Partnerships & Services Media kits Branded content Professional development Nature Careers Nature Conferences Regional websites Nature Africa Nature China Nature India Nature Italy Nature Japan Nature Middle East Privacy Policy Use of cookies Your privacy choices/Manage cookies Legal notice Accessibility statement Terms & Conditions Your US state privacy rights © 2024 Springer Nature Limited Close banner Close Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily. Email address Sign up I agree my information will be processed in accordance with the Nature and Springer Nature Limited Privacy Policy. Close banner Close Get the most important science stories of the day, free in your inbox. Sign up for Nature BriefingSuamico's Ava Rae Schmidt dies of flu; Wisconsin's 2nd pediatric deathSkip to main content HomeElection 2024Voter GuideNewsSportsPackersBusinessHealthCommunitiesNation / WorldObituarieseNewspaperLegals 14-year-old from Suamico dies of influenza, becoming Wisconsin's second pediatric flu deathKelly Meyerhofer , Jessica Van Egeren Milwaukee Journal SentinelShow Caption Hide Caption RSV, Influenza, COVID-19: What you need to knowThere's a strong possibility of a tripledemic this winter. Here's what you need to know.Self Improved, Problem SolvedAs flu cases continue to rise, state health officials confirmed Friday that a second Wisconsin child has died of influenza.Citing privacy concerns, the state Department of Health Services declined to provide details on the death, including the child's age, gender, location and flu vaccination status.But an obituary and GoFundMe page identified the child as Ava Rae Schmidt, 14, of Suamico, who died Wednesday "after a very short fight with Influenza A and Strep B."Schmidt became sick over the weekend and went into sepsis by Monday evening, according to Facebook posts from her mother, Katerina Schmidt. On the way to a Green Bay hospital, her daughter became unresponsive, so the mom performed CPR. Schmidt was eventually transferred to Children's Hospital in Milwaukee.Schmidt was a straight-A student in her freshman year at Bay Port High School who had just received a 99% on a recent exam and told her dad she could have gotten 100%, according to her obituary and the GoFundMe page created by her godmother, Kerry Reis.Schmidt loved shopping, painting, animals and was "always ready for the next babysitting job." She danced at a Green Bay dance company and recently told her mom she couldn't see an upcoming solo performance because she wanted it to be a surprise."She was so thoughtful and was always looking for ways to show you she loved you. Whether it was a Starbucks drink, an order of cheese curds or just a hug she wanted to find a way to put a smile on your face," Reis wrote on the GoFundMe page. "She was a planner and had everything from her sixteenth birthday to her wedding day planned."The state health department earlier this week announced the influenza-related death of a child in western Wisconsin the first pediatric influenza death this season. That child showed no evidence of receiving a flu shot earlier this year, officials said.Nationally, 47 children have died from complications related to the flu, according to the Centers for Disease Control and Prevention.Wisconsin typically sees three to four pediatric flu deaths a year, said Tom Haupt, the health department's influenza surveillance coordinator. Flu rates in the past few years, however, have been lower because so many more people took precautions during the pandemic, such as wearing masks and washing their hands, that also helped prevent catching the flu.Health officials have warned that flu cases are spiking earlier than in previous seasons and urge everyone who is 6 months or older to get vaccinated. State data show only 1 in 3 Wisconsinites had gotten their annual flu shot as of Friday, which is lower than in past years.Find where to get a flu shot by visiting vaccines.gov, or calling 211 or 877-947-2211.Our subscribers make this reporting possible. Please consider supporting local journalism by subscribing to the Journal Sentinel at jsonline.com/deal.DOWNLOAD THE APP: Get the latest news, sports and more Facebook Twitter EmailShare your feedback to help improve our site!HelpTerms of ServiceSubscription Terms & ConditionsPrivacy PolicySite MapAccessibilityOur Ethical PrinciplesResponsible DisclosureYour Privacy Choices © Copyright Gannett 2024Netherlands experiencing multiple respiratory viruses; now also flu epidemic | RIVM Skip to main content Skip to main navigation National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport Nederlands English RIVM Committed to health and sustainability Menu Home Topics About RIVM Publications International Contact Agenda Nederlands English Search form Search Search Home News Netherlands experiencing multiple respiratory viruses; now also flu epidemic Netherlands experiencing multiple respiratory viruses; now also flu epidemic Publication date 23-12-2022 | 17:12 The Netherlands is experiencing a flu epidemic. The number of people with flu (influenza) increased significantly in the past two weeks. Laboratories, hospitals and GPs throughout the country report that the flu virus has been turning up in more throat and nasal samples from people with flu-like symptoms. More and more people contact their GP with flu-like symptoms. In addition to the flu virus, several other viruses that cause respiratory symptoms are currently circulating in the Netherlands. They include the respiratory syncytial virus (RSV), the SARS-CoV-2 virus (coronavirus), the human metapneumovirus and the rhinovirus. Each week, 19 laboratories in the Netherlands report the number of patients with a particular viral infection, including infection with the flu virus. For the second consecutive week, these laboratories have reported a significant increase in the number of people who have the flu. Laboratories have also been sending more flu samples to the Dutch National Influenza Centre to identify specific strains of the flu virus. Lastly, GPs have seen a growing number of people with flu-like symptoms who indeed have the flu, according to information from the Nivel monitoring stations. All of this information together indicates that there is a flu epidemic. Flu epidemic threshold In the Netherlands, the normal threshold for declaring a flu epidemic is as follows: more than 58 in 100,000 people visit their GP with flu-like symptoms for two weeks in a row, and at least 10 per cent of those people are indeed infected with the flu virus. This is monitored by the Nivel monitoring stations. As was the case during the winter of 2021–2022, it is currently difficult to establish if there is a flu epidemic based on these figures alone. This is because the symptoms of the flu strongly resemble those of COVID-19. Many people with flu-like symptoms are currently self-testing for the coronavirus, which may make them less likely to consult a GP. Although the threshold of 58 in 100,000 people visiting their GP with flu-like symptoms has not been reached yet, the Nivel monitoring stations have noted a sharp increase in patients with flu-like symptoms. RIVM has also detected flu viruses in a growing number of these patients’ samples. About the flu The onset of ‘real’ flu (influenza) is usually quite sudden, with cold shivers, a runny nose, a headache, severe muscle aches and fatigue, a sore throat, a dry cough and a fever. The patient’s body temperature may quickly rise to 39 °C or higher. In addition to the flu (influenza) virus, various other respiratory viruses can also cause flu-like symptoms. They include the respiratory syncytial virus (RSV), the SARS-CoV-2 virus (coronavirus), the human metapneumovirus and the rhinovirus. These viruses also cause symptoms such as a runny nose, a sore throat, a headache, a cough and possibly a fever. Flu prevention Getting a flu vaccine offers the best protection against serious complications of the flu. The basic recommendations to prevent the spread of the coronavirus also work to prevent the spread of the flu virus. Washing your hands frequently, coughing and sneezing into the fold of your elbow and social distancing reduce the risk of passing the virus to others. The same goes for other respiratory viruses, such as RSV, the human metapneumovirus and the rhinovirus. This is especially important when coming into contact with vulnerable groups of people, such as the elderly and young children. They can become seriously ill from the flu virus and other respiratory viruses. Flu monitoring At the Dutch National Influenza Centre, RIVM, Nivel and the Erasmus MC monitor the development of the flu virus in the Netherlands on an ongoing basis. They also take part in international networks of the World Health Organization (WHO) and the European Centre for Disease Prevention and Control (ECDC). More information Flu and flu vaccine RSV (Respiratory Syncytial Virus) COVID-19 Share this page Facebook X Twitter LinkedIn WhatsApp Email Service Contact Information for the press Working for RIVM Complaints Submitting WOO requests to RIVM Doing business with RIVM About this site Cookies Privacy Accessibility Disclaimer and copyright Responsible disclosure Website archive Languages English Nederlands Follow us RIVM Newsletters RSS feed X Twitter Facebook LinkedIn Youtube Instagram MastodonFAQs: Avian Influenza – SPICe Spotlight | Solas air SPICe Skip to content SPICe Spotlight | Solas air SPICe MENUMENUHomeBusiness & IndustryCulture & SportEconomy & FinanceEducationEnvironment & EnergyEqualitiesEU & International AffairsHealthHousing & PlanningJusticeParliament & GovernmentPeople & CommunitiesRural AffairsSocial SecurityTransport FAQs: Avian Influenza December 21, 2022 SPICe Environment & Energy, Rural Affairs Comments Off on FAQs: Avian Influenza Reading Time: 8 minutes The UK has experienced an unprecedented avian flu outbreak in 2021-22. Similarly, the European Centre for Disease Prevention and Control stated that the 2021-22 epidemic in Europe was “the largest observed in Europe so far”. The Rural Affairs, Islands and Natural Environment (RAINE) Committee heard from Scotland’s Chief Veterinary Officer (CVO) Dr Sheila Voas on 30 November on the avian flu situation in Scotland and across the UK. This blog summarises answers to some of the frequently asked questions around the current avian flu outbreak. Use the contents list below to browse the questions. Contents show 1 What is avian flu? 2 How is avian flu spread between birds? 3 How bad is the current avian flu outbreak? 4 How can avian flu be prevented? 5 How can governments respond to avian flu? 6 Can you vaccinate birds against avian flu? 7 What happens when avian flu is found in wild birds? 8 What happens when avian flu is found in commercial or backyard flocks? 9 Is avian flu causing a shortage of eggs or other poultry products? 10 Is avian flu a threat to humans? 11 Share this: 12 Like this: What is avian flu? Avian influenza, avian flu or bird flu, is a viral disease that is largely spread between birds. It is similar to, but not the same as other strains of influenza virus that causes flu in humans or in other species. It can affect different bird species differently, but in the most affected it can cause rapid illness and death. There are both ‘highly pathogenic’ and ‘low pathogenic’ varieties, which refers to the severity with which it affects birds (not humans). The current outbreak is of a ‘highly pathogenic’ variety. How is avian flu spread between birds? In wild birds, bird flu spreads around the world with migrating species. For the UK, the Chief Veterinary Officer explained to the RAINE Committee that wild birds, particularly water birds, spend summers in their Arctic breeding grounds where populations from all over the world mix. This causes the virus to mutate from year to year. The birds then fly south to the UK where they spend the winter in different parts of the country. There is usually a winter season for bird flu for this reason, though this year was particularly unusual as cases were found into the summer, particularly in seabird populations. In commercial or backyard flocks, avian flu usually spreads through direct contact with migrating wild birds or contact with faeces of an infected bird. This can happen via materials such as bedding. The Chief Veterinary Officer clarified that, at this time of year, it is less likely that the disease will move northward compared to southward, given that migrating birds in the northern hemisphere are generally moving south for warmer weather. She said: “It is not so much that the disease is likely to spread from England to Scotland. Once the wildfowl reach their overwintering grounds, a cold snap will make them move again, and as it is very unlikely that England will be colder than we are, they will tend not to come north again. However, we are monitoring the weather further north. If it becomes very cold in Norway or Iceland, that might drive even more birds south to us, thereby increasing the risk.” How bad is the current avian flu outbreak? The current outbreak is unprecedented. In relation to impacts on commercial flocks , a House of Lords Library briefing published on 14 November 2022 highlights that for the whole of the UK the number of birds culled annually has fluctuated between 0 and 250,000 birds between 2006 and 2020, rising steeply to 3.25m birds in 2022. The Chief Veterinary Officer stated that as of 30 November 2022, 224,000 birds have had to be culled in Scotland; in England nearly 1.7m turkeys and over 2m chickens have had to be culled, as well as ducks and geese. Further outbreaks have been recorded in both Scotland and England since this date. The outbreak has been particularly severe in some parts of England. As of 21 December, 133 cases have been confirmed in England since 1 October 2022. In the same period, 12 cases have been confirmed in Scotland, and a handful of cases in Wales and Northern Ireland respectively. The current outbreak is also having a significant impact on wild bird populations, particularly seabirds. In a letter to the RAINE Committee on 22 August 2022, the Cabinet Secretary for Rural Affairs and Islands outlined the impact on wild birds at that point. Some species have been particularly affected. For example, for the great skua, key colonies such as St Kilda, Fetlar, Handa, Noss and Hermaness were reporting 64-85% population reductions in breeding pairs since the last count. Scotland supports 60% of the world breeding population of great skua. In August, the scale of the impact was estimated to be a loss of 7.7% of the world’s breeding population and 12.8% of the GB breeding population. The letter noted that the full scale of the impact on wild birds will not be known until next year when the birds return to the UK to breed or overwinter. How can avian flu be prevented? The Chief Veterinary Officer emphasised that good biosecurity – hygiene measures to prevent the spread of disease – is ‘the single most important thing that people can focus on’ in preventing the spread of avian flu. Other preventative measures include bringing birds indoors to prevent contact with wild birds, though for housing to be effective in significantly reducing the risk of disease it also requires rigorous biosecurity measures to be in place. The CVO used the example of recent outbreaks among housed birds. It is difficult to prevent avian flu spreading among wild birds. However, the severity of the most recent outbreak of avian flu in wild bird populations has given rise to some precautionary measures. In July 2022, NatureScot advised that public landings (e.g. through boat tours) to 23 Scottish islands should stop during the seabird breeding season, to limit “the spread of avian flu and give seabirds the best possible chance to survive and recover from the current severe outbreak”. NatureScot has set up a Scottish Avian Flu Wild Bird Taskforce to coordinate activity to monitor and minimise the impact of highly pathogenic avian flu in wild birds. How can governments respond to avian flu? The Scottish Government has powers to take steps to reduce the risk of transmission of avian flu. Under the Avian Influenza and Influenza of Avian Origin in Mammals (Scotland) Order 2006, Scottish Ministers have a duty to do one or more of the following if the Scottish Ministers consider it necessary (having carried out a risk assessment) to reduce the risk of spread: Declare an avian influenza prevention zone (APIZ) in all or part of Scotland. Serve a restrictions notice on the occupier of premises where certain poultry or captive birds are kept. The Scottish Government may require birds to be housed or kept separate from wild birds, require that kept birds are provided with feed and water that has not been into contact with wild birds, preventing the use of certain birds as hunting decoys, and requiring extra biosecurity measures. Restrict ‘bird gatherings’ (any situations where birds come together for fairs, markets, shows, exhibitions, etc). An APIZ has been in place across the whole of the UK since October 2022. The APIZ Declaration for Scotland contains a number of biosecurity measures which must be followed while the Zone is in force. The general licence for bird gatherings has not permitted gatherings of pheasants, partridge, quail, chickens, turkey, guineafowl, ducks, geese, swans or poultry since November 2021. Can you vaccinate birds against avian flu? Vaccines are available, but they are not widely used for a number of reasons. Vaccinating captive bird flocks for avian flu is not generally permitted unless it is ordered by Scottish Ministers under specific conditions. This is set out in the Avian Influenza (Slaughter and Vaccination) (Scotland) Regulations 2006. However, Scottish Ministers can order emergency or preventative vaccination in certain situations. As explained to the RAINE Committee by the Chief Veterinary Officer on 30 November 2022, flu vaccines are ‘suppressive’, rather than ‘curative’. This means that vaccinated birds may not show signs of infection but may still carry and spread the disease. This can be a problem for disease detection and for trade. She further explained that, in some cases, it is also not practical to vaccinate. Birds need two doses, several weeks apart, which is not feasible in the short lifespan of a broiler chicken (a chicken produced for meat), for example. There are also obvious practical challenges to vaccinating millions of birds regularly. New strains of avian flu emerge frequently, so as with the seasonal flu vaccine for humans, repeated vaccinations are required. However, further research is ongoing. More information on this can be found on the Animal and Plant Health Agency’s website. What happens when avian flu is found in wild birds? Wild birds are monitored for avian flu. The Scottish Government states that: “The purpose of the surveillance and testing of wild birds is to capture information on the location and strains of avian influenza that might be prevalent in Great Britain. This data then helps government to build up a picture of the current risks, and shapes the response to this risk” The UK-wide Animal and Plant Health Agency is responsible for monitoring and surveillance of avian flu in wild birds. In Great Britain, if you find: a single dead bird of prey 3 dead gulls or wild waterfowl (swans, geese or ducks), or 5 or more dead wild birds of any other species at the same place and at the same time, it should be reported to Defra’s national GB helpline. It is advised not to touch sick or injured birds. What happens when avian flu is found in commercial or backyard flocks? Avian flu is a “notifiable disease” in domestic flocks. This means that any suspected cases must be notified to the Animal and Plant Health Agency. Failure to do so is an offence. Where avian flu is confirmed in a commercial or backyard flock, the whole flock will usually be humanely culled. A ‘protection zone’, extending at least 3km around the premises, will be declared. A ‘surveillance zone’ extending at least 10km around the infected premises will also be declared. A number of additional prevention measures are in place within these zones. Measures include, for example, enhanced record keeping, restrictions on moving poultry, and prohibitions on releasing game birds. These rules are set out in the Avian Influenza and Influenza of Avian Origin in Mammals (Scotland) Order 2006. Is avian flu causing a shortage of eggs or other poultry products? Avian flu is not directly causing a shortage of eggs but is one of a number of current challenges for egg producers. The National Farmers’ Union of Scotland has highlighted that current input costs are “exceptionally high”, which has made it difficult to receive a sustainable return. This has led to a reduction in the number of chicks placed on UK farms in the last 12 months. The Chief Veterinary Officer explained to the RAINE Committee that bird flu has affected egg production to some extent, but that the effect of increases to the cost of production and low prices to producers have been greater. She said: “I do not have the Scottish figures, but I believe that the GB figures show that the number of hens on the ground is about 1.7 million down from where it was last year purely because people have chosen not to restock because they lose money on egg production. By comparison, avian flu has killed perhaps 1 million birds but a lot of the people whose flocks were affected are going back into production.” Turkeys are particularly susceptible to avian flu and turkey production has been badly affected. Scotland has a small number of farmed turkeys, though production is much greater in England (a few tens of thousands of birds are farmed in Scotland, in the context of about 8 million across the UK). The Chief Veterinary Officer told the RAINE Committee that as of 30 November nearly 1.7 million turkeys had been culled in England for the purposes of disease control. MPs in the Environment, Food and Rural Affairs Committee were told by the British Poultry Council on 29 November 2022 that around half of all free-range turkeys have been directly affected. There may therefore be fewer free-range turkeys available this season. The Chief Veterinary Officer told the RAINE Committee that “Turkey may be scarcer, but I am not concerned that there will not be any turkey around this Christmas”. To secure supplies and livelihoods, producers have been given the option to slaughter and prepare some types of birds early this season, freeze them, and sell them defrosted in supermarkets for a limited time in November and December 2022. These must be marked as “defrosted”. Is avian flu a threat to humans? Humans can contract avian flu, though this is rare and usually involves close contact with birds, their droppings or bedding, or in preparing infected poultry. Therefore, the risk to humans from the current bird flu outbreak is considered very low. You cannot catch bird flu from eating fully cooked poultry or eggs. To prevent infection in humans, it is not advisable to touch sick or injured birds. Anna Brand, Senior Researcher Header image by svklimkin from Pixabay Share this:TwitterFacebookLike this:Like Loading... EnvironmentRural affairs Post navigation Previous Post: Court ruling on the revised guidance of the Gender Representation on Public Boards (Scotland) Act 2018 Next Post: What’s happening with common frameworks? Views from the House of Lords and Scottish Parliament The Scottish Parliament Information Centre provides impartial, factual, accurate information and analysis to Members in support of Scottish Parliament parliamentary business. Visit the SPICe website.Constituency dashboardExplore data by Scottish Parliament constituencies and regions through the Scottish Parliament constituency dashboard. Search for: Search SPICe on XMy TweetsTags20th Anniversary Academia Agriculture Benefits Budget Business Care child poverty Civil Law Climate Change Communities Constitution COP26 Coronavirus (COVID-19) Criminal justice Culture Debt and bankruptcy Economy Education Energy Environment Equality EU-UK Agreement Europe Families and Children FAQs Finance Further education Gaelic Guest Blog Health Higher education Housing Housing and Planning Hub human rights Infrastructure Interactive International Labour Market Legislation Local Government Marine and Fisheries Parliament and Elections Parliament and Government People and communities Planning Podcast Police Poverty Prisons Public finance Rural affairs social care Social Security Sport Third Sector Tourism Trade Transport Follow blog via email Enter your email address to subscribe to this blog and receive notifications of new posts by email. Email Address Follow Follow by category E-mail Address: Unsubscribe Me Categories / Taxonomies All categories Categories Business & Industry Culture & Sport Economy & Finance Education Environment & Energy Equalities EU & International Affairs Health Housing & Planning Justice Parliament & Government People & Communities Rural Affairs Social Security Transport Uncategorized Update Me Subscribe Me Unsubscribe Me Search for: Search Categories Business & Industry Culture & Sport Economy & Finance Education Environment & Energy Equalities EU & International Affairs Health Housing & Planning Justice Parliament & Government People & Communities Rural Affairs Social Security Transport Uncategorized Recent Posts The Product Regulation and Metrology Bill: devolution and the UK Internal Market The Product Regulation and Metrology Bill – a path to EU alignment? Public Health/Planetary Health – how key is the NHS in bringing the emergency home? Intergovernmental activity update: Quarter 3 2024 How Robust Are Scotland’s Elections? Identifying the strengths and weaknesses of Scottish Parliamentary Elections Recent CommentsArchives November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 June 2021 May 2021 March 2021 February 2021 January 2021 December 2020 November 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 April 2020 March 2020 February 2020 January 2020 December 2019 November 2019 October 2019 September 2019 August 2019 July 2019 June 2019 May 2019 April 2019 March 2019 February 2019 January 2019 December 2018 November 2018 October 2018 September 2018 August 2018 July 2018 June 2018 May 2018 April 2018 March 2018 February 2018 January 2018 Meta Log in Entries feed Comments feed WordPress.org Recent Posts The Product Regulation and Metrology Bill: devolution and the UK Internal Market The Product Regulation and Metrology Bill – a path to EU alignment? Public Health/Planetary Health – how key is the NHS in bringing the emergency home? Intergovernmental activity update: Quarter 3 2024 How Robust Are Scotland’s Elections? Identifying the strengths and weaknesses of Scottish Parliamentary Elections Recent CommentsArchives November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 June 2021 May 2021 March 2021 February 2021 January 2021 December 2020 November 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 April 2020 March 2020 February 2020 January 2020 December 2019 November 2019 October 2019 September 2019 August 2019 July 2019 June 2019 May 2019 April 2019 March 2019 February 2019 January 2019 December 2018 November 2018 October 2018 September 2018 August 2018 July 2018 June 2018 May 2018 April 2018 March 2018 February 2018 January 2018 Categories Business & Industry Culture & Sport Economy & Finance Education Environment & Energy Equalities EU & International Affairs Health Housing & Planning Justice Parliament & Government People & Communities Rural Affairs Social Security Transport Uncategorized Meta Log in Entries feed Comments feed WordPress.org Recent Posts The Product Regulation and Metrology Bill: devolution and the UK Internal Market The Product Regulation and Metrology Bill – a path to EU alignment? Public Health/Planetary Health – how key is the NHS in bringing the emergency home? Intergovernmental activity update: Quarter 3 2024 How Robust Are Scotland’s Elections? Identifying the strengths and weaknesses of Scottish Parliamentary Elections Follow Us Facebook Twitter Instagram YouTube Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use. To find out more, including how to control cookies, see here: Cookie Policy Pages Accessibility statement Powered by WordPress.com. Discover more from SPICe Spotlight | Solas air SPICe Subscribe now to keep reading and get access to the full archive. Type your email… Subscribe Continue reading %dWSU Center for Emerging and Infectious Diseases urges keeping healthy for the holidays - School of Medicine News - Wayne State University Skip to site menu Skip to page menu Skip to main content Wayne State University Warrior strong Login Search Search: Search School of Medicine News Research Community Medicine People Menu Browse topics All news School of Medicine Research Community Medicine People December 19, 2022 WSU Center for Emerging and Infectious Diseases urges keeping healthy for the holidays The holidays are a time for reconnecting with family, sharing special foods, presents and celebrating the season. Unfortunately, it’s also a time when we can share viruses. “With three major viral infections circulating and dozens of others that can cause respiratory illness, we can share more than gifts during the holiday season,” said Paul Kilgore, M.D., co-director of the Wayne State Center for Emerging and Infectious Diseases. “While COVID-19 rates are not nearly as high as they were last year at this time, the virus is still circulating, still causing hospitalizations and deaths, especially among those who are not fully vaccinated. Seasonal influenza is also circulating at moderate levels, according to the CDC, and Respiratory Syncytial Virus Infection, or RSV, levels are also quite high.” So how do we avoid bringing a viral Grinch to our holiday parties? While it’s not possible to avoid all possible exposures, there are steps we can take to be healthy for the holidays. “First and foremost, get up-to-date with Covid-19 and influenzas vaccines” said Mark Zervos, M.D. co-director, of the Wayne State Center for Emerging and Infectious Diseases, assistant dean for Global Affairs at the WSU School of Medicine and head of Infectious Diseases for Henry Ford Health. “Vaccines are widely available and are your best line of defense. Second, practice good infection hygiene. Wash your hands with soap and warm water, and ask your guests to do so as well. Have hand sanitizer readily available so guests can clean their hands when they come to visit. It’s still important to avoid being in large gatherings of people in close quarters unmasked. Masks are still very helpful to prevent spread of respiratory infections. Wiping down frequently-touched surfaces like doorknobs, sink faucets and countertops, with a disinfecting cleaner can also help reduce chances of exposure.” “In addition, if you feel sick or unwell, it’s best to stay home and take care of yourself to aid in your recovery as soon as possible and avoid exposing others to infectious agents,” said Teena Chopra, M.D., M.P.H., professor of Infectious Diseases at Wayne State University and an expert with the Center for Emerging and Infectious Diseases “If you have symptoms of COVID-19, influenza or RSV, it’s important to take steps with your health care provider to discuss how and where to get tested. Testing can help you know what the best treatment is so you can feel better faster.” Public health professionals expect an additional surge of viral illness after the holidays, putting additional pressure on already-stressed hospitals. These simple steps can help reduce the level of illness and keep families holiday healthy. Subscribe to Today@Wayne Direct to your inbox each week Name Email Address facebook twitter instagram School of Medicine Scott Hall Public Affairs, Room 1320 540 E. Canfield Detroit, MI 48201 313-577-6943 Privacy and University Policies Wayne State University © 2023Dual COVID-flu antigen home-test kits go on sale in Japan | NHK WORLD-JAPAN News Dual COVID-flu antigen home-test kits go on sale in Japan This article is part of a series on important coronavirus-related information. Click here to read other installments: #Coronavirus the facts. Find the latest information on everything COVID-19. Dual COVID-flu test kits on sale Japan's health ministry has approved the retail sale of government-certified antigen self-testing kits that can detect both COVID-19 and influenza. In anticipation of a potential double outbreak, officials hope to reduce the burden on medical institutions by allowing people to conduct tests at home. Prior to this approval, these dual test kits were only available to healthcare institutions. A certified antigen test kit that can check both COVID-19 and influenza Pharmacists guidance required People can purchase the test kits at pharmacies, drug stores or online retailers, on the condition that pharmacists explain how to properly collect samples and what to do if they test positive. How to use the kits As with current antigen test kits for the coronavirus, users take samples from their nose with a swab and insert into the test receptacle. If the specimen contains antigens for either the coronavirus, influenza or both, lines will appear on the test strip. Taking a picture of the test kit is recommended because the lines may fade as time passes. Wait before taking the test Tokita Akifumi, a doctor and member of the public health committee of the Japan Pediatric Association, warns that some users may see a false negative if they test immediately upon developing a fever from the coronavirus or influenza. He says influenza in particular may take time to show a positive result after a fever. For more precise results, he suggests people use the kit about 12 hours after developing a fever. What to do next People who test positive for the coronavirus should apply for a follow-up at a health center in the vicinity of their home and recuperate at home. If the condition is serious, for either coronavirus or influenza, people should call a doctor. If the condition is mild, people should arrange a telephone or online medical consultation. Distinguish between high and low risk Toho University Professor Tateda Kazuhiro, a member of the government's coronavirus advisory panel, says it is important to distinguish whether a person is suffering from the coronavirus or influenza, so those at low risk of serious illness can receive treatment through online consultations or other means and recuperate at home, while those at high risk can be prioritized at fever clinics. Tateda warns that coronavirus and influenza may return positive test results at different times, so a dual negative does not guarantee there is no infection. He urged people to test again the following day if they are unwell and avoid going out if they show any signs of sickness. Test kit supply As of December 14, one product is ready for sale. Products by other firms have been given the green light, but the makers say it is difficult to both sell them commercially and maintain stocks for medical institutions. The ministry wants to secure more test kits for the general public. On December 9, officials said those already used at medical institutions can go on sale without approval. This information is accurate as of December 19, 2022. Edited by Nakanishi Nao NHK World ProducerWhich prevention measures will help keep viruses at bay this Christmas? Our medical analyst explains | CNN CNN values your feedback 1. How relevant is this ad to you? 2. Did you encounter any technical issues? Video player was slow to load content Video content never loaded Ad froze or did not finish loading Video content did not start after ad Audio on ad was too loud Other issues Ad never loaded Ad prevented/slowed the page from loading Content moved around while ad loaded Ad was repetitive to ads I've seen previously Other issues Cancel Submit Thank You! Your effort and contribution in providing this feedback is much appreciated. Close Ad Feedback Close icon Health Life, But Better Fitness Food Sleep Mindfulness Relationships More Life, But Better Fitness Food Sleep Mindfulness Relationships Watch Listen Live TV Subscribe Sign in My Account Settings Topics You Follow Sign Out Your CNN account Sign in to your CNN account Sign in My Account Settings Topics You Follow Sign Out Your CNN account Sign in to your CNN account Live TV Listen Watch Edition US International Arabic Español Edition US International Arabic Español Life, But Better Fitness Food Sleep Mindfulness Relationships Follow CNN World Africa Americas Asia Australia China Europe India Middle East United Kingdom US Politics SCOTUS Congress Facts First 2024 Elections Business Tech Media Calculators Videos Markets Pre-markets After-Hours Fear & Greed Investing Markets Now Nightcap Health Life, But Better Fitness Food Sleep Mindfulness Relationships Entertainment Movies Television Celebrity Tech Innovate Foreseeable Future Mission: Ahead Work Transformed Innovative Cities Style Arts Design Fashion Architecture Luxury Beauty Video Travel Destinations Food & Drink Stay News Videos Sports Football Tennis Golf Motorsport US Sports Olympics Climbing Esports Hockey Watch Live TV CNN Fast Shows A-Z CNN10 CNN Max CNN TV Schedules Listen CNN 5 Things Chasing Life with Dr. Sanjay Gupta The Assignment with Audie Cornish One Thing Tug of War CNN Political Briefing The Axe Files All There Is with Anderson Cooper All CNN Audio podcasts Science Space Life Unearthed Climate Solutions Weather Features As Equals Call to Earth Freedom Project Impact Your World Inside Africa CNN Heroes Weather Video Climate Ukraine-Russia War Israel-Hamas War About CNN Photos Investigations CNN Profiles CNN Leadership CNN Newsletters Work for CNN Ad Feedback Which prevention measures will help keep viruses at bay this Christmas? Our medical analyst explains By Katia Hetter, CNN 6 minute read Updated 1:04 PM EST, Mon December 19, 2022 Link Copied! Video Ad Feedback Hospitals are opening triages in parking lots amid 'tripledemic' surge 02:35 - Source: CNN CNN — Families all over the world are gathering to celebrate Hanukkah, Christmas, Kwanzaa, New Year’s Eve and other winter holidays. Unfortunately, these celebrations are taking place during multiple viral surges. For weeks, children’s hospitals have been overwhelmed due to an earlier-than-usual rise in respiratory syncytial virus (RSV) and influenza. Covid-19 cases are on the rise, too, and a CNN analysis showed that hospitals are at higher capacity now than they have been throughout the coronavirus pandemic. young woman in medical face protection mask indoors on blue background. Sick person Adobe Stock Yes to masks, no to mandates What can families do in advance of holidays gatherings and what measures can they implement during the festivities to keep viruses at bay? When should everyone wear masks? How can people reduce the risk of getting sick on flights and during transit? Who might want to consider postponing travel and holiday celebrations? And what should people do if they do become ill after gatherings? To help us with these questions, I spoke with CNN Medical Analyst Dr. Leana Wen, an emergency physician, public health expert and professor of health policy and management at the George Washington University Milken Institute School of Public Health. She is also author of “Lifelines: A Doctor’s Journey in the Fight for Public Health.” CNN: What can families do now to preserve their holiday get-togethers as much as possible? Dr. Leana Wen: It’s always important to stay healthy, and particularly so before the holidays. Even if people aren’t so concerned about getting ill, no one wants to become infected just before a long-awaited holiday get-together and have to miss events for fear of transmitting viruses to elderly loved ones and other high-risk family and friends. My advice is to first identify which gatherings are most important for you to attend. Count backward from the first of these events. For about five days to a week before that first event, try to reduce your risk of catching respiratory viruses as much as possible. This year's winter holidays and celebrations are taking place during multiple viral surges. sonyakamoz/Adobe Stock That includes frequent handwashing, especially after touching frequently used surfaces. Wear a high-quality N95 or equivalent mask in all indoor crowded settings. And try to reduce unmasked social gatherings during this period. If you have not already received the flu vaccine or the updated Covid-19 booster, do not delay. The vaccines reach optimal protection about two weeks after the inoculation, but even if it’s a little bit less than that until your events, there will still be some additional protection. I’d also encourage you to have a discussion with all the households that are getting together with you. Ideally, everyone who is gathering should reduce their risk, too. If there are vulnerable individuals expected at the gatherings, everyone should agree not to attend if they develop symptoms like fever and coughing. CNN: What measures can help keep viruses at bay during the gatherings? Wen: Many respiratory infections like influenza, RSV and the common cold are primarily spread through droplets. Droplets are expelled when someone coughs or sneezes. This is why encouraging people not to attend if they are symptomatic is important, and so is good hand hygiene. The coronavirus is airborne and spread through aerosols, which are tiny, microscopic droplets. Good ventilation helps to reduce the spread of Covid-19 and other respiratory viruses. If you live in a warm weather environment, consider hosting your gathering outdoors — that will be lower risk than indoors. A man takes a COVID-19 test at a mobile testing site in New York City, New York, U.S., December 12, 2022. Eduardo Munoz/Reuters Flu and RSV hit hard and early; now, Covid-19 is starting to rise If outdoors is not possible, consider your setting. Can you choose a larger space where people don’t need to cluster very close together? Can you keep some windows and doors open, and run HEPA filters for improved ventilation? For Covid-19 specifically, having everyone take a rapid home antigen test the same day as the gathering can also reduce risk. You may choose to provide the tests at the door to better ensure that everyone takes one. Wearing a mask also reduces risk, too. Some people, especially if they are immunocompromised or have other chronic underlying conditions, may wish to mask during the gathering, though this is often challenging when food and drinks are involved. CNN: A lot of people need to travel to be with their loved ones. What can be done to reduce the risk of getting sick on flights and during transit? Wen: Expect that airports, train stations and bus depots will be quite crowded during the holidays and plan ahead to reduce your risk in these crowds. If your goal is to keep safe during the holidays, I highly recommend masking in these settings. Even if you have returned to pre-pandemic activities and stopped masking months ago, I think it’s a good idea to get your mask back out in these crowds so that you don’t become sick and end up having to miss holiday gatherings. High-quality respiratory masks, such as N95, KN95 or KF94, are very protective against droplets. Figure out, if you have not already, which masks you can wear comfortably for long periods of time during transit. Bring several with you in case one of them gets soiled or bent out of shape. Everyone should have a plan for what happens if they develop a viral illness while traveling, says Dr. Leana Wen. Yelizaveta Tomashevska/Adobe Stock I encourage you to wear masks the whole time while traveling around a lot of people. If you find masks uncomfortable, at least wear them during the highest risk settings — for example, when packed together with dozens of other people waiting to board the plane. CNN: Who might want to consider postponing travel and/or holiday celebrations? Wen: The threat of respiratory infections requires weighing risks and benefits. For most generally healthy people, especially if they are vaccinated against the flu and Covid-19, the benefits of holiday gatherings — including the socialization and mental health benefits — will far outweigh potential risks. The calculation may be different for some individuals who are particularly vulnerable to severe outcomes. These individuals may need to gauge each event separately. A small gathering with relatives who all took precautions in advance, who are doing a Covid-19 test at the door, and who are seeing one another in a well-ventilated space is much lower risk compared with, say, a New Year’s Eve celebration with hundreds of people who have not taken precautions. FILE - A flu vaccine is readied at the L.A. Care and Blue Shield of California Promise Health Plans' Community Resource Center where they were offering members and the public free flu and COVID-19 vaccines Friday, Oct. 28, 2022, in Lynwood, Calif. The U.S. flu season is off to an unusually fast start, adding to a 2022 autumn mix of viruses that have been filling hospitals and doctor waiting rooms. (AP Photo/Mark J. Terrill, File) Mark J. Terrill/AP/FILE Vaccine fatigue is leaving the US vulnerable to flu Travel is generally not the major concern; one-way masking with a high-quality mask works very well to protect the wearer. I’m much more concerned about the risk of the gathering once people are together. People who are particularly vulnerable should clarify the precautions in advance with the hosts. Importantly, they should feel empowered to leave if the event turns out to be higher risk than they anticipated. CNN: What should people do if they do become ill while traveling? Wen: This is a very important point. Everyone should have a plan for what happens if they develop a viral illness while traveling. The US Centers for Disease Control and Prevention has a checklist of what a Covid-19 plan looks like. That includes, for example, making sure you have enough home tests, speaking with your doctor to know if you are high-risk, and having a plan for treatment, including with the antiviral medication Paxlovid. Since it’s not just Covid-19 that’s circulating, also have a plan for what happens if you or someone in your party develops the flu or other respiratory infections. Do you know where you can isolate if needed? What if a young child becomes ill — will you be able to quarantine with your child and then take time off from work if necessary? This holiday season, there are a lot of circulating viruses, but we also have many tools that help to reduce the risk of contracting them and becoming severely ill. Using these tools helps to keep us healthy, and allows us to keep viruses from interfering with our holiday celebrations. Ad Feedback Ad Feedback Ad Feedback Ad Feedback Ad Feedback Ad Feedback Ad Feedback Sign in My Account Settings Topics You Follow Sign Out Your CNN account Sign in to your CNN account Live TV Listen Watch World Africa Americas Asia Australia China Europe India Middle East United Kingdom US Politics SCOTUS Congress Facts First 2024 Elections Business Tech Media Calculators Videos Markets Pre-markets After-Hours Fear & Greed Investing Markets Now Nightcap Health Life, But Better Fitness Food Sleep Mindfulness Relationships Entertainment Movies Television Celebrity Tech Innovate Foreseeable Future Mission: Ahead Work Transformed Innovative Cities Style Arts Design Fashion Architecture Luxury Beauty Video Travel Destinations Food & Drink Stay News Videos Sports Football Tennis Golf Motorsport US Sports Olympics Climbing Esports Hockey Watch Live TV CNN Fast Shows A-Z CNN10 CNN Max CNN TV Schedules Listen CNN 5 Things Chasing Life with Dr. Sanjay Gupta The Assignment with Audie Cornish One Thing Tug of War CNN Political Briefing The Axe Files All There Is with Anderson Cooper All CNN Audio podcasts Science Space Life Unearthed Climate Solutions Weather Features As Equals Call to Earth Freedom Project Impact Your World Inside Africa CNN Heroes Weather Video Climate Ukraine-Russia War Israel-Hamas War About CNN Photos Investigations CNN Profiles CNN Leadership CNN Newsletters Work for CNN Health Watch Listen Live TV Follow CNN Sign in My Account Settings Topics You Follow Sign Out Your CNN account Sign in to your CNN account Terms of Use Privacy Policy Ad Choices Accessibility & CC About Newsletters Transcripts © 2024 Cable News Network. A Warner Bros. Discovery Company. All Rights Reserved. CNN Sans ™ & © 2016 Cable News Network.Flu, Covid-19 and RSV: Tracking hospitalizations this brutal virus season | CNN CNN values your feedback 1. How relevant is this ad to you? 2. Did you encounter any technical issues? Video player was slow to load content Video content never loaded Ad froze or did not finish loading Video content did not start after ad Audio on ad was too loud Other issues Ad never loaded Ad prevented/slowed the page from loading Content moved around while ad loaded Ad was repetitive to ads I've seen previously Other issues Cancel Submit Thank You! Your effort and contribution in providing this feedback is much appreciated. Close Ad Feedback Close icon Health Life, But Better Fitness Food Sleep Mindfulness Relationships More Life, But Better Fitness Food Sleep Mindfulness Relationships Watch Listen Live TV Subscribe Sign in My Account Settings Topics You Follow Sign Out Your CNN account Sign in to your CNN account Sign in My Account Settings Topics You Follow Sign Out Your CNN account Sign in to your CNN account Live TV Listen Watch Edition US International Arabic Español Edition US International Arabic Español Life, But Better Fitness Food Sleep Mindfulness Relationships Follow CNN 2024 Elections US Crime + Justice World Africa Americas Asia Australia China Europe India Middle East United Kingdom Politics SCOTUS Congress Facts First 2024 Elections Business Tech Media Calculators Videos Markets Pre-markets After-Hours Fear & Greed Investing Markets Now Nightcap Health Life, But Better Fitness Food Sleep Mindfulness Relationships Entertainment Movies Television Celebrity Tech Innovate Foreseeable Future Mission: Ahead Work Transformed Innovative Cities Style Arts Design Fashion Architecture Luxury Beauty Video Travel Destinations Food & Drink Stay Videos Sports Pro Football College Football Basketball Baseball Soccer Olympics Hockey Watch Live TV CNN Headlines CNN Shorts Shows A-Z CNN10 CNN Max CNN TV Schedules FlashDocs Listen CNN 5 Things Chasing Life with Dr. Sanjay Gupta The Assignment with Audie Cornish One Thing Tug of War CNN Political Briefing The Axe Files All There Is with Anderson Cooper All CNN Audio podcasts CNN Underscored Electronics Fashion Beauty Health & Fitness Home Reviews Deals Money Gifts Travel Outdoors Pets CNN Store Science Space Life Unearthed Climate Solutions Weather Weather Video Climate Ukraine-Russia War Israel-Hamas War About CNN Subscribe Photos Investigations CNN Profiles CNN Leadership CNN Newsletters Work for CNN Ad Feedback Flu, Covid-19 and RSV: Tracking hospitalizations this brutal virus season By Matt Stiles, Curt Merrill and Deidre McPhillips, CNN 2 minute read Updated 11:29 AM EST, Thu December 22, 2022 Link Copied! CNN — A tough respiratory virus season is underway in the United States, as influenza and the respiratory syncytial virus came early and hit hard this year, straining the nation’s health care system and driving up hospitalizations to rates not seen in years — even as Covid-19 continues spreading across the country. While this historic season progresses, CNN will be tracking the impact as updated illness figures are released. Influenza Influenza hospitalizations surged this fall: The cumulative hospitalization rate per 100,000 residents, compiled by the US Centers for Disease Control and Prevention, has eclipsed at least five of the past 12 seasons. While the seven-day rolling average of hospitalization cases derived from US Health and Human Services’ data has come down in recent weeks, experts warn a resurgence is possible as people travel and gather for the holidays. Covid-19 While Covid levels remain far below prior surges, trends are definitely on the rise across the US, according to data the US Department of Health and Human Services. After a relatively quiet summer, hospitalizations have been on the rise again since early November. More than 100 million cases have been reported in the United States since the start of the pandemic. However, the actual number of cases is likely much higher, as many individuals who are infected do not test or do not report the results of tests taken at home. As cases are undercounted, hospitalization has become a better indicator of disease trends. RSV RSV has hit particularly hard and early this season, with a hospitalization rate greater than the previous four seasons already. Young children are especially vulnerable to RSV, and the virus has a particularly strong impact on children this season. Hospitalization rates for those younger than 5 are more than twice as high as any season since 2018-2019 — when the CDC began tracking data specific to kids. The symptoms The flu and other respiratory illnesses often have overlapping symptoms, such as congestion and coughing. But some are unique. RSV, for example, can cause wheezing or decreased appetite while Covid can cause shortness of breath. Testing can help determine which illness is at play, which health experts say is helpful to ensure individuals are receiving the appropriate treatment in a timely manner. For example, the antiviral Tamiflu can help treat flu, while Paxlovid is available for Covid patients. Ad Feedback Ad Feedback Ad Feedback Ad Feedback Sign in My Account Settings Topics You Follow Sign Out Your CNN account Sign in to your CNN account Live TV Listen Watch 2024 Elections US Crime + Justice World Africa Americas Asia Australia China Europe India Middle East United Kingdom Politics SCOTUS Congress Facts First 2024 Elections Business Tech Media Calculators Videos Markets Pre-markets After-Hours Fear & Greed Investing Markets Now Nightcap Health Life, But Better Fitness Food Sleep Mindfulness Relationships Entertainment Movies Television Celebrity Tech Innovate Foreseeable Future Mission: Ahead Work Transformed Innovative Cities Style Arts Design Fashion Architecture Luxury Beauty Video Travel Destinations Food & Drink Stay News Videos Sports Pro Football College Football Basketball Baseball Soccer Olympics Hockey Watch Live TV CNN Headlines CNN Shorts Shows A-Z CNN10 CNN Max CNN TV Schedules FlashDocs Listen CNN 5 Things Chasing Life with Dr. Sanjay Gupta The Assignment with Audie Cornish One Thing Tug of War CNN Political Briefing The Axe Files All There Is with Anderson Cooper All CNN Audio podcasts CNN Underscored Electronics Fashion Beauty Health & Fitness Home Reviews Deals Money Gifts Travel Outdoors Pets CNN Store Science Space Life Unearthed Climate Solutions Weather Weather Video Climate Ukraine-Russia War Israel-Hamas War About CNN Subscribe Photos Investigations CNN Profiles CNN Leadership CNN Newsletters Work for CNN Health Watch Listen Live TV Follow CNN Sign in My Account Settings Topics You Follow Sign Out Your CNN account Sign in to your CNN account Terms of Use Privacy Policy Ad Choices Accessibility & CC About Subscribe Newsletters Transcripts Help Center © 2024 Cable News Network. A Warner Bros. Discovery Company. All Rights Reserved. CNN Sans ™ & © 2016 Cable News Network.Fact check: Millions of flu cases last year in the U.S.Skip to main content HomeU.S.SportsEntertainmentLifeMoneyTechTravelOpinionFor SubscribersWeatherInvestigationsCrosswordsHumankindNewslettersMediaFor YouContributor Content Fact check: COVID-19, flu cases reported separatelyNate Trela | USA TODAYShow Caption Hide Caption COVID-19 tools used to expand global surveillanceFrom Beijing to Jerusalem to Hyderabad, India, The Associated Press has found that authorities used COVID-19 technologies and data to halt travel for activists and ordinary people, and link people’s health information to other surveillance and law enforcement tools.(Dec. 20)APThe claim: There were no flu cases last year because they were all reported as COVID-19A theme in COVID-19 misinformation that has been debunked for years is an insistence that the virus is the same as the flu.A video shared Dec. 6 on Instagram contends that all flu cases were reported by health officials as COVID-19 last year, possibly to drive up demand for vaccines.“In the USA, already, there are record high cases of flu,” a woman walking through a wooded area says in the video. “That's right, flu. And last year there were none at all on the whole planet.”She adds: “It's almost as if flu was counted as COVID last year and now suddenly it's back again. But obviously we'd never be lied to by our own governments so that they could profit from big pharma."The video was liked more than 20,000 times in two weeks.But the claim is wrong on multiple fronts. The Centers for Disease Control and Prevention reported 9 million flu cases in the 2021-22 flu season. Data for both diseases has been reported separately. Experts say the flu and COVID-19 are different diseases that affect the body and spread in different ways.USA TODAY reached out to the social media user who made the claim for comment.Follow us on Facebook! Like our page to get updates throughout the day on our latest debunksDifferent viruses, different dataWhile both are respiratory diseases with some overlapping symptoms, COVID-19 is caused by a coronavirus, SARS-CoV-2, while the flu is caused by the influenza A and B viruses. The coronavirus is more contagious, more deadly and spreads more quickly than the flu. It also causes some different symptoms such as the loss of taste or smell and symptoms generally take longer to appear after exposure, according to the Mayo Clinic.Since the CDC first announced a lab-confirmed case of COVID-19 on Jan. 20, 2020, it has reported data separately for COVID-19 and influenza.The CDC reported an estimated 9 million flu illnesses, 4 million flu-related medical visits, 100,000 flu-related hospitalizations and 5,000 flu deaths in the 2021-2022 flu season. The flu season roughly spans September through May, with peak activity coming between December and February. Those numbers are significantly lower than the 36 million cases, 390,000 hospitalizations and 25,000 deaths estimated in the 2019-20 flu season by the CDC.It also is significantly more than the 2020-21 season, when the CDC said there were just 1,675 lab-confirmed cases in the U.S. The CDC attributed that season's low numbers to mask-wearing, social distancing, lockdowns and other preventative measures undertaken to reduce the spread of COVID-19. Such measures were particularly stressed in the 2020-21 season, when the seriousness of COVID-19 was recognized but vaccines were not readily available. By comparison, the CDC reports there have been 99.7 million cases of COVID-19 and more than 1 million deaths from the disease since it was first detected in the U.S. in January 2020.USA TODAY recently debunked a claim that a kit testing for COVID-19 and the flu proved both are caused by the same virus, noting that the kit tested separately for antigens for each underlying virus.PolitiFact and the Associated Press also debunked the claim that there were no flu cases last year.Our rating: FalseBased on our research, we rate FALSE the claim that there were no cases of flu last year because they were reported as COVID-19. Millions of flu and COVID-19 cases were reported – separately – in publicly available data. The number of flu cases was likely lower in the past two flu seasons because of the safety measures being taken to reduce possible COVID-19 exposure, experts say. The diseases are caused by different viruses.Our fact-check sources:Mayo Clinic, accessed Dec. 21, Coronavirus vs. flu: Similarities and differenceCDC, accessed Dec. 20, CDC Museum COVID-19 TimelineCDC, Oct.25, 2021, 2020-2021 Flu Season SummaryCDC, accessed Dec. 20, Estimated Influenza Illnesses, Medical visits, and Hospitalizations Prevented by Vaccination in the United States — 2019–2020 Influenza SeasonCDC, accessed Dec. 20, Preliminary Estimated Influenza Illnesses, Medical visits, Hospitalizations, and Deaths in the United States – 2021-2022 influenza seasonCDC, updated Dec. 16, COVID Data Tracker Weekly ReviewUSA TODAY, Dec. 5, Fact check: Post claiming COVID-19 and flu viruses are same misrepresents at-home test kitUSA TODAY, Dec. 31, 2020, Fact check: Post claims COVID-19 is another flu strain, misattributed to Cornell professorPolitiFact, Dec. 15, Influenza caused 9 million illnesses, 5,000 deaths last flu season, CDC says Associated Press, Dec. 16, COVID-19 and flu cases both rising, despite claims onlineThank you for supporting our journalism. You can subscribe to our print edition, ad-free app or electronic newspaper replica here.Our fact-check work is supported in part by a grant from Facebook. Facebook Twitter EmailShare your feedback to help improve our site!HelpTerms of ServiceSubscription Terms & ConditionsPrivacy PolicySite MapAccessibilityOur Ethical PrinciplesResponsible DisclosureYour Privacy Choices © Copyright Gannett 2024Vaccine cuts risk of influenza illness by about half, BCCDC finds | CBC News ContentSkip to Main ContentAccessibility HelphamburgerMenuWhen search suggestions are available use up and down arrows to review and enter to select.SearchSearchSign InQuick LinksNewsSportsRadioMusicListen LiveTVWatchnewsTop StoriesLocalClimateWorldCanadaPoliticsIndigenousBusinessThe NationalHealthEntertainmentScienceCBC News InvestigatesGo PublicAbout CBC NewsBeing Black in CanadaMore Vaccine cuts risk of influenza illness by about half, BCCDC finds | CBC News LoadedBritish ColumbiaVaccine cuts risk of influenza illness by about half, BCCDC findsA new study has found that the influenza vaccine is providing substantial protection during this early's early and ongoing flu season, said the B.C. Centre for Disease Control.BCCDC says flu season's early arrival means there's already data showing vaccine's efficacyCBC News · Posted: Dec 23, 2022 10:37 PM EST | Last Updated: December 24, 2022The flu vaccine has cut the risk of influenza illness by about half, according to preliminary findings from the Canadian Influenza Sentinel Practitioner Surveillance Network (SPSN). (Alexandre Silberman/CBC)Social SharingA new study has found the influenza vaccine is providing substantial protection during this year's early and ongoing flu season. The B.C. Centre for Disease Control said preliminary findings show the vaccine has cut the risk of influenza illness by about half. "We will update our analyses in the new year, but these interim findings show a substantial reduction in the risk of influenza illness for vaccinated people who seek medical care." said Dr. Danuta Skowronski, physician epidemiologist at the B.C. Centre for Disease Control (BCCDC).Skowronski says the flu season's early arrival means they were able to get estimates on vaccine efficacy sooner than normal. Why doctors recommend you get a flu shot this week"It's nice to be able to deliver some good news going into the holiday period," she said. The early findings came from the Canadian Sentinel Practitioners Surveillance Network (SPSN), which is headquartered at the BCCDC and includes hundreds of primary care providers in B.C., Alberta, Ontario and Quebec.Skowronski says their estimates on the performance of the annually-revised influenza vaccine are sent to the World Health Organization to help it make decisions on future flu vaccines. WATCH | What to watch for in health in 2023:The road ahead for Canada’s health care system in 20232 years agoDuration 6:39CBC senior health reporters Christine Birak and Lauren Pelley discuss what the most prominent health issues will be in 2023, including why 2023 could be a make-or-break year for Canada’s strained health-care system and the future of the COVID-19 pandemic.The majority of flu cases this season have been due to the H3N2 subtype of influenza A, which the BCCDC says is often associated with more severe epidemics and lower vaccine effectiveness compared other types of influenza A or B.Skowronski said this year's vaccine is providing good protection against the H3N2 subtype.She notes that older people can have a harder time with the H3N2 viruses. "If they haven't been vaccinated yet, now is the time to get vaccinated," she said.Seniors who want added protection, especially if they have high-risk conditions, may also want to consider having a conversation with their primary care provider about access to treatment options such as oseltamivir, sold under the brand name Tamiflu, according to Skowronski. Northern Health doctor rings alarm of rising flu cases among children in Prince GeorgeSkowronski says we may be on the downslope of the epidemic curve, but that doesn't mean people should not get vaccinated.The virus will is likely to be circulating for several more weeks, she said, and social gatherings during the holidays could amplify its spread. She also notes a secondary wave due to influenza B sometimes arrives later in the season.Preliminary findings by the Cdn Influenza Sentinel Practitioner Surveillance Network show the flu vaccine has cut the risk of influenza illness by half during this unusual flu season. Vaccines are free for everyone six months &amp; older in B.C. Learn more: <a href="https:/.co/QcfrGGTzuQ">https:/.co/QcfrGGTzuQ</a>&mdash;@adriandixB.C's Minister of Health, Adrian Dix, is also advocating for those who've yet to be vaccinated against flu to do so now."Vaccines are available for everyone six months and older in B.C. and these preliminary findings show how vaccination remains our best defence against respiratory illnesses," he said in a release."By getting vaccinated against influenza, you can help protect our public health system and the young children and elderly people around you."With files from Breanna HimmelrightCBC's Journalistic Standards and Practices|About CBC NewsCorrections and clarifications|Submit a news tip|Report errorRelated Stories Top stories from British Columbia More than 300 flights cancelled at Vancouver airport during the latest winter storm Bridges closed, flights suspended across Southwest B.C. Friday as winter storm slowly transitions to rain B.C. shelters turning people away in the middle of housing crisis Wildlife rescue group reminds people to look out for struggling birdsFooter LinksMy AccountProfileCBC GemNewslettersAbout CBC AccountsConnect with CBCFacebookXYouTubeInstagramMobileRSSPodcastsContact CBCSubmit FeedbackHelp CentreAudience Relations, CBC P.O. Box 500 Station A Toronto, ON Canada, M5W 1E6 Toll-free (Canada only): 1-866-306-4636About CBCCorporate InfoSitemapReuse & PermissionTerms of UsePrivacyPrivacy PreferencesJobsOur UnionsIndependent ProducersPolitical Ads RegistryAdChoicesServicesOmbudsmanCorrections and ClarificationsPublic AppearancesCommercial ServicesCBC ShopDoing Business with UsRenting FacilitiesRadio Canada InternationalCBC LiteAccessibilityIt is a priority for CBC to create products that are accessible to all in Canada including people with visual, hearing, motor and cognitive challenges.Closed Captioning and Described Video is available for many CBC shows offered on CBC Gem.About CBC AccessibilityAccessibility Feedback©2024 CBC/Radio-Canada. All rights reserved. Visitez Radio-Canada.canowThe Flu Shot for Babies: What Every Parent Should Know ​ Skip to content Parents Search Please fill out this field. Newsletters Sweepstakes Search Please fill out this field. Starting a Family Starting a Family Trying to Conceive Ovulation Ovulation Calculator Infertility View All Pregnancy Pregnancy Pregnancy Week-by-Week Baby Names Due Date Calculator Pregnancy Conditions & Complications Labor & Delivery View All Baby Names Baby Names Top Girl Names Top Boy Names Trending Names Gender-Neutral Names Nicknames View All Parenting Parenting Babies Toddlers Big Kids Tweens & Teens Health & Safety View All Life With Kids Life With Kids Travel Entertainment Food Familia Kindred View All What to Buy What to Buy Black Friday Toys & Gifts for Every Age and Occasion Baby & Toddler Gear Pregnancy Gear Clothes, Shoes & Accessories for the Whole Family View All News About Us About Us Editorial Guidelines Expert Review Board Diversity & Inclusion Pledge Read More Newsletters Sweepstakes Follow Us Starting a Family Trying to Conceive Ovulation Ovulation Calculator Infertility View All Pregnancy Pregnancy Week-by-Week Baby Names Due Date Calculator Pregnancy Conditions & Complications Labor & Delivery View All Baby Names Top Girl Names Top Boy Names Trending Names Gender-Neutral Names Nicknames View All Parenting Babies Toddlers Big Kids Tween & Teens Health & Safety View All Life With Kids Travel Entertainment Food Familia Kindred View All What to Buy Black Friday Toys & Gifts Baby & Toddler Gear Pregnancy Gear Clothes, Shoes & Accessories View All News About Us Our Editorial Guidelines Expert Review Board Diversity & Inclusion Pledge Health & Safety Vaccines All About the Flu Shot for Babies Every child over 6 months old should get vaccinated against influenza. Find out when babies can get a flu shot and why it's so important. By Nicole Harris Updated on December 24, 2022 Medically reviewed by Wendy L. Hunter, M.D. Close Africa Studio/Shutterstock The number of vaccines recommended for infants can be overwhelming to new parents. But here's one less thing to worry about: Getting the influenza shot is perfectly safe for babies 6 months and older. It's also important for preventing scary flu-related complications—like pneumonia and dehydration—that can arise in children younger than 5 years old. Here's everything you need to know about the flu shot for babies. Why Babies Should Get the Flu Shot Young children who catch the flu get pneumonia at higher rates than older kids and can become dehydrated more easily. They may also develop ear infections, sinus problems, and a worsening of conditions like asthma or heart disease. Since 2010, flu-related complications have led to between 7,000 and 28,000 hospitalizations per flu season in children younger than 5 years old, according to the Centers of Disease Control and Prevention. The flu can also cause death in rare cases. Indeed, the CDC estimates that between 130 and 1,200 children (younger than 18 years old) have died from the flu each year since 2010. How the Pandemic May Still Affect Delivery Room Rules Vaccinated babies have a decreased chance of contracting the flu. And if they do catch influenza, the flu shot can make the illness less severe, which decreases the risk of hospitalization and death. Side Effects of the Flu Vaccine for Babies Despite common misconception, the flu vaccine doesn't actually cause the flu. That's because most shots are made with inactivated viruses, or they use a single gene from a flu virus (as opposed to the full virus), according to the CDC. That said, your baby may experience mild side effects, including low-grade fever, aches, and soreness or redness near the injection site. These symptoms only last a day or two. Serious allergic reactions (usually attributed to egg protein in the shot) are rare. But if your child is experiencing breathing problems, wheezing, hives, dizziness, accelerated heartbeat, or other worrisome symptoms, inform a doctor immediately. Is the Flu Vaccine Safe for Babies? Although the flu shot for babies can reduce the risk of many health complications, some parents worry about thimerosal in vaccines. This mercury-based preservative has previously been falsely linked to autism in young children. In actuality, study after study continues to disprove any link between thimerosal in vaccines and autism in children. Plus, only the flu vaccines packaged in multi-dose vials contain thimerosal nowadays, and parents can always ask for thimerosal-free alternatives. Research shows that the risks associated with a baby contracting the flu are far worse than any side effects that may occur as a result of the shot. "Hundreds of millions of Americans have safely received flu vaccines over the past 50 years, and there has been extensive research supporting the safety of flu vaccines," says the CDC. Vaccines Don't Cause Autism (and Here's the Proof) When Can Babies Get the Flu Shot? Babies younger than 6 months can't receive the flu vaccine. Those older than 6 months should get the flu shot every season to prevent health complications and spreading the illness to others. So when is the best time to get it? Because flu season strengthens in the fall and winter—and because it takes two to four weeks to build effectiveness—the CDC recommends getting the flu vaccine by the end of October. However, getting the vaccine later still protects against the illness. 12 Cold and Flu Myths Parents Should Know What Does the Flu Vaccine for Babies Look Like? There are two types of vaccines: the flu shot (approved for anyone 6 months and older) and a nasal vaccine spray (approved for people ages 2 through 49 without underlying medical issues like asthma). Your baby will most likely receive the flu shot. Flu Symptoms in Babies and When to Call the Doctor If your child is less than 9 years old and has never received a flu vaccination, they will need two doses. The second dose, which is administered about one month after the first, gives your child's immature immune system time to respond. It's important to note that the vaccine isn't perfect. Vaccines are made to target the viruses that are most likely to cause illness each year, so the success rate usually ranges from 40 to 60%. Even so, the reduced risk of illness is worth getting the flu vaccine, particularly for babies as the complications from infection can be quite severe. What to Do About Recurring Illnesses Was this page helpful? Thanks for your feedback! Tell us why! Other Submit Related Articles How to Treat a Baby's Runny Nose Why Is My Baby Coughing? 8 Possible Causes and When to Worry What Your Baby’s Poop Says About Milk Protein Allergies 9 Natural Home Remedies for Cough in Kids What To Expect After Your Baby's 2-Month Vaccinations The Do's and Don'ts of Fighting a Fever 7 Newborn Vaccines Your Baby Needs A Parent's Guide to the Recommended Infant Vaccine Schedule 6 Gross (But Common!) Conditions Parents Don't Talk About How Often Should You Bathe Your Newborn? What Vaccines Do You Need Before and During Pregnancy? The Truth About Mercury in Vaccines The Most Important Vaccines for Children: An A-Z List for Parents Vaccines Don't Cause Autism (and Here's the Proof) What Causes a Dry Cough in Kids? FDA Approves RSV Vaccine for Pregnant People To Protect Newborns Parents Newsletters Follow Us Starting a Family Pregnancy Baby Names Parenting Life With Kids Products & Gear News About Us Expert Review Board Editorial Guidelines Product Review Guidelines Diversity Pledge Privacy Policy Careers Terms of Service Contact Advertise Parents is part of the Dotdash Meredith publishing family. Newsletter Sign Up Newsletter Sign UpRamona Boy, 6, Hospitalized With Influenza, Gets His Christmas Wish – NBC 7 San Diego Skip to content Main Navigation Search Search for: Local Weather Traffic Sports Entertainment In Your Neighborhood Submit Photos Watch News 24/7 Trending ✅ Election results 🎖️ Salute to Service 🗳️ Decision 2024 📺 Free Streaming 24/7 🎧 News Podcast 🍳 Breakfast Buzz 🔎 I-team tips Expand Ramona Ramona Boy, 6, Hospitalized With Influenza, Gets His Christmas Wish The diagnosis came as shocking news to the boy's mother By Melissa Adan • Published December 21, 2022 • Updated on December 22, 2022 at 6:24 am NBC Universal, Inc. More than half of the flu cases in San Diego County so far this season have been in people younger than 17. A 6-year-old boy from Ramona is one of them and he recently spent 10 days at Rady Children's Hospital fighting the flu. "Little did I know that the flu could end up being something so severe," said Yariela Aguiar, the boy's mom. 24/7 San Diego news stream: Watch NBC 7 free wherever you are When Juan Carlos Aguiar Jr. was struggling to breathe, doctors first diagnosed him with influenza A. This came as shocking news for his mom Yariela Aguiar who said her son does not have any underlying health conditions. Aguiar said her son was first treated at Pomerado Hospital, then Kaiser Permanente until finally she took him to Rady Children's where he was diagnosed with a severe case of pneumonia due to bacteria getting buildup in his lungs. Get top local stories in San Diego delivered to you every morning. Sign up for NBC San Diego's News Headlines newsletter. "It’s the worst moment, feeling that a mother can go through, seeing your child just intubated in a bed, motionless," said Aguiar. Juan Carlos was put on an oxygen tube, had a blood transfusion and was monitored at the pediatric intensive care unit. "That’s the moment when I lost, I was scared, I said, what would my life be without my 6-year old," questioned Aguiar. Local Elections Nov 5 Voting results: Here's how San Diego County voted in the 2024 election Mental Health 11 hours ago Deadly Failure: A sailor's struggle in a fractured military mental-health system Rady Children’s Hospital said they’ve reported 132 cases of influenza in the last two weeks and have 15 patients admitted for it. Juan Carlos has a Christmas wish to make it home and enjoy toys, cookies, ice cream, chicken nuggets and his favorite: pizza. Yariela AguiarJuan Carlos Aguiar Jr., 6, battled a severe case of pneumonia where bacteria was getting buildup in his lungs . Luckily, he got that wish as he was released from Rady Children's in time for Christmas. "He's that happy child that he used to be now," said Aguiar. "His smile is contagious, his laugh is contagious, his happiness is contagious, he's everything." While Aguiar shared how challenging these past weeks have been both emotionally and financially, one present she considers priceless is her son's health. This article tagged under: Ramona on now Live: NBC7 News @ 5PM Trending Stories NBC 7 Responds National City family paid $150 a month for years for canceled service Homelessness City begins clearing out San Diego Riverbed homeless encampments Veterans These restaurants are honoring vets with deals and giveaways this Veterans Day Laws New California law aims to improve pedestrian safety by changing parking rules Kearny Mesa Man in wheel chair hit and killed by Toyota Camry driver in Kearny Mesa Weather Forecast Facebook Instagram TikTok Submit Tips for Investigations Newsletters About NBC 7 San Diego Our News Standards Xfinity: Internet, TV, streaming, more KNSD Public Inspection File KNSD Accessibility KNSD Employment Information Send Feedback FCC Applications Terms of Service Privacy Policy Your Privacy Choices Advertise with us Careers at NBC 7 CA Notice Ad Choices Copyright © 2024 NBCUniversal Media, LLC. All rights reserved Close Menu Search for: Decision 2024 Local In Your Neighborhood Listen: NBC 7's Podcasts NBC 7 Responds NBC 7 Community Breakfast Buzz Military Weather Investigations Submit a tip California SportsWrap San Diego Padres U.S. & World Videos Entertainment In Your Neighborhood California Live Worth The Trip About Us Our News Standards Submit a Consumer Complaint Submit Photos and Video Contests TV Schedule Our Apps Newsletters Cozi TV Follow Us Facebook Instagram TikTok Contact UsIt is time to re-establish practice goals News All NewsPNP CornerAAP NewsMediaAround the PracticeCure ConnectionsExpert InterviewsInsightsMedical World NewsPeer ExchangePeers & PerspectivesPodcastsWebinarsPuzzlerPublicationsContemporary Pediatrics JournalSupplements And Featured PublicationsCME/CEResourcesHandoutsJob BoardSponsoredConferencesConference CoverageConference ListingPartnershipsSubscribeEditorialEditorial Advisory BoardWriter’s GuidelinesReference GuidelinesMeet the EditorsChoose SpecialtyAllergy, Immunology, and ENTAllergy, Immunology, and ENTAllergy, Immunology, and ENTCardiologyCardiologyDermatologyDermatologyDermatologyEmergency MedicineEndocrinologyEndocrinologyGastroenterologyGastroenterologyGastroenterologyGastroenterologyInfectious DiseasesInfectious DiseasesInfectious DiseasesInfectious DiseasesInfectious DiseasesInfectious DiseasesInfectious DiseasesInfectious DiseasesInfectious DiseasesMental, Behavioral and Development HealthMental, Behavioral and Development HealthMental, Behavioral and Development HealthMental, Behavioral and Development HealthMental, Behavioral and Development HealthMental, Behavioral and Development HealthMental, Behavioral and Development HealthMental, Behavioral and Development HealthMental, Behavioral and Development HealthNeurologyNeurologyNeurologyNeurologyOB/GYNOB/GYNPainPharmacologyPharmacologyPractice ImprovementPractice ImprovementRespiratoryRespiratoryRespiratoryRheumatologyChoose SpecialtyAllergy, Immunology, and ENTAllergy, Immunology, and ENTAllergy, Immunology, and ENTCardiologyCardiologyDermatologyDermatologyDermatologyEmergency MedicineEndocrinologyEndocrinologyGastroenterologyGastroenterologyGastroenterologyGastroenterologyInfectious DiseasesInfectious DiseasesInfectious DiseasesInfectious DiseasesInfectious DiseasesInfectious DiseasesInfectious DiseasesInfectious DiseasesInfectious DiseasesMental, Behavioral and Development HealthMental, Behavioral and Development HealthMental, Behavioral and Development HealthMental, Behavioral and Development HealthMental, Behavioral and Development HealthMental, Behavioral and Development HealthMental, Behavioral and Development HealthMental, Behavioral and Development HealthMental, Behavioral and Development HealthNeurologyNeurologyNeurologyNeurologyOB/GYNOB/GYNPainPharmacologyPharmacologyPractice ImprovementPractice ImprovementRespiratoryRespiratoryRespiratoryRheumatologyNews AAP NewsMediaPuzzlerPublicationsCME/CEResourcesConferencesPartnershipsSubscribeEditorialAdvertisementIt is time to re-establish practice goalsDecember 20, 2022By Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN Article Establish new practice goals, timelines for evaluating the progress on meeting the goals, and use continuous quality improvement measures to meet the established goals.It is time to re-establish practice goalsIn reviewing the article in the Contemporary Pediatrics 2022 November/December issue, by Krewson,1 Gearing up for a triple threat, it is apparent that practice goals need to be revisited by pediatric nurse practitioners (PNPs) and all pediatric health care providers to improve the overall health of the children and adolescents that receive care every day. As I write this commentary, children throughout the United States are seeking care in emergency departments for respiratory infections including influenza, COVID-19, and respiratory syncytial viruses (RSV) resulting in pediatric hospital units being filled to capacity caring for children with one or a combination of these infections. The question all providers must ask is: How can my practice change the current course of infants, children, and adolescents from contracting influenza, COVID-19 and RSV? The answer requires a practice commitment and established goal to increase flu and COVID-19 coverage within the practice. The answer also requires practice providers to discuss ways to avoid RSV infections in young children.Reviewing weekly data from the CDC on flu vaccine coverageThe Centers for Disease Control (CDC) presents weekly data on flu vaccine coverage throughout the United States.2 These data support the absolute need for practices to establish new goals for vaccine coverage. Nationally, as of December 16, 2022, coverage for the flu vaccine is 46.7%. Thus, this low percentage is the reason that so many children and adolescents (and adults) have contracted influenza. Likewise, flu vaccination coverage was lower for pregnant persons for all race/ethnicity groups at the end of November 2022 when compared with data from November 2021, thus placing infants born to non-vaccinated pregnant persons at greater risk of contracting influenza.New CDC recommendations for COVID-19 vaccine boostersOn December 9, 2022, the Centers for Disease Control published the updated COVID-19 bivalent booster for children aged 6 months to 5 years adding to the recommendations published in September for children aged 12 years and older and on October 12, 2022 for children aged 5 to 11 years.3 These new recommendations for infants 6 months old to children 5 years old require every provider to carefully review what vaccines the infant/child has received and to follow the guidance on which vaccine to administer to assure safety and prevention of medication errors.In clinical trials: RSV vaccine for pregnant persons and RSV vaccine approved in Europe for infantsKrewson, in the article, “Gearing up for a triple threat,” talks about current clinical studies by Pfizer for their RSV vaccine to be administered to pregnant persons to reduce the incidence of RSV in infants in the first few months of life.1 In addition, AstraZeneca and Sanofi have received approval for their single dose RSV vaccines for infants from the European Medicines Agency, even though it did not reduce RSV hospitalizations more than a placebo administered during the clinical trials.1 While it takes time for vaccines to receive FDA approval, providers should follow the outcomes of the clinical trials to be prepared to talk with parents about the vaccines when approved.Applying this information to clinical practiceThe above detailed information supports establishing a goal for proactive practices in which each provider gives evidence-based information to parents about the vaccines and makes a strong recommendation for the vaccines to be given to avoid missed vaccine opportunities. The electronic medical records (EMRs) easily allow providers to access immunization data and reach out to parents to make appointments for vaccine updates for their children. Make the goals attainable by engaging all who work in the practice to participate in achieving the practice goals.How can parents avoid exposure to RSV infections? Parents can ask day care centers and schools to have all staff who interact with their infants and children under 5 years old to wear masks. Any infant or child who has a cough, cold or flu symptoms should not attend the day care or school. Handwashing and social distancing have been shown to be effective strategies to reduce the spread of respiratory infections. Reinforce this information to the parents.In summary, establish new practice goals, time lines for evaluating the progress on meeting the goals, and use continuous quality improvement measures to meet the established goals.References1. Krewson, C. Contemporary Pediatrics. Gearing up for a triple threat. November/December, 2022.2. Centers for Disease Control. Weekly Flu Vaccination Dashboard. December 16, 2022. Accessed December 17, 2022. Retrieved from https://www.cdc.gov/flu/fluvaxview/dashboard/vaccination-dashboard.html3. Centers for Disease Control. Staying up to date with COVId-19 vaccines including boosters. December 9, 2022. Accessed December 17, 2022. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.htmlRelated Content Office preparation for fall vaccine administration: Are you ready?Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN October 24th 2024ArticleDonna Hallas, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, highlights key takeaways from our October Vaccine issue of Contemporary Pediatrics. Technology: How far we have come and how far can we go?Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN September 23rd 2024ArticleIn her September 2024 article, Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, highlights the potential of digital health tools to improve care for pediatric mental health, obesity, and medically complex conditions. Self-esteem and feeling good about yourself as a child with a dermatological disorderDonna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN August 23rd 2024ArticleDonna Hallas PhD, PPCNP-BC, CPNP, PMHS, FAANP FAAN, highlights the August issue of our journal with commentary and recommendations.Obesity in the adolescent and young adult populationsDonna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN July 23rd 2024ArticleDonna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, shares her thoughts on the July 2024 issue of Contemporary Pediatrics. Sickle Cell Disease: Promises for a brighter futureDonna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN June 24th 2024ArticleThe first thought that emerges is: how can we, as strong and persistent advocates for children and health equity, effectively remove barriers for accessing care that is driven by a dependency on financial resources? Integrating behavioral health within primary care settings Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN May 22nd 2024ArticleDonna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, shares her thoughts on the latest issue of Contemporary Pediatrics and how these articles can be utilized in the everyday practice of PNPs.Related Content Office preparation for fall vaccine administration: Are you ready?Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN October 24th 2024ArticleDonna Hallas, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, highlights key takeaways from our October Vaccine issue of Contemporary Pediatrics. Technology: How far we have come and how far can we go?Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN September 23rd 2024ArticleIn her September 2024 article, Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, highlights the potential of digital health tools to improve care for pediatric mental health, obesity, and medically complex conditions. Self-esteem and feeling good about yourself as a child with a dermatological disorderDonna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN August 23rd 2024ArticleDonna Hallas PhD, PPCNP-BC, CPNP, PMHS, FAANP FAAN, highlights the August issue of our journal with commentary and recommendations.Obesity in the adolescent and young adult populationsDonna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN July 23rd 2024ArticleDonna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, shares her thoughts on the July 2024 issue of Contemporary Pediatrics. Sickle Cell Disease: Promises for a brighter futureDonna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN June 24th 2024ArticleThe first thought that emerges is: how can we, as strong and persistent advocates for children and health equity, effectively remove barriers for accessing care that is driven by a dependency on financial resources? Integrating behavioral health within primary care settings Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN May 22nd 2024ArticleDonna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, shares her thoughts on the latest issue of Contemporary Pediatrics and how these articles can be utilized in the everyday practice of PNPs.About UsAdvertiseContact UsEditorialJob BoardTerms and ConditionsPrivacyDo Not Sell My Personal InformationContact Info2 Commerce Drive Cranbury, NJ 08512609-716-7777© 2024 MJH Life Sciences All rights reserved.As Several Viruses Surge, How To Avoid Getting Sick Over the Holidays IE 11 is not supported. For an optimal experience visit our site on another browser.Walmart's Black Friday deals event starts today — what to shop, according to an expertSkip to ContentToday LogoOn The ShowAbout TODAY3rd Hour of TODAY Hoda & JennaSaturday TODAYSunday TODAYShop the ShowShopShop the ShowBlack FridayProduct ReviewsSteals & DealsGift GuidesNewsletterWellnessStart TODAYMental HealthWomen's HealthFitnessSleepDiet & NutritionParentsBaby NamesKids HealthFamilyBabiesParenting TipsLOLFoodOn the Show RecipesMost Popular RecipesAll RecipesFood NewsWhat to Cook This WeekLifeAstrologyEssaysHolidaysInspirationJokesBlack FridayTODAY PlazaJoin us on the PlazaHistory of the PlazaCiti Concert SeriesSearchShare this —Search TodaySearchSectionsHealth & WellnessParentingFoodShopPop CultureNewsLifeStyleShowsTODAY3rd Hour of TODAYTODAY with Hoda & JennaSaturday TODAYSunday TODAY with Willie GeistWatch Full EpisodesMoreNewsLifeBooksTrendingRecipesRead With JennaAstrologyInspirational HolidaysRelationshipsTODAY TableHelpNewslettersStart TODAYJokesShop TODAY AwardsCiti Concert SeriesListen All DayFollow todayMore BrandsNBC News LogoMSNBC LogoFacebookPinterestEmailSMSPrintWhatsappRedditPocketFlipboardTwitterLinkedinOn The ShowShopWellnessParentsFoodLifeBlack FridayTODAY PlazaHealth & WellnessLots of people will get sick over the holidays this year. Here's how to avoid itBetween COVID-19, flu and RSV, a lot of people will get sick this holiday season. Here's how to stay healthy and safe, according to experts.Dec. 19, 2022, 6:22 PM UTC / Source: TODAYBy Caroline KeeDuring the last two holiday seasons, COVID-19 was pretty much the only virus on peoples’ minds. But this year, a “tripledemic” of COVID, influenza and respiratory syncytial virus (RSV) is straining the U.S. health system, causing lengthy emergency department wait times and medication shortages.It's unusual that these three viruses are all spiking at the same time, Dr. Eric Cioè-Peña, director for global health at Northwell Health in New York City, tells TODAY.com. While the RSV wave appears to be slowing down after surging much earlier in the season than usual, flu started early, causing more hospitalizations at this point in the season than over the past 10 years, and COVID cases are up 36%.What's more, people are taking fewer precautions, such as masking and distancing, compared to the last two winters, and the holidays mean spending lots of time with large groups mostly indoors.In short: a lot of people will be spreading respiratory viruses instead of holiday cheer over the next few weeks.Fortunately, there are actions you can take to reduce transmission and keep yourself and your loved ones — especially those who are high risk for severe illness — safe during the holidays. Limit exposure before seeing loved onesThis time of year comes with lots of parties, and the safest choice may be not attending them all, NBC News medical contributor Dr. Natalie Azar said during a Dec. 19 segment on TODAY."You want prioritize (and) really think about how many exposures you want to actually encounter, and then you do your own risk assessment for yourself and for your own family," she explained. "If you’re traveling, limit your exposure beforehand."Stay up to date on your COVID-19 vaccinesVaccines not only reduce transmission, but they also prevent severe illness and hospitalization, Dr. Michael Phillips, chief hospital epidemiologist at NYU Langone Health, tells TODAY.com. "Even if you're young and otherwise healthy, if you're visiting your grandparents who may be at risk for severe disease, vaccination makes a difference."And people hosting holiday gatherings should encourage guests to get up to date on their vaccines before attending (meaning the two-dose primary series and the most recent booster recommended by the Centers for Disease Control and Prevention), says Cioè-Peña. The new COVID-19 booster targeting omicron variants and the original strain is approved for everyone 6 months and older. Although Christmas is six days away, "you're going to be more protected after a booster than before a booster, no matter what the duration, so I'd certainly strongly recommend it," says Cioè-Peña.Get a flu shot as soon as possibleIt’s not too late to get your seasonal influenza shot, as cases and hospitalizations surge across the country, the experts note. The flu shot is recommended for everyone 6 months and older. Even if it may not preventing you from catching the flu, it will reduce how sick you get, which is important as hospitals are already struggling.All of the flu shots available this season are quadrivalent, meaning they protect against four different flu viruses, and there are already signs that the vaccine is a good match for the strains circulating right now, Dr. Luis Ostrosky, an infectious disease specialist at UTHealth Houston and Memorial Hermann in Houston, previously told TODAY.com.Stay home if you're feeling sickTry to avoid holiday gatherings or travel if you're feeling sick, the experts emphasize. Even if your COVID-19 test is negative, you should stay home when you have any cold- or flu-like symptoms, Cioè-Peña says, because it could be influenza or another respiratory virus that might make a vulnerable person, like a grandparent or a young baby, very sick.Parents should try to keep their sick children home or away from gatherings, especially if they have a fever, a sign that "they're probably very infectious," says Cioè-Peña.If you’re hosting an event, Cioè-Peña suggests checking in with guests about how they're feeling in the days leading up to the event, and encouraging anyone who feels sick to stay home or attend via Zoom, for example.“We know that folks that are at real risk for severe disease can get really sick and die, so let’s do everything we can to protect them,” says Phillips. People who are high risk for COVID, flu, RSV or other respiratory viruses include: anyone over 65, immunocompromised people, those with underlying medical conditions like diabetes or heart disease, pregnant people and young children.Test for COVID-19 before gatheringsThe current testing guidelines per the CDC are that anyone who has COVID-19 symptoms (cough, sore throat, congestion, fever, fatigue, aches) should test immediately, and anyone exposed to COVID-19 should start testing five days afterward.But even if you're feeling well and have no known exposures, it's a good idea to test before spending time unmasked with anyone high risk, because you can be infectious before symptoms appear and many COVID infections have no symptoms or they're so mild that you might not notice them, Phillips advises.“Getting a COVID-19 rapid test just before you’re about to visit somebody really vulnerable is a good way to protect them,” he says. If none of the above circumstances apply to you, it's still reasonable to test before holiday gatherings or travel simply to know your COVID status. But keep in mind that rapid antigen tests tend to be less accurate at detecting infections without symptoms, and a negative rapid test doesn't guarantee that you don't have COVID.Regardless of your circumstances, the best time take a rapid antigen test before a gathering is right beforehand; if you're traveling, test before leaving and when you arrive at your destination.Wear a mask when traveling or in crowdsWhen worn properly and consistently, masks are an effective way to reduce the spread of COVID-19 and other viruses like influenza, the experts note. A well-fitted, high-quality surgical mask or N95-type respirator can protect the mask-wearer even if people around them are unmasked, says Cioè-Peña.Anyone can benefit from wearing a mask in crowded indoor settings with poor ventilation, Phillips says, but masking up is especially important if you're vulnerable or traveling to someone vulnerable.Last week, the CDC director Dr. Rochelle Walensky recommended wearing a mask when traveling by plane, train, bus or other public transportation, if you're immunocompromised, at increased risk of severe disease, or if you live in a county with high COVID-19 levels.People who are sick but must leave the house should wear a tight-fitting mask or N95 to protect other and should only travel if it's an emergency — while wearing a mask — Cioè-Peña says. Caroline KeeCaroline Kee is a health reporter at TODAY based in New York City.RelatedCostcoCostco recalls nearly 80,000 pounds of butter — and you’ll never guess whyRecall / Updated Nov. 11, 2024Getty ImagesWhat is the healthiest cheese? The No. 1 pick, according to a dietitianDiet & Fitness / Updated Nov. 11, 2024Cindy Ord / Getty ImagesWhat Selena Gomez has shared about her lupus and other health issuesMind & Body / Updated Nov. 11, 2024Courtesy Becky HooverWoman loses 160 pounds with walking and these 2 simple diet changesDiet & Fitness / Updated Nov. 11, 2024Todor Tsvetkov / Getty ImagesIs stair climbing a good workout? Here's how many steps to climb to get the most benefitsDiet & Fitness / Updated Nov. 11, 2024Courtesy Sydney Towle Woman, 23, had a ‘burning sensation’ in her stomach. It was the first sign of a rare cancerDisease / Updated Nov. 11, 2024Arturo Holmes / WireImageWhat Shonda Rhimes has shared about her 150-pound weight lossDiet & Fitness / Updated Nov. 11, 2024Getty Images11 snacks to eat if you’re following the Mediterranean diet, according a dietitianDiet & Fitness / Updated Nov. 11, 2024Ivan-balvan / Getty Images5 common skin rashes that can be caused by COVID, according to dermatologistsCoronavirus / Updated Nov. 9, 2024Yulia Reznikov / Getty ImagesIs spicy food good for you? This what happens to your body when you eat itDiet & Fitness / Updated Nov. 9, 2024AboutContactHelpVisitTODAY AppsAD ChoicesPrivacy PolicyDo Not Sell My Personal InformationCA NoticeNEW TERMS OF SERVICE (UPDATED JULY 7, 2023)NEW TERMS OF SERVICE (UPDATED OCTOBER 3, 2024)CareersClosed CaptioningTODAY SitemapAdvertiseTODAY Store Shop TODAYSelect ShoppingSelect Personal Finance© 2024 NBCUniversal Media, LLCNBC News LogoMSNBC LogoToday Logo2 cases of avian influenza flu confirmed in N.W.T. ravens | CBC News ContentSkip to Main ContentAccessibility HelphamburgerMenuWhen search suggestions are available use up and down arrows to review and enter to select.SearchSearchSign InQuick LinksNewsSportsRadioMusicListen LiveTVWatchnewsTop StoriesLocalClimateWorldCanadaPoliticsIndigenousBusinessThe NationalHealthEntertainmentScienceCBC News InvestigatesGo PublicAbout CBC NewsBeing Black in CanadaMore 2 cases of avian influenza flu confirmed in N.W.T. ravens | CBC News LoadedNorth2 cases of avian influenza flu confirmed in N.W.T. ravensThe new cases bring the total count to three so far in the territory, according to a news release Wednesday from the territory.It brings the total number of cases to 3 cases so far in the N.W.T.CBC News · Posted: Dec 21, 2022 6:07 PM EST | Last Updated: December 21, 2022A file photo of a mountain raven. Two ravens found dead in the N.W.T.'s Dehcho region in late October were infected with Highly Pathogenic Avian Influenza (HPAI). (Vincent Bonnay/Radio-Canada)Social SharingTwo ravens found dead in the N.W.T.'s Dehcho region in late October have been confirmed to have Highly Pathogenic Avian Influenza (HPAI). The new cases bring the total case count of avian flu to three so far in the territory, according to a news release WednesdayThe two ravens were found dead just a few days apart, on Oct. 26 and Oct. 28. The Department of Environment and Natural Resources said it submitted the birds to the Canadian Wildlife Health Cooperative to have them tested. Both tested positive on Dec. 16, the department said.No other cases have been reported, the territory said, and there's no indication of an outbreak in the N.W.T. right now.There's also been no reports of sick birds from any agriculture or environmental operators.Eighty-three birds from the N.W.T. were tested in 2022. The territory said there are no outstanding samples waiting to be analyzed. No people were reported infected with avian flu this year, though the outbreak has been detected across the country.The virus affects domestic and wild birds around the world, the release said. This year's strain is known as HPAI, the territory said, because it is "highly infectious and more likely to spill over into domestic and agricultural birds." The strain has been identified as H5N1.Other jurisdictions are still grappling with the outbreak, as birds continue their migration southward. The territory said the risk to birds in the N.W.T. at this time of year is "exceedingly low as the majority of migratory birds have left the North for the winter season."The territory advises people to not handle dead wild birds or live birds "that are acting strangely." Anyone who sees a sick, injured, or dead wildlife, should call your ENR regional office or contact the ENR Wildlife Health Program at WildlifeVeterinarian@gov.nt.ca.CBC's Journalistic Standards and Practices|About CBC NewsCorrections and clarifications|Submit a news tip|Report errorFooter LinksMy AccountProfileCBC GemNewslettersAbout CBC AccountsConnect with CBCFacebookXYouTubeInstagramMobileRSSPodcastsContact CBCSubmit FeedbackHelp CentreAudience Relations, CBC P.O. Box 500 Station A Toronto, ON Canada, M5W 1E6 Toll-free (Canada only): 1-866-306-4636About CBCCorporate InfoSitemapReuse & PermissionTerms of UsePrivacyPrivacy PreferencesJobsOur UnionsIndependent ProducersPolitical Ads RegistryAdChoicesServicesOmbudsmanCorrections and ClarificationsPublic AppearancesCommercial ServicesCBC ShopDoing Business with UsRenting FacilitiesRadio Canada InternationalCBC LiteAccessibilityIt is a priority for CBC to create products that are accessible to all in Canada including people with visual, hearing, motor and cognitive challenges.Closed Captioning and Described Video is available for many CBC shows offered on CBC Gem.About CBC AccessibilityAccessibility Feedback©2024 CBC/Radio-Canada. All rights reserved. Visitez Radio-Canada.canowWhat is the contagious period for the flu? — Those Nerdy Girls Search for: SUBSCRIBEDONATE Who We Are About Us Team Board Posts Videos In the News Shop Donate Who We Are About Us Team Board of Directors Posts Videos In the News New! Shop Donate December 19, 2022 What is the contagious period for the flu? Infectious Diseases Uncategorized Chana Davis, PhD People with flu are most contagious in the three to five days after they first feel sick. This is a bit later than COVID-19, which often spreads a day or two before symptoms. You might infect someone as early as a day before or as late as a week after becoming sick, but this is less likely. Some people may be contagious even longer – such as young children or people with weakened immune systems. Those Nerdy Girls recommend dialing up your precautions for the first five days to play it safe, even if you’re not sure which nasty bug you have. We know this isn’t always realistic, especially for parents of young children who need snuggles. We’ve been there! Just do the best you can. Getting your flu shot stacks the odds in your favour. It’s also worth layering other precautions, like limiting close contact, masking, and frequent hand-washing. Beyond five days of symptoms, the risk of spreading flu (influenza virus) is low, but not zero. If you’re spending time with people who are vulnerable to severe flu outcomes, it’s worth playing it safe for a full week. The phrase “just the flu” does a disservice to the toll of this illness. Flu can be devastating for babies, toddlers, older adults, and people with other health conditions (see link below on vulnerable populations). Fun fact: You’ll have to wait a few days to know whether or not the flu (influenza virus) has spread. The amount of time from flu exposure to symptoms is usually about two days, but can range from one to four days. BOTTOM LINE: With flu, most people are contagious when they have symptoms. This means that staying home when sick, even if you don’t know what virus you have, is very effective in preventing further spread. Stay safe. Stay well. Those Nerdy Girls —————————————————————— Other posts from Those Nerdy Girls: Do flu shots work? How do I know if we have RSV, the flu, or COVID-19? Tips for safer family gatherings References: Key facts about flu /influenza (CDC) Stop the spread of flu and COVID-19 (Health Canada) Risk factors for severe flu outcomes (CDC) Link to original Those Nerdy Girls Facebook post Post navigation ← ✨¡REGRESAN LAS PRUEBAS RÁPIDAS DE COVID-19 GRATUITAS!✨✨I want to use an effective method of birth control, but how can I pay for it? It can be expensive! → Nerdy Merch Get the perfect gift for the Nerds in your life! Your purchases help financially support the science communication mission of Those Nerdy Girls. Shop Get the Newsletter! Those Nerdy Girls want to help you stay on the frontline of science and health information. Sign up hree to receive our twice weekly newsletter. Stay safe. Stay well. Subscribe on Substack Post Categories: Aging (18) Biology/Immunity (106) Clinical Symptoms (81) COVID Variants (76) Data and Metrics (155) Data Literacy (70) Families/Kids (336) General Health (145) Health Policy (10) Hot Health Topics (14) Infection and Spread (296) Infectious Diseases (166) Long COVID (35) Masks (94) Mental Health (206) Nerdy Notes (1) Posts en Español (527) Reopening (50) Reproductive Health (111) School (49) Social and Racial Justice (63) Socializing (98) Staying Safe (417) Testing and Contact Tracing (140) Travel (36) Treatments (100) Uncategorized (115) Uncertainty and Misinformation (192) Vaccines (641) Videos (94) Women in STEM (44) Browse posts by date: November 2024 M T W T F S S 123 45678910 11121314151617 18192021222324 252627282930 « Oct Donate RSS Feed Content and Comment Policy: The content found on Those Nerdy Girls’ digital platforms, including graphics, images, text, and all other materials is provided for reference and educational purposes only. The content is not meant to be exhaustive or to be applicable to any specific individual’s medical condition. Nothing on Those Nerdy Girls’ page should be taken as medical advice of any kind. Neither our posts nor the comments of our readers are a substitute for the advice of your healthcare provider. We do not vet all comments and cannot vouch for their content. We do not represent any institution, rather a collaborative network of scientists operating independently, with the goal of informing the general public with factual information related to the pandemic. Stay safe. Stay well. The content of Those Nerdy Girls Posts by Those Nerdy Girls is licensed under CC BY-NC-ND 4.0 Stay Safe. Stay Well. Privacy Policy Donate Media RequestsCounty Urges People to Get the Best Gift Available-Vaccinations! | News | San Diego County News Center Skip to content Primary Menu San Diego County News Center Direct To You Facebook Twitter YouTube Instagram RSS Subscribe Home News Watch CNC TV Live CNC TV Schedule CNC Videos About CNC TV Topics Board Meetings County Website Search for: Search for: Home News Watch Topics Board Meetings County Website County Website Archive About Contact Help Disclaimer Facebook Twitter YouTube Instagram RSS Subscribe HealthCounty Urges People to Get the Best Gift Available-Vaccinations! By Gig Conaughton, County of San Diego Communications OfficeDec. 22, 2022 | 6:23 PMDec. 22, 2022 | 6:44 PM Reading Time: 4 minutesThe County Health and Human Services Agency is urging people to give themselves, their family and friends the best gift available this holiday season― vaccinations to protect against COVID-19 and the flu. The updated bivalent COVID-19 boosters that provide the greatest protection against COVID-19 were recently made available to everyone six months of age and older. COVID-19 and the flu are circulating at high levels this winter and vaccinations for both are widely available at local pharmacies and medical providers. The County will also be offering vaccinations throughout the holidays at its vaccination sites. Check online here for the days and hours sites will be open. “Many San Diegans have taken advantage of the ability to get vaccinated,” said County Public Health Officer Dr. Wilma Wooten, M.D., M.P.H. “But we can still vaccinate and protect more people. COVID-19 remains highly prevalent in San Diego County, and we’re entering January, the month historically when we’ve had our highest peak number of cases. So please take advantage and complete your vaccinations to protect yourself, your family, and others.” County officials report that through this week, 80.5% of eligible San Diegans have received their two-shot primary vaccinations, 60.8% have received the primary vaccinations and a booster. They also report that one in five, 20%, of all eligible San Diego residents 5 years and older have received the new bivalent booster. In addition, 40% of people 65 years of age and older have received the new bivalent booster. People across the country and here in San Diego County continue to deal with multiple respiratory diseases this winter season, including COVID-19, flu and respiratory syncytial virus (RSV). Public Health officials still strongly urge people to get vaccinated for both COVID-19 and the flu. The bivalent COVID-19 booster and flu vaccinations are separate shots, but they can be given at the same visit. They decrease the chances of getting infected, but more importantly, they effectively reduce the risk of severe illness and complications like hospitalization and death. Boosters are available through local participating pharmacies and healthcare providers. People can visit the state’s My Turn website to schedule an appointment. Booster dose availability is listed on the County’s COVID-19 vaccinations schedule webpage. Holiday Prevention Measures County officials also recommend wearing a mask if you are able, particularly during indoor public gatherings, to protect yourself and those around you. In addition to vaccination and masking, San Diegans can take other precautions to protect themselves against COVID-19, as well as seasonal illnesses like the flu. These measures include: Cleaning hands thoroughly and often Staying away from sick people Staying home and avoiding contact with others when sick Regularly cleaning commonly touched surfaces Home testing when exposed or when ill. The federal government is providing free at-home COVID-19 tests available again through the winter for a limited time. Households can order one pack of four free tests through the U.S. Postal Service. For more information about testing, go to the County of San Diego COVID-19 testing webpage. COVID-19 Vaccination Progress: More than 2.69 million or 80.5% of San Diegans received the primary series of one of the approved COVID-19 vaccines. Bivalent boosters administered: 497,928 or 20% of 2,494,948 eligible San Diegans. More vaccination information can be found at coronavirus-sd.com/vaccine. COVID-19 Deaths: 18 additional deaths were reported since the last report on Dec. 15, 2022. The region’s total is 5,626. Of the 18 additional deaths, nine were women and nine were men. They died between March 8, 2022, and Dec. 14, 2022. Thirteen of the newly reported deaths occurred in the past two weeks. Thirteen of the people who died 80 or older, three were in their 70s and two were in their 60s. 14 of these people had been vaccinated and four had not received any COVID-19 vaccines. 18 had underlying medical conditions. COVID-19 Cases, Case Rates and Testing: 4,764 COVID-19 cases were reported to the County in the past seven days (Dec. 13, 2022, to Dec. 19, 2022). The region’s total is now 957,586. The 4,764 cases reported in the past week were lower compared to the 4,821 infections identified the previous week (Dec. 6, 2022 through Dec. 12, 2022). 4,730 tests were reported to the County on Dec. 17, and the percentage of new positive cases was 11.4% (Data through Dec. 17). The 14-day rolling percentage of positive cases, among tests reported through Dec. 17, is 9.8%. Influenza Activity The County Health and Human Services Agency now publishes the Respiratory Virus Surveillance Report weekly. The report is published each Thursday and tracks key respiratory illness indicators, including flu cases and deaths. For the week ending Dec. 17, 2022, the report shows the following: Seven additional flu deaths; the season’s total is now 27. Four of the additional flu deaths were women and three were men. They died between Nov. 30, 2022, and Dec. 13, 2022. One of them had received a flu shot this season and six had not. Six of the seven had underlying medical conditions; one had no underlying medical conditions. None of the newly reported deaths were coinfected with COVID-19. Emergency department visits for influenza-like illness: 6% of all visits (compared with 7% the previous week). Lab-confirmed influenza cases for the week: 1,141 (compared to 1,609 the previous week). Total lab-confirmed cases to date: 18,439 (compared to 888 at the same time last season and a 1,201 prior 5-year average during the same week). More Information: Data updates to the County’s coronavirus-sd.com website will be published Thursdays around 5 p.m., with the exception of holidays. More information about the flu is available on the County’s influenza website. Related: COVID-19fluinfluenzavaccinations Gig Conaughton is a communications specialist with the County of San Diego Communications Office. Contact Related Stories County Offices Will Close for Christmas Day Holiday County Office Closures for New Year’s Holiday VIDEO: The 2022 Live Well Advance Returns With Thousands of Attendees More from Health Post navigation Previous Story Previous Story: County Office Closures for New Year’s HolidayNext Story Next Story: Resolve to Give Yourself the Gift of Health in 2023 TranslateGet Updates Subscribe for email updates Get County News Center stories emailed direct to you. Latest News Bomb Threat at Registrar of Voters Investigated, Is Not Credible Video Wall Adds Safety, Awareness for CAL FIRE County and Prebys Foundation Join Forces to Help Local Artists, Support Art and Culture Sustainability Vista Azul Affordable Housing Opens in Carlsbad Archive Archive Select Month November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 June 2021 May 2021 April 2021 March 2021 February 2021 January 2021 December 2020 November 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 April 2020 March 2020 February 2020 January 2020 December 2019 November 2019 October 2019 September 2019 August 2019 July 2019 June 2019 May 2019 April 2019 March 2019 February 2019 January 2019 December 2018 November 2018 October 2018 September 2018 August 2018 July 2018 June 2018 May 2018 April 2018 March 2018 February 2018 January 2018 December 2017 November 2017 October 2017 September 2017 August 2017 July 2017 June 2017 May 2017 April 2017 March 2017 February 2017 January 2017 December 2016 November 2016 October 2016 September 2016 August 2016 July 2016 June 2016 May 2016 April 2016 March 2016 February 2016 January 2016 December 2015 November 2015 October 2015 September 2015 August 2015 July 2015 June 2015 May 2015 April 2015 March 2015 February 2015 January 2015 December 2014 November 2014 October 2014 September 2014 August 2014 July 2014 June 2014 May 2014 April 2014 March 2014 February 2014 January 2014 December 2013 November 2013 October 2013 September 2013 August 2013 July 2013 June 2013 May 2013 April 2013 March 2013 February 2013 January 2013 December 2012 November 2012 October 2012 September 2012 August 2012 July 2012 June 2012 May 2012 April 2012 March 2012 February 2012 January 2012 December 2011 November 2011 October 2011 September 2011 August 2011 July 2011 June 2011 May 2011 April 2011 February 2011 December 2010 September 2010 August 2009 Subscribe for email updates Get County News Center stories emailed direct to you. Contact County Communications Office communications@sdcounty.ca.gov 619-595-4633 Instagram Thank you to all Veterans for your service and sac A grand opening ceremony was held this week for Vi Who do you think won the staring contest? 👀 Pa The County of San Diego Registrar of Voters receiv You Belong Here! In honor of Veterans Day, we invi The photo on the left shows how San Diego County r Workers at the San Diego County Registrar of Voter The polls have closed. Find election results at sd The County Administration Building is lit tonight Voters cast their ballots at the San Diego LGBT Co Polls are open until 8 p.m. today (Tuesday, Nov. 5 The Mission Valley @sdpubliclibrary is one of more It’s Election Day! Voters were casting their bal Good morning! Vote Centers are now open for the 20 Tuesday, Nov. 5, is the final day to cast your bal Meet Athena! She is a shy girl that loves to play Additional vote centers and six super centers open You Belong Here! Job openings this week include bu On Halloween, we thought you should know. Some gho Today hundreds of students at Castle Park HS in Ch Load More... Follow on Instagram Footer Menu County Website Archive About Contact Help Disclaimer Facebook Twitter YouTube Instagram RSS SubscribeA Wellesley woman died of flu complications in what a doctor said was a 'one-in-a-million case' Skip to Main Content Open Close Menu Home News Local News National News 2024 Election Politics Crime COVID Traffic Sports Celtics Jayson Tatum Jaylen Brown Patriots Bruins Red Sox Revs Chad Finn Weather Maps Storms Climate Change Snow David Epstein Real Estate Reno Developments News Buying Open Houses Renting Luxury Food Restaurants News Reviews Events Breweries & Bars Closings Openings Sign up for The Dish 🍽️ Love Letters Latest Post Send Letter About Podcast Book Culture Arts Entertainment Movies TV Streaming Celebs Music Things To Do Newsletter Travel Fall in New England Visiting Boston Cape Cod New England Flights Outdoors Skiing Sign up for Scenic Six Community Tell Us Neighborhoods Readers Say Book Club Wickedpedia The B-Side Cocktail Club Extra Customer Support Advertise Classified Ads Careers Contact Us Obituaries Newsletters Mass. Lottery Powerball Mega Millions Horoscopes Comics Today in History Fresh Start Weddings Cars New Car Specials Games Boston.com Search Search for: Search Boston.com News Local News National News 2024 Election Politics Crime COVID Traffic Sports Celtics Jayson Tatum Jaylen Brown Patriots Bruins Red Sox Revs Chad Finn Weather Maps Storms Climate Change Snow David Epstein Real Estate Reno Developments News Buying Open Houses Renting Luxury Food Restaurants News Reviews Events Breweries & Bars Closings Openings Sign up for The Dish 🍽️ Love Letters Latest Post Send Letter About Podcast Book Culture Arts Entertainment Movies TV Streaming Celebs Music Things To Do Newsletter Travel Fall in New England Visiting Boston Cape Cod New England Flights Outdoors Skiing Sign up for Scenic Six Community Tell Us Neighborhoods Readers Say Book Club Wickedpedia The B-Side Cocktail Club Extra Customer Support Advertise Classified Ads Careers Contact Us Obituaries Newsletters Mass. Lottery Powerball Mega Millions Horoscopes Comics Today in History Fresh Start Weddings Cars New Car Specials Games Drake Maye Seth Moulton Bill Burr Local News A Wellesley woman died of flu complications in what a doctor said was a ‘one-in-a-million case’ Price Meropol McMahon, 36, was a mother of two and a successful athlete. Price Meropol McMahon (left), her husband, Jimmy McMahon, and their children, Rosalie and James, on the green at Woodland Golf Club. The couple had taken a photo in that spot every year since their marriage in 2013. Courtesy photo via The Boston Globe By Christopher Gavin December 23, 2022 FacebookTwitterEmailEmail... Price Meropol McMahon spent Sunday at her parent’s house, taking in the final match of the World Cup and celebrating the first night of Hanukkah.On Monday night she began feeling feverish, according to The Boston Globe. The following morning she had trouble breathing.Tuesday afternoon she was rushed to the hospital — and there, McMahon, 36, took her final breaths.“The doctor’s words, I’ll always remember this,” Ian Meropol, her brother, told the newspaper. “‘This is a one-in-a-million case of influenza.’”Millions of Americans catch the flu annually, and of those cases between 12,000 and 50,000 are fatal, according to the Globe.Advertisement:But it is incredibly rare for a person like McMahon to be counted among them. The Wellesley mother of two was young, otherwise healthy, and an accomplished athlete — a Boston sports fan who played tennis, went skiing, and finished the New York City Marathon in under four hours, her family told the Globe.At the time of her death, she was training to run her first Boston Marathon next year.“She was always incredibly smart, hardworking, driven, she was the one that everyone knew would be successful,” Meropol said.Her siblings and father described a woman dedicated to those closest to her. Meropol recalled how, when his sister worked her corporate job in New York, she’d hop an early morning flight so she could be home to tuck her children into bed that same night.Advertisement:“She never talked about her successes in business, or running, or tennis,” McMahon’s father, Jeffrey Meropol, 71, said. “It was 100 percent family.”McMahon was the youngest of three but always took care of her older brothers, he told the Globe.“I always said she’d be the one that would take care of mom and me when we got older,” Jeffrey Meropol said.Massachusetts is facing an intense flu season this year.The illness arrived weeks earlier than it typically does, and has taken off at a higher rate much faster than usual years, public health officials have said.Last week’s state flu report, the latest available, listed the current estimated severity of influenza as “very high,” with 4.35 percent of hospitalizations in the commonwealth stemming from flu cases.According to the Globe, as many as 33 million people are believed to have contracted the flu across the United States between Oct. 1 and Dec. 10, the U.S. Centers for Disease Control and Prevention reports. Twenty-eight thousand people have died from flu complications. Newsletter Signup Stay up to date on all the latest news from Boston.com Submit your email Enter your email address Sign up Most Popular Bernie Sanders has some post-election advice for Democrats This New England metro was ranked most livable. It's not Boston. Tom Brady’s career crisis 🎤 Belichick focuses more on Bears’ dysfunction than Patriots’ strides New and upcoming restaurant openings in Boston, late 2024 In Related News Karen Read’s lawyers went before the state’s highest court Wednesday. Here’s what they said. Local News Independent firm chosen to audit Canton police Crime 24-year-old Bedford woman indicted in parents’ fatal shooting Follow Boston.com on Instagram (Opens in a New Tab) Follow Boston.com on Twitter (Opens in a New Tab) Like Boston.com on Facebook (Opens in a New Tab) ©2024 Boston Globe Media Partners, LLC Tell Us What You Think Do not sell my data GAMBLING DISCLAIMER Privacy Policy Your Privacy Choices ADVERTISE Terms of Service Member Agreement CONTACT US CAREERS Site Map Close Modal Boston.com Newsletter Signup Boston.com Logo Stay up to date with everything Boston. Receive the latest news and breaking updates, straight from our newsroom to your inbox. Enter your email address Submit your email Enter your email address Subscribe No thanks - Closes Modal windowIs Everyone Sick? Boston Doctors Talk Colds, Flu, RSV, COVID – NBC Boston Skip to content Main Navigation Search Search for: Local Weather Investigations Videos Sports U.S. & World Traffic Newsletters Watch News 24/7 Trending 24/7 streaming news Download our app! Donald Trump Drake Maye Celtics Karen Read trial @Issue Expand Boston Feel Like Everyone's Sick Right Now? Boston Doctors Explain What's Going Around "There's a lot circulating out there ... there are many things you can catch beyond COVID, RSV and influenza," Brigham and Women's Hospital's Dr. Daniel Kuritzkes said By Mary Markos • Published December 21, 2022 • Updated on February 13, 2023 at 11:10 am NBC Universal, Inc. Feel like everyone's getting sick right now? You're not alone. Aside from "the big three" of COVID-19, RSV and influenza, Boston doctors say there are plenty of other upper respiratory viruses circulating right now that are causing people to be under the weather. WATCH ANYTIME FOR FREE Stream NBC10 Boston news for free, 24/7, wherever you are. Why does it seem like so many people are sick? Brigham and Women's Hospital's Chief of Infectious Disease Dr. Daniel Kuritzkes and Tufts Medical Center's Dr. Shira Doron explained that changes in human behavior related to COVID-19 have interrupted the natural cycles of viruses and reduced population-level immunity during NBC10 Boston's weekly "COVID Q&A" series. "There are several viruses going around," Kuritzkes said, naming various rhinoviruses, adenoviruses and parainfluenza virus as examples. Get updates on what's happening in Boston to your inbox. Sign up for our News Headlines newsletter. Between COVID-19, the flu and RSV, doctors are worried about the triple threat of infections we’re facing this holiday season. Pointing to a piece she recently published in The Boston Globe, Doron explained the concept of population-level immunity, which she noted is different from an individual's immune system. "Our immune systems are still working just fine," Doron said. What's happening, Doron explained, is a result of stay-at-home orders, school and business closures, travel cessation and drastic changes in day-to-day human interactions. Because people behaved differently, those viruses didn't traverse the globe in the pattern that they normally would, thereby reducing population-level immunity. We are all just so susceptible to colds because we didn't have them for so long.Tufts Medical Center's Dr. Shira Doron "As we normalize our behaviors again, it takes a while for the patterns to restore into normalcy. All of the viruses have started to come roaring back and in a disrupted pattern. That's a consequence of our disrupted human interactions and travel that have thrown everything off. We are all just so susceptible to colds because we didn't have them for so long," Doron said. Doron continued, emphasizing that what people may experience on a personal level is different from what the population experiences on the whole. "Nobody needs to get a cold to have a normal immune system. You are welcome to try to avoid cold and flu for the rest of your life and it won't harm you in any way to do that," she said. "But on a population level, epidemiologically, it's been disruptive." Pharmacists across the country are reporting low inventory of cold and flu medications as the nation deals with a spike in illness. They say children's medications are particularly tough to find. Doron pointed to an early start to the flu season, as well as summertime cases of respiratory syncytial virus, or RSV for short. "People talk about the worst season in 10 years. It's not the worst season in 10 years. It's the worst season for November and early December in 10 years," Doron said. "So it's a disrupted pattern." Public health experts don't frequently test for lower-risk viruses, according to Kuritzkes, especially not outside of special populations in the hospital. "We're all more susceptible because we're not as well protected against these otherwise routine and generally harmless -- or at least not seriously harmful -- viruses," Kuritzkes said. "There's a lot circulating out there and that's why it's important for people to realize that there are many things you can catch beyond COVID, RSV and influenza," Kuritzkes said, adding, "although for the most part, they're much less likely to cause any kind of medically serious illness." More COVID news Massachusetts Dec 18, 2022 Doctors Concerned About Viruses During the Holiday Season news Dec 15, 2022 Biden Administration Makes At-Home Covid Tests Available for Free Again This Winter This article tagged under: Boston on now 8PM: NBC 10 Boston News Trending Stories Taylor Swift Taylor Swift politely corrects security guard while arriving at Chiefs game Social Security Social security recipients will see an increase in 2025 — and an extra check in November Boston Restaurant Talk Tree House Brewing may be opening new brewery, distillery, and tasting room in Boston Cybersecurity Data breaches in Massachusetts — by the numbers Sandwich Person's remains found in burning vehicle in Cape Cod woods Weather Forecast Facebook Instagram TikTok About NBC10 Boston NBC Sports Boston Our News Standards Submit a Tip for Investigations Connect With Us Newsletters Xfinity: Internet, TV, streaming, more WBTS Public Inspection File WBTS Accessibility WBTS Employment Information FCC Applications NBC Non-Profit News Partnership Reports Send Feedback Terms of Service Privacy Policy Your Privacy Choices CA Notice Ad Choices Advertise with us Copyright © 2024 NBCUniversal Media, LLC. All rights reserved Close Menu Search for: Meet the Team Local Weather School Closings Weather Alerts Investigations NBC10 Boston Responds Submit a tip Video Health Traffic NBC Sports Boston Sports Celtics New England Patriots Bruins Red Sox Entertainment Hub Today Politics About NBC10 Boston Our News Standards TV Listings Submit a Tip Submit a Consumer Complaint Submit Photos and Video Newsletters TV Schedule Download Our Apps Cozi TV Follow Us Facebook Instagram TikTok Contact UsThe Earliest Flu Symptoms Can Be Some of the Easiest to Miss | SELFSkip to main contentOpen Navigation MenuMenuThe Earliest Flu Symptoms Can Be Some of the Easiest to MissFitnessFoodHealthLoveBeautySportsLifeHealth ConditionsShoppingMoreChevronSearchSearchFitnessFoodHealthLoveBeautySportsLifeHealth ConditionsShoppingVideoChallengesWorkoutsNewsletter SignupHealth ConditionsChevronInfectious DiseasesChevronCold and FluChevronRelated Condition CentersInfectious DiseasesCOVID-19 (Coronavirus)The Earliest Flu Symptoms Can Be Some of the Easiest to Miss“Listen to your body, because it’s trying to tell you something.”By Julia RiesDecember 21, 2022IKON Images - stock.adobe.comSave this storySave this storySave this storySave this storyThink back to the last time you had the flu, or just generally felt really unwell. You probably remember hunkering down in bed for a few days while you fought off a fever. But do you remember the symptoms that appeared right before you got blatantly sick? If you’re like me, perhaps you shrugged off those early flu symptoms as sleepiness or a tickle in your throat caused by the dry winter air. They’re easy to ignore but important to pay attention to. Why? Sometimes, before it’s obvious that you’re sick with the flu (or some other illness), you can be pretty contagious, Daniel Pastula, MD, MHS, a professor of infectious diseases, epidemiology, and neurology at the University of Colorado Anschutz Medical Campus, tells SELF. Those early warning signs are your body telling you it’s time to rest up so your immune system can work more efficiently. If you pick up on those clues quickly enough, you could potentially start treatment sooner and recover faster.It can take up to four days for flu symptoms to fully appear after the virus takes root in your respiratory tract, according to the Centers for Disease Control and Prevention (CDC). In the first few days after you’re exposed to influenza, the virus makes copies of itself in your body and begins to spread, primarily latching onto cells in your nose, throat, and lungs. This is when the first signs of infection tend to manifest. They can look and feel slightly different from person to person, Dr. Pastula says, but research suggests these early symptoms generally include:Feeling a little off, run down, sluggish, or achyAn uncomfortable, almost scratchy feeling in the throat when swallowingFeeling more sneezy than usualRunny nose or post-nasal drip (before the full-fledged congestion strikes)At this stage, the immune system is starting to respond to the viral replication by releasing a ton of chemicals to ramp up its defenses—and that can cause people to feel icky, Dr. Pastula says. From an evolutionary standpoint, your body does this to force you to rest, so it can spend less energy on, say, exercise classes and more effort on fending off the virus. A day or so later, and depending on how severe your infection becomes, classic flu symptoms may strike: a fever, persistent chills, a painfully sore throat, and/or a deep-in-the-lungs cough. Even if you don’t get a fever, that doesn’t necessarily mean you don’t have the flu. “You might just have a mild case,” Dr. Pastula says. The timing and intensity of your symptoms depend on the strain and amount of virus you’ve been exposed to, Dr. Pastula says. Your overall health, genetics, and age can also play a role in how sick you end up getting. Looking at symptoms alone, it’s nearly impossible to discern between the flu and other respiratory infections that tend to spike in the winter like COVID, RSV, and even the common cold, Dr. Pastula says. They all have a similar spectrum: fatigue, runny nose, muscle aches, headache, sore throat, cough, and sometimes, a fever. These viruses cause the immune system to put up a fight, which triggers inflammation. “That’s why all the symptoms look similar,” Dr. Pastula says.The flu, like COVID, tends to come on fast and hard, even suddenly, whereas common cold symptoms gradually appear and may intensify. Other than that clue, the only surefire way to figure out what you have is to get tested at a medical facility. (You can get a test done to determine whether you have COVID or the flu. If your symptoms seem to be getting worse or feel persistent, your doctor may consider a full respiratory panel, depending on your insurance coverage). Bottom line: If you start feeling vaguely crappy, it’s worth paying attention to those subtle cues. “Listen to your body, because it’s trying to tell you something,” Dr. Pastula says. Stay hydrated, eat nutritious snacks and meals, and take it easy so your body can get the rest it needs. Even if your symptoms seem to be mild or moderate, it’s best to check in with a doctor if you have access to one so you have a care plan in mind, just in case you start to feel worse. Make sure you ask about antiviral meds; when it comes to the flu and COVID, these treatments work the best the sooner you can take them, Dr. Pastula says. Give your friends or loved ones—especially those who have a higher risk of developing a serious illness—a heads up that you think you might be coming down with something. If you absolutely have to go out, wear a high-quality face mask. You could very well be contagious and a few hours away from shivering with a fever in bed—even if you don’t really feel like it. Related:6 Flu Complications to Be Aware of If You Start Feeling Super SickI Don’t Feel Sick Anymore—But Is My Cold Still Contagious?Should You Postpone Your Flu Shot If You’re Feeling Sick?Julia Ries is a Philly-based freelance writer who covers health and wellness for SELF, HuffPost, Health, Healthine, and Condé Nast Traveler, among others. You can check out some of her work at www.juliaries.com.SELF does not provide medical advice, diagnosis, or treatment. Any information published on this website or by this brand is not intended as a substitute for medical advice, and you should not take any action before consulting with a healthcare professional.Topicscold and flusymptomsinfluenzanewsMore from SelfA Massive Frozen Waffle Recall Is Underway Due to Possible Listeria ContaminationDozens of stores and brands are on the list including Target, Kodiak Cakes, Great Value, and Publix.Why the NY Liberty’s Historic WNBA Title Means So Much to These Fans“Twenty-eight years I’ve been waiting for this.”8 G-Spot Sex Positions That’ll Hit All the Right AnglesHit all the right angles with these expert-approved moves.10 Cute and Comfy Travel Outfits to Wear on Your Next TripApproved by flight attendants and SELF staffers.5 Sneaky Ways You Might Be Sabotaging Your RelationshipsPushing great people away is a subconscious attempt to stay emotionally safe.The Best Pillows for Every Type of SleeperDreamy picks to help you wake up refreshed and ache-free.Alpaca Wool Is My Secret to Staying Comfy During Cold-Weather RunsThese pieces help me train outdoors all winter long.The Best Queen Size Mattresses for Sharing a Bed or Spreading Out SoloHere's what to look for in order to maximize the space you have.Discover new workout ideas, healthy-eating recipes, makeup looks, skin-care advice, the best beauty products and tips, trends, and more from SELF.FacebookXPinterestInstagramTiktokMore from SelfAbout SELFNewsletter Sign UpVideoMastheadAccessibility helpContactContactCareersUser AgreementPrivacy PolicyYour California Privacy RightsRSS FeedsAccessibility HelpCondé Nast Store© 2024 Condé Nast. All rights reserved. SELF may earn a portion of sales from products that are purchased through our site as part of our Affiliate Partnerships with retailers. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Condé Nast. Ad ChoicesCovid, flu and RSV: What science shows about being contagiousIE 11 is not supported. For an optimal experience visit our site on another browser.Skip to ContentNBC News Logo2024 ElectionU.S. NewsWorldBusinessSportsHealthScienceShoppingTiplineCulture & TrendsShare & Save —My NewsManage ProfileEmail PreferencesSign OutSearchSearchProfile My NewsSign Out Sign InCreate your free profileSectionsU.S. NewsDecision 2024PoliticsWorldLocalBusinessSportsInvestigationsCulture & TrendsHealthScienceTech & MediaWeatherVideo FeaturesPhotosNBC SelectNBC Asian AmericaNBC BLKNBC LatinoNBC OUTtvTodayNightly NewsMSNBCMeet the PressDatelineFeaturedNBC News NowNightly FilmsStay TunedSpecial FeaturesNewslettersPodcastsListen NowMore From NBCCNBCNBC.COMNBCU AcademyPeacockNEXT STEPS FOR VETSNBC News Site MapHelpFollow NBC News news AlertsThere are no new alerts at this timeSearchSearchFacebookTwitterEmailSMSPrintWhatsappRedditPocketFlipboardPinterestLinkedinLatest Stories2024 ElectionU.S. NewsWorldBusinessSportsHealthScienceShoppingTiplineCulture & TrendsCoronavirus'Tripledemic' viruses still spreading. What science shows about being contagious.How long do people remain infectious with respiratory viral diseases like Covid, flu and RSV?Get more newsLiveonDec. 18, 2022, 11:00 AM UTCBy Benjamin RyanHow can we stop the winter "tripledemic" of respiratory viruses from wrecking upcoming holiday travel and family gatherings? People know when they have Covid symptoms, but do minor sniffles at the end of a coronavirus infection, for example, mean they’re still contagious?So many Covid questions! It’s a good time to brush up on what scientists know, and still don’t know, about how long people remain infectious with viral diseases — Covid, influenza, RSV — that are spreading across the U.S.How long am I contagious with Covid?If you’ve been exposed to someone who has tested positive for Covid, symptoms from any of the omicron subvariants generally appear two to four days later. How contagious you are is connected to how much of the virus, known as the viral load, is in your body. Your viral load will likely peak soon after the start of symptoms, according to Dr. Chanu Rhee, an infectious disease physician and associate professor of medicine at Harvard Medical School. This means you are likely most contagious a day or so before symptoms appear and during at least the first two or three days after. As your immune system reduces your viral load, your infectiousness should decline in tandem. “If folks are still very, very symptomatic, with a lot of coughing and a lot of upper respiratory symptoms, then the thought is they’re probably more infectious,” said Dr. Lisa. A. Cosimi, an infectious disease specialist at Harvard Medical School.But determining whether you’re still somewhat infectious during the waning days of a Covid illness can be tricky.The Centers for Disease Control and Prevention recommends that people who are experiencing moderate to severe symptoms to isolate for 10 days. If your Covid illness is mild, the CDC advises that to protect others you should consider yourself infectious for at least five days from the onset of symptoms — or five days after a positive test, which counts as day zero. A study of 66 people with nonsevere Covid published in the New England Journal of Medicine in July found that the median time until the participants were likely no longer infectious was six days when the delta variant of the virus was dominant, and eight days during the omicron wave.According to an October study of 4,565 people with Covid, “overall, existing data suggest that infectiousness (using viral culture as a proxy) beyond 10 days is possible although less common.” The investigators called for more research about whether people remain infectious after that point.There have, however, been cases of immunocompromised people who have remained infectious for months, according to various infectious disease experts. As far as relying on Covid tests to determine whether someone is still contagious, PCR tests are good at diagnosing Covid. They are not reliable for determining ongoing infectiousness because they can detect fragments of the virus, which pose no risk of transmitting to others, for weeks or months after infection. At-home rapid antigen tests aren’t perfect either. Researchers rely on what are known as viral culture tests in which they take a swab of the coronavirus and see if they can grow the virus in the lab, as the best proxy for infectiousness. But everyday people don’t have access to such tests. In a recent study of 40 people with Covid, three quarters of them tested positive six days after their first positive test or the start of their symptoms, whichever came first. As part of the research, the participants also received what are known as viral culture tests in which scientists see if they can grow the virus taken from a swab in the lab. It's considered the best proxy for infectiousness.About half of that group had a negative viral culture test at that time, suggesting they weren’t contagious. Cosimi, the Harvard Medical School infectious disease specialist, was the lead author of the study and said that after day five of Covid — if people test negative when they have improved yet still have lingering symptoms — they’re likely not contagious.She also said that if non-immunocompromised people feel well by day 11 but still test positive on an antigen test, “it is exceedingly unlikely” they’re still infectious.According to the CDC, if you have no symptoms after day five, or if your Covid symptoms are improving and you haven’t had a fever for 24 hours, you can end your isolation period. For days six through 10, you can go out but should wear a mask.You don’t need to test to end your isolation period in these contexts. The CDC says you can take the mask off early if you test negative on two consecutive rapid antigen tests 48 hours apart. There's a condition, though. “You should still wear a mask through day 10 because theoretically, you’re still infectious, even if your degree of infectivity has gone down,” said Rhee.How long am I contagious if I've had Covid or am fully vaccinated and have a breakthrough infection? Several studies have shown that vaccination helps the body clear the coronavirus more quickly. Most of the studies, however, looked at patients infected with the older variants, Rhee said.“The impact of prior immunity on infectiousness is not as clear for omicron variants.”More news on the tripledemicWhat Covid has taught scientists about the flu. Is it Covid, flu or RSV? A chart compares symptoms.U.S. hospitals report a rise in severe cases of invasive strep A, a rare and sometimes life-threatening bacterial illness. The White House is offering 4 more free at-home Covid tests. Here's how to get them. On average, unvaccinated people do indeed take longer to beat the infection, said Dr. Yonatan H. Grad, associate professor of immunology and infectious diseases at the Harvard T.H. Chan School of Public Health and senior author of a recent paper in the journal eLife in which he and his colleagues reached this conclusion. “We do not know about duration of infectiousness,” Grad said in an email.If I’m taking Paxlovid, am I contagious?A study published in Clinical Infectious Diseases in July found that taking Paxlovid accelerates coronavirus clearance, which the authors said might reduce infectiousness.Recent research has cast doubt on whether Paxlovid is driving cases of viral rebound, given that people who don’t take Paxlovid commonly rebound as well.“What we don’t know is whether those rebounds are infectious or not,” said Dr. Donald Milton, a professor of environmental and occupational health at the University of Maryland.Consequently, the CDC recommends restarting the isolation clock at day zero if a rebound occurs.How long am I contagious with the flu or other viral illnesses?With flu, RSV (respiratory syncytial virus) and the common cold, experts say, people are generally most infectious between a day or two before symptoms begin and then for a few days afterward.The CDC recommends that people with the flu stay home until at least 24 hours after their fever subsides without the use of fever- reducing medication or after their symptoms have improved — at least four to five days after getting sick.A 2010 study identified a close correlation between the decrease of flu symptoms, in particular fever, and a decrease in viral shedding, which indicates infectiousness.“If you’re really sick, if you’ve got a fever, you may be infectious for a little bit longer,” said Aubree Gordon, an associate professor of epidemiology at the University of Michigan School of Public Health. “The level of symptoms can be a guide for when you need to stay home. But that does not mean if you have mild symptoms you aren’t contagious.”Classic common cold symptoms include congestion, cough, a runny nose and low-grade fever. Some cold symptoms can last from 10 to 14 days, according to the CDC.For colds — which for adults may include RSV, a virus that can pose a serious threat to children under age 2 — Dr. David Strain, a senior clinical lecturer at the University of Exeter Medical School, said, “on the most part, you will only be infectious for as long as you’ve got symptoms.”Benjamin RyanBenjamin Ryan is independent journalist specializing in science and LGBTQ coverage. He contributes to NBC News, The New York Times, The Guardian and Thomson Reuters Foundation and has also written for The Washington Post, The Nation, The Atlantic and New York.AboutContactHelpCareersAd ChoicesPrivacy PolicyYour Privacy ChoicesCA NoticeTerms of Service (Updated JULY 7, 2023)NBC News SitemapClosed CaptioningAdvertiseSelect ShoppingSelect Personal Finance© 2024 NBCUniversal Media, LLCNBC News LogoMSNBC LogoToday LogoDeaths of thousands of wild birds from avian flu is ‘new Silent Spring’ | Bird flu | The Guardian Skip to main contentSkip to navigationClose dialogue1/2Next imagePrevious imageToggle captionSkip to navigationPrint subscriptionsSearch jobs Sign inIntInternational editionUK editionUS editionAustralia editionEurope editionThe Guardian - Back to homeThe GuardianNewsOpinionSportCultureLifestyleShow moreHide expanded menuNewsView all NewsWorld newsUS elections 2024UK newsClimate crisisUkraineEnvironmentScienceGlobal developmentFootballTechBusinessObituariesOpinionView all OpinionThe Guardian viewColumnistsCartoonsOpinion videosLettersSportView all SportFootballCricketRugby unionTennisCyclingF1GolfUS sportsCultureView all CultureBooksMusicTV & radioArt & designFilmGamesClassicalStageLifestyleView all LifestyleFashionFoodRecipesLove & sexHealth & fitnessHome & gardenWomenMenFamilyTravelMoneySearch input google-search SearchSupport usPrint subscriptionsSearch jobsHolidaysDigital ArchiveGuardian LicensingAbout UsThe Guardian appVideoPodcastsPicturesNewslettersToday's paperInside the GuardianThe ObserverGuardian WeeklyCrosswordsWordiplyCorrectionsSearch input google-search SearchSearch jobsHolidaysDigital ArchiveGuardian LicensingAbout UsEnvironmentClimate crisisWildlifeEnergyPollution A northern gannet lies dead on a beach in Brittany, France, in September. Photograph: Stéphane Mahé/ReutersView image in fullscreenA northern gannet lies dead on a beach in Brittany, France, in September. Photograph: Stéphane Mahé/ReutersThe age of extinctionBird flu This article is more than 1 year oldDeaths of thousands of wild birds from avian flu is ‘new Silent Spring’This article is more than 1 year oldExpert warns impact of H5N1 virus across the world is on a scale akin to the devastation wreaked by the use of DDT pesticides in the 1950s and 1960sThe age of extinction is supported byAbout this contentPhoebe WestonFri 23 Dec 2022 07.45 GMTLast modified on Thu 5 Jan 2023 06.39 GMTShareThe planet is experiencing a new “Silent Spring” of wildlife destruction because so many wild birds have died from avian flu, according to a leading scientist, who said the past year has seen the most significant and sudden loss of birds in decades.James Pearce-Higgins, director of science at the British Trust for Ornithology, said: “The last time we experienced such large-scale and rapid losses of wild birds in the UK would be the impacts of DDT on birds of prey in the 1950s and 1960s associated with the Silent Spring narrative, or the widespread declines of farmland birds during the 1970s and 80s as a result of agricultural intensification.”The Silent Spring narrative refers to the seminal 1962 book by Rachel Carson about how pesticides, particularly DDT, were killing birds. DDT caused egg shells to become so thin that adults crushed them during incubation, leading to nest failure and the deaths of thousands of birds.The World Organisation for Animal Health estimates that more than 50,000 wild birds have died of the highly pathogenic avian influenza H5N1 since October 2021, mainly in Europe and America. But experts say this is likely to be a huge underestimate. In the UK alone, numbers could be in the hundreds of thousands, although conservationists say the true impact is still unknown, and most are unwilling to speculate.In the UK, the effects of avian flu started in the northernmost islands of Scotland in spring, spreading south down the east coast of England reaching as far south as Sussex, with colonies of nesting seabirds the worst hit.‘The scale is hard to grasp’: avian flu wreaks devastation on seabirdsRead moreAlready there are more than a dozen outbreaks dotted across the country among wintering waterbirds. This suggests it is already widespread and will be found in breeding seabird colonies again next year, said Pearce-Higgins.There were more than 3,500 virus detections in wild birds across Europe in the 2021-2022 season, with reports from 37 countries that it was being seen in 63 wild bird species, according to an avian influenza overview published by the European Food Safety Authority. For wild birds, Germany, France, the Netherlands and the UK had the most reported cases, with most coming from coastal areas because seabirds were the worst affected.The first US case in this current outbreak was in an American wigeon duck in South Carolina on 14 January 2022. Since then, there have been 3,700 positive tests in 47 states, according to the US Centers for Disease Control and Prevention.Yet testing should not be taken as an indicator of impact, because only a fraction of birds that die will be collected and sent for laboratory testing, researchers say. “Reported numbers are likely a vast underestimate,” said Michelle Wille from the University of Sydney.“For example, of the approximate 8,000 sandwich terns that died in the Netherlands, only a handful are included in the official numbers – in this case a more than 200x difference between reported numbers and observed. The lack of appreciation for the scale of wild bird mortality is concerning as there may be species/population level ramifications.”Globally, most reports are coming from Europe, and then America, according to UN mapping data, but the disease has also spread through Africa and Asia. In November this year, bird flu was found in South America, with concerns that it will reach the Galápagos. Scientists suspect that a migratory Franklin’s gull brought the subtype H5N1 from the US. More than 13,000 seabirds died, including more than 5,500 pelicans in Peru.skip past newsletter promotionSign up to Down to EarthFree weekly newsletterThe planet's most important stories. Get all the week's environment news - the good, the bad and the essentialEnter your email address Sign upPrivacy Notice: Newsletters may contain info about charities, online ads, and content funded by outside parties. For more information see our Privacy Policy. We use Google reCaptcha to protect our website and the Google Privacy Policy and Terms of Service apply.after newsletter promotionView image in fullscreenMunicipal workers collect dead pelicans on Santa Maria beach in Lima, Peru. In November alone, at least 13,000 birds on the Peruvian coast died from bird flu, according to the National Forest and Wildlife Service. Photograph: Guadalupe Pardo/APIt has since spread to five countries in South America, according to the Pan American Health Organization. “The high-pathogenicity avian influenza outbreak recently reported for coastal Peru is a severe situation … evidence has shown the possibility of the virus spreading among other groups of birds,” said Luis German Naranjo, the conservation director at WWF Colombia.The UK has about 60% of the world population of great skua and northern gannets. Both have seen “unprecedented levels of mortality”, said Pearce-Higgins, with population impacts likely to last decades as they are long-lived, slow reproducing species.Experts say the picture will become clearer in the coming years, as we see how many migratory seabirds come back to breed, giving a better idea of how many died.Find more age of extinction coverage here, and follow biodiversity reporters Phoebe Weston and Patrick Greenfield on Twitter for all the latest news and featuresExplore more on these topicsBird fluThe age of extinctionHealthShareReuse this contentMost viewedMost viewedEnvironmentClimate crisisWildlifeEnergyPollutionNewsOpinionSportCultureLifestyleOriginal reporting and incisive analysis, direct from the Guardian every morningSign up for our emailHelpComplaints & correctionsSecureDropWork for us Privacy policyCookie policyTerms & conditionsContact usAll topicsAll writersDigital newspaper archiveTax strategyFacebookYouTubeInstagramLinkedInXNewslettersAdvertise with usSearch UK jobsBack to top© 2024 Guardian News & Media Limited or its affiliated companies. All rights reserved. (dcr)This flu season could be the worst we've seen in a decade 1 weather alerts 1 closings/delays Watch Now Watch Now 1 weather alerts 1 closings/delays Menu Search site Watch Now Watch Now Close × Live Watch Alerts Search site Go News Local News Northern Kentucky Ohio Kentucky Indiana National News Galleries Weather Daily Forecast Hourly Forecast Weather Radar Weather Alerts Closings Traffic Videos 24/7 News Livestream Don't Waste Your Money I-Team Homefront Positively Cincinnati Finding Solutions Sports Reds Bengals FC Cincinnati College Sports High School Sports Arts & Entertainment Food & Dining Government & Politics Local Politics Cincy Lifestyle Marketplace Ohio Lottery Brand Spotlight Mercy Health MDInsider BHMK Law About Us Bios Contact Us TV Listings Jobs at WCPO 9 Contests RSS Feeds Video Licensing Corrections Unpublish Advertise with us Trust Kelly Clarkson Show Sign In Newsletters Sign Out Manage Emails Apps Careers Search Weather Traffic I-Team Sports Don't Waste Your Money Finding Solutions Homefront Contests Quick links... Weather Traffic I-Team Sports Don't Waste Your Money Finding Solutions Homefront Contests 1 weather alerts 1 closings/delays NewsLocal News Actions Facebook Tweet Email This flu season could be the worst we've seen in a decade Here's where things stand right now in the Tri-State Prev Next Posted Health experts across the Tri-State are concerned that this year's flu season could be the worst we've faced in a decade. Ohio, Kentucky, and Indiana are all in the "very high" spread category according to the CDC. Kentucky has the highest overall cases in the Tri-State. According to the latest available data from Kentucky, there have been 29,240 flu cases reported. Kentucky reported more than 6,000 new cases between December 4 and 10. However, that number is down about 1,000 from the previous week. All Northern Kentucky counties are reporting a decrease in reported cases. Despite that good news, the state still considers the illness to be "widespread." Photo by: Team Kentucky Flu activity in Kentucky in week 49 compared to week 48. Week 49 is considered December 4-10 Most Kentuckians who are getting sick are between the ages of 1 and 10, according to data from Team Kentucky. On Monday, Governor Andy Beshear reported six flu-related pediatric deaths, meeting Kentucky's prior record for the highest number of pediatric influenza deaths in a single flu season. “This is a milestone we did not want to cross, and our prayers are with each of these families as they mourn the loss of their loved one,” Beshear said.None of the children who died in the current influenza season received a flu shot, according to the Department for Public Health.Dr. Steven Stack, commissioner of the Department for Public Health, said the current flu season is on track to be Kentucky's worst in at least 10 years.Ohio is reporting more than 10,000 flu cases so far this season. The Ohio Department of health measures flu data based on hospitalizations. In the past week there have been nearly 1,200 hospitalizations. Southwest Ohio accounts for the second highest number of new hospitalizations in the state. The good news is that hospitalizations aredown about 15% from the previous week, according to the Ohio Department of Health. As of December 10, only one pediatric influenza death has been reported in Ohio.In Indiana, 48 people have died from the flu so far this year, according to data from the Indiana Department of health. In the previous week alone, the number of deaths was 24. Only one person between the ages of 5 and 24 has died, the Indiana Department of Health said. The vast majority of those who have died were above the age of 50. Earlier this month, the U.S. Centers for Disease Control and Prevention said that the rise in hospitalizations in the U.S. for the flu was the most they'd seen in the last decade.Here's a look at where things stand right now: Photo by: The CDC According to the CDC cases are up significantly from this time last year. Photo by: CDC This is a look at the flu numbers from this time last year If we look back even further, the flu seasons that were during the height of the COVID-19 lockdowns were pretty mild, likely due to all of the increased protections and travel restrictions. Photo by: CDC This is during the height of the COVID-19 lockdowns Here's a look at the flu season right before COVID-19 was discovered in the U.S. Photo by: CDC The influenza outbreak comes as the CDC also sees a spike in other respiratory diseases, such as respiratory syncytial virus (RSV). According to CDC data, as of Dec. 16, 23,503 patients were admitted to hospitals with influenza. The CDC estimates that there have been at least 15 million illnesses, 150,000 hospitalizations, and 9,300 deaths so far this flu season.Amid the nationwide outbreak of respiratory illnesses affecting young patients, two have the country's largest pharmacy chains are limiting purchases of children's pain-relief medicines.CVS is implementing a two-product limit on all children's pain relief products online and in-store. According to The Associated Press, Walgreens implemented a limit of six over-the-counter fever-reducing children's medication products for online purchases. The limitation reportedly doesn’t apply to in-store purchases.According to health experts, the flu is spread by respiratory droplets released when infected people cough or sneeze nearby or when people touch surfaces or objects contaminated with those infectious respiratory droplets. People can also become infected by touching surfaces or objects contaminated with influenza viruses and then touching their eyes, mouth or nose.Symptoms include:fever of 100 degrees Fahrenheit or greaterheadachefatiguecoughmuscle achessore throatWhile there is no cure for the flu, some medications can help ease symptoms, according to health officials.If you think that you are sick with the flu, COVID-19 or RSV, call your doctor. READ MORELong COVID has contributed to thousands of deaths, CDC study saysRSV cases impact adults more than normal, not as easy to detectNKY shelter requesting cold, flu supply donations Mark J. Terrill/AP FILE - A flu vaccine is readied at the L.A. Care and Blue Shield of California Promise Health Plans' Community Resource Center. (AP Photo/Mark J. Terrill, File) Watch Live: America Tonight More local news: Every NKY city approved medical cannabis operations this election. What's next? Summit Country Day boys soccer team wins the Division V state championship SPCA Cincinnati program helps connect veterans with fur-ever friends Copyright 2024 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Sign up for the Breaking News Newsletter and receive up to date information. now signed up to receive the Breaking News Newsletter. Click here to manage all Newsletters The team that helps you save, so you Don't Waste Your Money Traffic News Money Sports Entertainment Life Marketplace Support Sitemap Privacy Policy Privacy Center Journalism Ethics Guidelines Corrections Policy Terms of Use EEO Careers FCC Public Files FCC Application Public File Contact Accessibility Statement Scripps Media Trust Center Closed Captioning Contact WCPO9 wcpo9_news wcpo @wcpo9news Scripps Local Media© 2024 Scripps Media, Inc Give Light and the People Will Find Their Own Way </htmlBay Port High School student is 2nd child to die from influenza this season in Wisconsin | WHBY Menu Listen Live News Local News Beyond News Audio Sports News & Schedules Milwaukee Brewers High School Sports Weather Forecast Shows AM Fox Valley Outside the Box Focus Fox Valley Dave Ramsey Show Your News Now on WHBY WHBY Staff Connect WHBY App Smart Speaker Email the Studio Join the WHBY Insider Email Club Join the WHBY Insider Text Club Advertise With Us Community Resources Events WHBY Events Entertainment Calendar Community Calendar Submit An Event Contests Contest Rules Big Deals × Sign In Search News Local News Beyond News Audio Sports News & Schedules Milwaukee Brewers High School Sports Weather Forecast Shows AM Fox Valley Outside the Box Focus Fox Valley Dave Ramsey Show Your News Now on WHBY WHBY Staff Connect WHBY App Smart Speaker Email the Studio Join the WHBY Insider Email Club Join the WHBY Insider Text Club Advertise With Us Community Resources Events WHBY Events Entertainment Calendar Community Calendar Submit An Event Contests Contest Rules Big Deals Appleton Police looking for suspect in armed robbery1 hurt in Oshkosh shootingKayaker believed to have drowned in Green Lake suspected of faking his deathFire damages machines at Green Bay paper mill (Photo from Go Fund Me) Bay Port High School student is 2nd child to die from influenza this season in Wisconsin By Jonathan Krause Dec 23, 2022 | 2:10 PM HOWARD, Wis–A second child has died from influenza in Wisconsin. The Howard-Suamico School District has identified the victim as Ava Schmidt–a 14-year old freshman at Bay Port High School. A Go Fund Me page created by the family to fund a memorial scholarship says Schmidt had been diagnosed with Influenza A and Strep B. The state Department of Health Services says this is the second child death due to the flu this season. Send local news tips, traffic reports, or weather information to whbynews@wcinet.com or call 920-831-5647. More On Air Now Investors Edge 7:00 PM - 8:00 PM The Score WAPL Razor Wisconsin 104.3 The Fuse KISS-FM WHBY Public File WCM Privacy Notice for EU Residents WCM Cookie & Tracking Policy WCM Social Media Community Policy FCC Applications EEO Report Contest Rules Advertise With Us Meet the Sales Team Contact Us Privacy Policy Terms Of Service Woodward Community Media, a division of Woodward Communications, Inc Copyright © 2024. All Rights Reserved. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. This website uses cookies to ensure you get the best experience on your website. Further use of this site implies agreement to Terms of Use and Privacy Policy. Learn More I AcceptGovernment adding Tamiflu doses to strategic stockpile - UPI.com Top News U.S. News World News Featured Odd News Entertainment Movies Music TV Science Health Sports NFL MLB NBA Soccer Voices Photos News US News World News Entertainment Sports Archive Almanac Trending Ukraine's military SS United States 'Wicked' doll Ashanti, Ciara 'Border czar' Famous birthdays 'Gladiator II' Arizona AG Cardiovascular disease Advertisement U.S. News Dec. 21, 2022 / 6:22 PM Government adding Tamiflu doses to strategic stockpile By Simon Druker The U.S. Department of Health and Human Services is increasing the country’s stockpile of Tamiflu, an antiviral medication used to treat influenza, officials confirmed in a statement Wednesday. Photo by Moriori/Wikimedia Commons Dec. 21 (UPI) -- The U.S. Department of Health and Human Services is increasing the country's stockpile of an antiviral medication used to treat influenza, officials confirmed in a statement Wednesday. The department is purchasing additional doses of Oseltamivir, which is marketed under the brand name Tamiflu. Advertisement Additional doses will be added to the Strategic National Stockpile through the department's Administration for Strategic Preparedness and Response. The announcement coincides with flu season. Tamiflu is used to treat and prevent influenza A and influenza B viruses. Related CDC warns of increase in dangerous strep A infections in kids COVID-19 spreading in Mainland China, though confirmed cases down; world weekly up 2% Britons urged to avoid risks during ambulance strike Upon request, additional doses will be distributed to regional health authorities based on requirements. "We have made it clear to every Governor that the Biden-Harris Administration stands ready to assist with resources and supplies," Health and Human Services Secretary Xavier Becerra said in a statement. "Today we are taking action so that every jurisdiction can meet the increased demand for Tamiflu this flu season. State stockpiles can be utilized, and if jurisdictions need access to the Strategic National Stockpile, they now have it to respond to the current seasonal flu outbreak." There have been at least 15 million illnesses, 150,000 hospitalizations and 9,300 deaths from flu in the United States so far this year, according to the U.S. Centers for Disease Control and Prevention. Advertisement Flu season is typically between October and May, peaking in December and January. "The actions taken today to increase access to Tamiflu show our preparedness system at work," Assistant Secretary for Preparedness and Response Dawn O'Connell said in a statement. "The country is more prepared for this surge because the SNS holds strategic stores of Tamiflu. As a result, jurisdictions will be able to get the support they need to keep Americans healthy as flu cases rise this winter." Topics Xavier Becerra Latest Headlines U.S. News // 1 hour ago Trump says EPA pick Lee Zeldin will promote clean air, water through deregulation Nov. 11 (UPI) -- President-elect Donald Trump has chosen former Republican Rep. Lee Zeldin of New York to run the Environmental Protection Agency. U.S. News // 2 hours ago Indiana jury finds Richard Allen guilty on all charges in murder of 2 teen girls Nov. 11 (UPI) -- The Indiana man accused of killing two teenage girls in a wooded area near Delphi was found guilty on Monday and faces a mid-December sentencing date. U.S. News // 13 hours ago Veterans Day: Biden expands benefits, urges Americans to 'keep faith' in one another Nov. 11 (UPI) -- President Joe Biden on Monday addressed a Veterans Day crowd at the national cemetery in Virginia where he revealed newly-expanded veteran benefits and urged Americans to "come together" and "keep faith." U.S. News // 5 hours ago Nazi protesters picket Anne Frank play in Michigan, call concentration camp victim 'whore' Nov. 11 (UPI) -- A handful of demonstrators carrying Nazi flags protested outside of a play presentation of The Diary of Anne Frank at an American Legion Hall in Howell, Mich. on Saturday Post officials and sheriff's deputies said. U.S. News // 6 hours ago Climate-change fight continues despite Trump's election, U.S. adviser Podesta says Nov. 11 (UPI) -- The climate fight is "bigger than one election" after Donald Trump's re-election amid a growing number of odd extreme weather events a result of climate change, says U.S. climate adviser John Podesta. U.S. News // 6 hours ago Stephen Miller to be named Donald Trump's deputy chief of staff Nov. 11 (UPI) -- President-elect Donald Trump on Monday named longtime immigration adviser Stephen Miller as his incoming deputy chief of staff for policy. U.S. News // 18 hours ago Trump's new pick for 'border czar' says workplace immigration raids planned Nov. 11 (UPI) -- President-elect Donald Trump late Sunday named his former Immigration and Customs Enforcement director, Thomas Homan, as the country's next "border czar." U.S. News // 7 hours ago Disney cruise ship rescues 4 boaters in Atlantic near Bermuda Nov. 11 (UPI) -- A Disney cruise ship responded to a distress call on Sunday morning in the Atlantic Ocean and rescued four stranded boaters. U.S. News // 7 hours ago Kremlin denies reported phone call between Trump, Putin Nov. 11 (UPI) -- Donald Trump has reportedly held a phone conversation with President Vladimir Putin, where the president-elect reportedly encouraged the Russian leader not to escalate the military situation in Ukraine. U.S. News // 8 hours ago Trump selects Elise Stefanik to be next U.S. ambassador to United Nations Nov. 11 (UPI) -- President-elect Donald Trump has tapped New York Rep. Elise Stefanik as his pick for U.S. ambassador to the United Nations. Advertisement Trending Stories Ukraine says it intercepts radio communications from North Korean soldiers in Russia SS United States to be towed from Phila., launching transition into artificial reef Nazi protesters picket Anne Frank play in Michigan, call concentration camp victim 'whore' Arizona AG says she won't drop state's fake electors case against Trump allies Trump's new pick for 'border czar' says workplace immigration raids planned Advertisement Follow Us Advertisement Back to top About UPI Contact Corrections Advertisements Copyright © 2024 United Press International, Inc. All Rights Reserved. Terms of UsePrivacy PolicyDon’t put others at risk this Christmas if you have flu symptoms, UK health experts urge | Health | The Guardian Skip to main contentSkip to navigationClose dialogue1/1Next imagePrevious imageToggle captionSkip to navigationPrint subscriptionsSearch jobs Sign inIntInternational editionUK editionUS editionAustralia editionEurope editionThe Guardian - Back to homeThe GuardianNewsOpinionSportCultureLifestyleShow moreHide expanded menuNewsView all NewsWorld newsUS elections 2024UK newsClimate crisisUkraineEnvironmentScienceGlobal developmentFootballTechBusinessObituariesOpinionView all OpinionThe Guardian viewColumnistsCartoonsOpinion videosLettersSportView all SportFootballCricketRugby unionTennisCyclingF1GolfUS sportsCultureView all CultureBooksMusicTV & radioArt & designFilmGamesClassicalStageLifestyleView all LifestyleFashionFoodRecipesLove & sexHealth & fitnessHome & gardenWomenMenFamilyTravelMoneySearch input google-search SearchSupport usPrint subscriptionsSearch jobsHolidaysDigital ArchiveGuardian LicensingAbout UsThe Guardian appVideoPodcastsPicturesNewslettersToday's paperInside the GuardianThe ObserverGuardian WeeklyCrosswordsWordiplyCorrectionsSearch input google-search SearchSearch jobsHolidaysDigital ArchiveGuardian LicensingAbout UsUKUK politicsEducationMediaSocietyLawScotlandWalesNorthern Ireland A crowded street in Edinburgh. Public health experts are urging those with flu-like symptoms not to mingle with others and to stay home. Photograph: Murdo Macleod/The GuardianView image in fullscreenA crowded street in Edinburgh. Public health experts are urging those with flu-like symptoms not to mingle with others and to stay home. Photograph: Murdo Macleod/The GuardianHealth This article is more than 1 year oldDon’t put others at risk this Christmas if you have flu symptoms, UK health experts urgeThis article is more than 1 year oldAs hospital admissions for the virus rise, doctors urge people who feel unwell to stay at homeNicola Davis Science correspondentFri 23 Dec 2022 12.32 GMTLast modified on Thu 5 Jan 2023 06.39 GMTShareWhile the draw of festive parties and family gatherings may be strong, experts have reiterated calls for people who feel unwell with flu-like symptoms to stay at home.Hospital admissions for flu are continuing to rise, according to data for England from the UK Health Security Agency, with the highest levels seen in people 85 years old and over and children under the age of five.The overall weekly hospital admission rate for influenza increased to 8.27 per 100,000 in the week beginning 12 December, from 6.80 per 100,000 the previous week, with the highest rate of hospital admissions observed in the north-east.“Emergency department attendances for influenza-like illness continue to increase nationally, for all age groups and regions,” the latest UKHSA report notes.Dr Mary Ramsay, the director of public health programmes at UKHSA called on people to avoid mixing if unwell. “Both Covid and flu can cause severe illness or even death for those most vulnerable in our communities, and so it is also important to avoid contact with other people if you are unwell in order to help stop infections spreading over the Christmas and new year period,” she said.Speaking on the BBC’s Today programme on Friday, Calum Semple, professor of child health and outbreak medicine at the University of Liverpool, said a lot of hospitals, including his own, were under pressure. “I’m looking at the figures particularly for the north-west, where I work, and we are seeing flu hard and very early,” he said.Semple said the UKHSA advice was correct. “If you have got symptoms – runny nose, sore throat, fever, headache and you feel flu-like – then please do stay at home,” he said. “You don’t know if the person sitting next to you or in the shop might have an underlying cancer or other susceptibility.”Semple said other precautions to consider included wearing face masks in crowded places where the ventilation was poor. “But the basics are really important too – catch coughs and sneezes in disposable tissues and wash your hands when you come home,” he added. “Don’t be touching things in public and then eating: because again that gets your hands on to your face.”Semple also dismissed debates about “immunity debt” that suggest Covid lockdowns have resulted in people having weaker immune systems.“Simply the fact that you haven’t been exposed to flu for two years, means that if it’s circulating, then you will catch it later,” he said. “It’s not because you’ve somehow weakened your immune system. If you caught it two years ago, you were going to have a severe flu two years ago as well.”Semple said vaccination was crucial to prevent diseases such as flu, but said an erosion of confidence in vaccination might be behind lower uptake in more deprived areas, including in children and pregnant women.“I think it’s understandable if you accept that there’s a degree of fatigue amongst the population in general and there’s been a huge amount of misinformation which really needs to be tackled head on,” he said. “And I think that’s something where there’s room for improvement.”Explore more on these topicsHealthFluHospitalsNHSVaccines and immunisationnewsShareReuse this contentMore on this storyMore on this story‘Long flu’: study finds flu patients at higher risk of longer-term illness14 Dec 2023UK detects its first human case of swine flu strain 27 Nov 2023Respiratory infection clusters in China not caused by novel virus, says health ministry26 Nov 2023England to deny Covid and flu jabs to under-65s despite fears for NHS this winter8 Aug 2023Flu and pneumonia deaths a quarter higher than usual in England and Wales20 Jan 2023Universal flu vaccine may be available within two years, says scientist25 Nov 2022Flu season in England is worst for a decade, says health secretary9 Jan 2023Ambulance staff reportedly urged to conserve oxygen amid ‘twindemic’30 Dec 2022Flu continues to spread in England with number of hospital patients up 79%30 Dec 2022Most viewedMost viewedUKUK politicsEducationMediaSocietyLawScotlandWalesNorthern IrelandNewsOpinionSportCultureLifestyleOriginal reporting and incisive analysis, direct from the Guardian every morningSign up for our emailHelpComplaints & correctionsSecureDropWork for us Privacy policyCookie policyTerms & conditionsContact usAll topicsAll writersDigital newspaper archiveTax strategyFacebookYouTubeInstagramLinkedInXNewslettersAdvertise with usSearch UK jobsBack to top© 2024 Guardian News & Media Limited or its affiliated companies. All rights reserved. (dcr)NHS England » Two thirds increase in hospital flu cases amid rising staff absences and pressure on NHS 111 Skip to main content Cookies on the NHS England website We’ve put some small files called cookies on your device to make our site work. We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site. Let us know if this is OK. We’ll use a cookie to save your choice. You can read more about our cookies before you choose. Change my preferences I'm OK with analytics cookies Home News Publications Statistics Blogs Events Contact us Search Search Menu About us Our work Commissioning Get involved Search news You can use the filters to show only news items that match your interests Keyword TopicSelect topicA greener NHSAbout usAcademic Health Science NetworkAccessible Information StandardAgeing wellAllied Health ProfessionalsAnnual reportArmed forcesBetter Care FundBoard meetingsBusiness planCancerCarersChildren and young peopleClinical auditCommissioningCommunity health servicesCoronavirusCulture and leadershipDementiaDiabetesDigitalEducation quality reportEfficienciesElective careEmergency Preparedness, Resilience and ResponseEnd of life careEquality and diversityEstatesEU ExitEventsExpoEye healthFinanceFive Year Forward ViewFriends and Family TestGender identityGeneral practiceGenomicsGet involvedGovernanceGP online servicesHealth and housingHealth and justiceHealth and WellbeingHealthcare inequalitiesHealthcare scienceHealthy new townsHearing lossHeart diseaseHot weather news and adviceImprovementInformation governanceInformation StandardInnovationIntegrated careLead Provider FrameworkLearning disabilities and autismLiaison and diversionLong term conditionsLong Term PlanMaternityMedicineMental healthMusculoskeletal conditionsNational Quality BoardNew business modelsNew care modelsNHS 111NHS BirthdayNHS ImprovementNHS payment systemNHS People PlanNHS People PlanNHS RightCareNHS Standard ContractNHS70Nursing, midwifery and careObesityOlder peopleOperational performanceOral healthOut of hospital careOutpatient Transformation ProgrammePatient carePatient safetyPersonal health budgetsPersonalised carePharmacyPlanning guidancePreventionPrimary carePrimary care co-commissioningQuality improvementReferral to Treatment TimesRespiratoryRevalidationSafe staffingSafeguardingSelf careSepsisSeven day servicesSpecialised commissioningStrokeSustainability and transformation partnershipsTest bedsUrgent and emergency careVaccinationVanguardsVirtual wardsVolunteeringWheelchair servicesWhistleblowingWinter news and guidanceWorkforce Date range From To News Two thirds increase in hospital flu cases amid rising staff absences and pressure on NHS 111 22 December 2022 NHS 111Urgent and emergency careWinter news and guidance The number of patients with flu in hospital has increased by two thirds in one week amid significant pressure on services, the NHS said today. New published data shows the post-pandemic impact of viruses circulating again with an average of 1,939 flu cases in England’s hospitals every day last week (up from 1,162). Weekly winter data shows the wide ranging set of pressures faced by the NHS ahead of Christmas, with another seven days of rising flu hospital cases, increased calls to 111 and more staff sickness. The number of flu patients in intensive care has also skyrocketed, up more than 70% on the week before to 149 a day (from 87). In mid-December last year, the NHS only had two flu patients a day in critical care and 32 in general and acute beds (week ending 19 Dec). This comes on top of continued near-record demand for the 111 service, with 721,301 calls last week – up from 706,129 the week before. The volume of calls is significantly more than usual for this time of year, up almost 60% on the same week in 2021 when there were 452,644 calls (w/e 19 Dec 2021). The rise in demand is understood to be partly driven by parents concerned about symptoms of Strep A. The NHS has prepared extensively for winter and industrial action, with plans already in place to manage rising demand including around the clock system control centres, additional bed capacity, more mental health support for ambulance services and community falls services. There was an average of 60,583 absences due to staff sickness every day last week, up almost a fifth on last month (51,342 w/e 20 Nov). The number of staff off work because of Covid has risen by a third since mid-November, to 7,218 a day (5,454 w/e 20 Nov). As well as the growing number of beds occupied by flu patients, high bed occupancy was affected by the 13,697 patients on average each day who were stuck in hospital despite being medically fit to leave. An average of 19 in 20 general and acute beds have been occupied since the NHS started to publish its weekly winter data last month. This is despite a huge effort by the NHS to boost bed capacity, with 100,101 general and acute beds open a day last week compared to 90,621 this time last year. Professor Sir Stephen Powis, NHS National Medical Director, said: “As well as the impact of industrial action last week, it is clear that the NHS is facing enormous pressure ahead of Christmas with the number of flu cases in hospital and in intensive care rising week-on-week, on top of significant increases in staff sickness rates and near-record demand for services like 111. “Despite this, NHS staff continue to deliver a significant amount for patients – dealing with near record 111 calls as well as continuing to make progress on covid-19 backlogs. “With more industrial action scheduled for next week, there will be disruption but we urge the public to continue to use services wisely by continuing to call 999 for life-threatening emergencies, use 111 online for other health conditions, and take sensible steps to keep yourself and others safe. “The NHS has prepared for winter extensively with more beds, extra call handlers as well as the expansion of falls response services, control centres and respiratory hubs, but with flu hospitalisations and Covid cases on the rise, the best things you can do to protect yourself is to get vaccinated if you’re eligible.” The weekly winter situation report can be found on our statistics page: Urgent and emergency care daily situation reports 2022-23. Date published: 22 December, 2022 Date last updated: 30 December, 2022 Topics NHS 111Urgent and emergency careWinter news and guidance Terms and conditions Privacy and cookies Social media and comment moderation Website feedback Accessibility statement Open Government Licence v3.0 Sign up to our email bulletins Follow us on X Follow us on Facebook Find us on Instagram Visit us on LinkedIn Watch videos on YouTubeSegmenting Speech Signals May Effectively Detect Presence of Common Cold, Flu NewsAll NewsFDA UpdatesPress ReleasesMediaAll VideosDigital DetailIndependent CornerInsightsInterviewsMEDcastMedical World NewsMicrositesPeer ExchangePerfect ConsultPodcastsPractice PearlsSponsored WebcastStudent VoicesWebinars/WebcastsConferencesConference CoverageConference ListingPublicationsPharmacy TimesPharmacy Practice in Focus: OncologyPharmacy Practice in Focus: Health SystemsPharmacy CareersAll PublicationsAbout the PublicationsAuthor SubmissionSubmit a ManuscriptBecome a Peer ReviewerClinical503B Compounding PharmacyADHDAllergyAlzheimer DiseaseAnxietyAsthmaAtopic DermatitisBiosimilarsBipolar DisorderBrain HealthBreast CancerC. DifficileCOPDCardiovascular HealthCervical CancerCholangiocarcinomaCholesterolChronic Kidney DiseaseChronic Lymphocytic LeukemiaColorectal CancerCoronavirusCough and ColdDepressionDermatologyDiabetesDigestive HealthDry Eye DiseaseEpilepsyEye CareFluFuture of PharmacyGastrointestinal CancerGastrointestinal HealthGoutHIVHeart FailureHematologyHepatitisIVIGImmunizationImmuno-oncologyInfectious DiseaseLung CancerLymphomaMacular DegenerationMental HealthMigraineMultiple MyelomaMultiple SclerosisMyelofibrosisNeurologyNeutropeniaOsteoporosisOvarian CancerPain ManagementParkinson DiseasePediatricsPharmacy HeroesPharmacy ManagementPneumococcalPrEPProstate CancerPsoriasisPsoriatic ArthritisPsychedelicsReimbursementReproductive HealthRespiratory Syncytial VirusRheumatoid ArthritisSchizophreniaShinglesSkin CancerSleepTravel VaccinesVeterinary PharmacyVitamins and SupplementsWeight ManagementWomen's HealthEventsUpcoming EventsUpcoming WebinarsCEResourcesClinical ForumCou-CoEducated PatientInformation for the PharmacistInteractive ToolsPartnersSponsoredWhiteboardsSubscribeSpotlightCommunity/RetailHospitalOncologyPharmacy TechnicianStudentClinical RoleCommunity/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudentClinicalCoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitisImmunizationMigrainePneumococcalVitamins and SupplementsSupplement SpotlightOctober 2023 Pharmacy Technician EditionNewsAll NewsFDA UpdatesPress ReleasesMediaAll VideosDigital DetailIndependent CornerInsightsInterviewsMEDcastMedical World NewsMicrositesPeer ExchangePerfect ConsultPodcastsPractice PearlsSponsored WebcastStudent VoicesWebinars/WebcastsConferencesConference CoverageConference ListingPublicationsPharmacy TimesPharmacy Practice in Focus: OncologyPharmacy Practice in Focus: Health SystemsPharmacy CareersAll PublicationsAbout the PublicationsAuthor SubmissionSubmit a ManuscriptBecome a Peer ReviewerClinical503B Compounding PharmacyADHDAllergyAlzheimer DiseaseAnxietyAsthmaAtopic DermatitisBiosimilarsBipolar DisorderBrain HealthBreast CancerC. DifficileCOPDCardiovascular HealthCervical CancerCholangiocarcinomaCholesterolChronic Kidney DiseaseChronic Lymphocytic LeukemiaColorectal CancerCoronavirusCough and ColdDepressionDermatologyDiabetesDigestive HealthDry Eye DiseaseEpilepsyEye CareFluFuture of PharmacyGastrointestinal CancerGastrointestinal HealthGoutHIVHeart FailureHematologyHepatitisIVIGImmunizationImmuno-oncologyInfectious DiseaseLung CancerLymphomaMacular DegenerationMental HealthMigraineMultiple MyelomaMultiple SclerosisMyelofibrosisNeurologyNeutropeniaOsteoporosisOvarian CancerPain ManagementParkinson DiseasePediatricsPharmacy HeroesPharmacy ManagementPneumococcalPrEPProstate CancerPsoriasisPsoriatic ArthritisPsychedelicsReimbursementReproductive HealthRespiratory Syncytial VirusRheumatoid ArthritisSchizophreniaShinglesSkin CancerSleepTravel VaccinesVeterinary PharmacyVitamins and SupplementsWeight ManagementWomen's HealthEventsUpcoming EventsUpcoming WebinarsCEResourcesClinical ForumCou-CoEducated PatientInformation for the PharmacistInteractive ToolsPartnersSponsoredWhiteboardsSubscribeAdvertisementCLINICAL ROLE - Community/Retail | Hospital | Oncology | Pharmacy Technician | Student ArticleDecember 20, 2022Segmenting Speech Signals May Effectively Detect Presence of Common Cold, FluAuthor(s):Erin Hunter, Assistant Editor The amplitude of vocal cord movement may indicate patient health and wellbeing.Monitoring unvoiced speech segments could help diagnose common cold and associated disorders, according to a study published in the National Library of Medicine. Understanding speech in the context of common cold and flu could facilitate remote monitoring of a patients’ health.“The analysis and classification of cold speech may be useful in the diagnosis of common cold and other related illnesses to stop the spread of these viral infections,” the study authors wrote.A speech signal contains linguistic (communicated) information and paralinguistic (emotion, health state, age, gender) information that are both involved in physiological and cognitive systems. Speech signals and vocals may even offer insight into the mental and physical conditions of the body, according to the investigators.“Speech is produced as a consequence of the vocal tract’s linear filtering of stimulation source data. Because the vocal tract is engaged during speech production, the acoustic properties of cold speech vary from those of normal speech,” the study authors wrote.Cold speech is pathological because it affects the nasal and esophagus—it reflects cold or flu symptoms such as stuffy nose, hoarse voice, coughing and sneezing—and can alter speech signal. Researchers evaluated regions of voiced (vibrating vocal cords) and unvoiced (non-vibrating vocal cords) speech to classify cold versus healthy speech, while also determining a framework for identifying cold speech.Identifying 630 participants from the Upper Respiratory Tract Infection Corpus (URTIC) database out of Germany, researchers listened to a voice recording from everyone. Voice recordings consisted of a binary 1-item measure based on the Wisconsin Upper Respiratory Symptom Survey (WURSS-24) and evaluated on a scale of 0 (not sick) to 7 (very ill).Researchers collected complete active speech (CAS)—non-silent speech segments comprised of voiced and unvoiced speech regions. They collected frame-wise mel frequency cepstral coefficients ([MFCC] from CAS, unvoiced, and voiced speech) to then segment speech, and also used a support vector machine (SVM) to evaluate the voiced and unvoiced regions of speech.The results show that unvoiced regions of speech signal have less frames than CAS or voiced regions of speech, suggesting that it can be an effective and efficient tool to detect the presence of upper respiratory tract infections (URTIs), such as the common cold and flu. URTIs impact millions of individuals every year and may severely affect up to 5 million people annually.“If someone is merely interested in common cold detection with the minimum effort and complexity, they can evaluate only the unvoiced portion of the speech,” the study authors wrote.Further, extracting voiced and unvoiced segments of speech to determine the presence of a cold can be used in smart devices to monitor cold and related conditions to stop the spread of illness, according to the study.“The results show that the feature extracted from voiced and unvoiced segments shows the same discrimination capability for cold and healthy speech,” the researchers wrote in the report.ReferenceWarule, Pankaj, Prasad Mishra, Siba, Deb, Suman. Significance of voiced and unvoiced speech segments for the detection of common cold. Natl Lib of Med. Nov 15, 2022. Accessed on Dec 16, 2022. doi: 10.1007/s11760-022-02389-8Related VideosRelated Content AdvertisementNovember 9th 2024Staying in the Know: Pharmacists, Drug Shortages, and What Lies AheadOlivia Riggi, PharmD CandidateSeptember 19th 2024Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based DecisionsNovember 8th 2024Researchers Evaluate the Safety and Efficacy of Brivudine as Oral Shingles Treatment Kennedy Ferruggia, Assistant EditorAugust 22nd 2024Public Health Matters: Healthcare Advocate Summit Emphasizes Advocates Have a Voice in Creating SolutionsNovember 8th 2024Moderna Bivalent COVID-19 Vaccine More Effective at Preventing Hospitalization in High-Risk Patients Compared With Pfizer-BioNTech VaccineLuke Halpern, Assistant EditorNovember 8th 2024History of Concussion Associated With Higher Risk of Adverse Psychiatric Outcomes PostpartumGillian McGovern, Assistant EditorRelated Content AdvertisementNovember 9th 2024Staying in the Know: Pharmacists, Drug Shortages, and What Lies AheadOlivia Riggi, PharmD CandidateSeptember 19th 2024Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based DecisionsNovember 8th 2024Researchers Evaluate the Safety and Efficacy of Brivudine as Oral Shingles Treatment Kennedy Ferruggia, Assistant EditorAugust 22nd 2024Public Health Matters: Healthcare Advocate Summit Emphasizes Advocates Have a Voice in Creating SolutionsNovember 8th 2024Moderna Bivalent COVID-19 Vaccine More Effective at Preventing Hospitalization in High-Risk Patients Compared With Pfizer-BioNTech VaccineLuke Halpern, Assistant EditorNovember 8th 2024History of Concussion Associated With Higher Risk of Adverse Psychiatric Outcomes PostpartumGillian McGovern, Assistant EditorConsent PreferencesAbout UsClinical ForumsAdvertiseContact UsEditorial StaffPrivacy PolicyTerms & ConditionsDo Not Sell My InformationContact Info2 Commerce Drive Cranbury, NJ 08512609-716-7777© 2024 MJH Life Sciences All rights reserved.Chicago students encouraged to get vaccinated, wear masks while on break - Chalkbeat Skip to main contentShow SearchEssential education reporting in ChicagoNEWSLETTERSDONATECommunitiesChicagoColoradoDetroitIndianaNew YorkNewarkPhiladelphiaTennesseeNational NewsJobs BoardEventsAbout UsMoreCommunitiesChicagoColoradoDetroitIndianaNew YorkNewarkPhiladelphiaTennesseeNational NewsJobs BoardEventsAbout UsMoreShow SearchBecome a Chalkbeat sponsorCOVID safetyCOVID and SchoolsChicago Public SchoolsAs COVID cases rise, Chicago students encouraged to get vaccinated, wear masks over breakBy Mauricio PeñaandBecky Vevea | December 20, 2022, 7:30pm UTCRepublishExpandChicago’s public health commissioner Dr. Allison Arwady and Chicago Public Schools CEO Pedro Martinez shared data about the city’s rising COVID, flu, and RSV cases and advised students to stay vigilant. (Emily Elconin for Chalkbeat) Ahead of winter break, Chicago Public Schools CEO Pedro Martinez and city public health commissioner Dr. Allison Arwady encouraged students and families to get vaccinated against COVID-19 and flu, take at-home tests before gathering, and mask in crowded spaces. The two made the plea during a weekly online health segment and shared the latest Chicago data on COVID-19, flu, and respiratory syncytial virus cases.“It’s a complicated time knowing that this is respiratory virus season, and that that surge that is coming is likely to hit across the whole city,” Arwady said. She noted last week was the two-year anniversary of the arrival of COVID-19 vaccines and said Chicagoans of all ages have a higher vaccination rate than the rest of the country. But rates for the youngest children are still very low. Roughly 10% of children under 5 in Chicago have gotten their initial COVID-19 vaccine series. “I’m glad we’re doing better than the U.S., but this is nothing to brag about,” Arwady said. About half of all students enrolled in Chicago Public Schools — roughly 154,000 children — have gotten their initial COVID-19 vaccination series as of Dec. 19, data shows. But a Chalkbeat analysis shows vaccination rates vary widely by school, with predominantly Black schools lagging behind. It’s unclear how many Chicago Public School students have received the updated booster. But city data show about 51,184, or 28.3% of 12- to 17-year-olds and 29,206 or 13.9% of 5- to 11-year-old Chicagoans have received the booster as of Dec. 19.Martinez urged families to get their shots over the holidays and take advantage of the city’s at-home vaccination program, which brings COVID-19 and flu vaccines directly to people’s homes to be administered to anyone 6 months and older. “I’m just going to be a broken record: We know they’re safe,” Martinez said. “We know they give you the best protection. They lessen the symptoms.” Since school started, there have been about 9,137 COVID cases among students and 5,382 cases among staff, according to district data.Become a Chalkbeat sponsorBut COVID-19 isn’t the only concern this holiday season, which comes as flu, respiratory syncytial virus, and other respiratory infections are on the rise nationally. In Chicago, hospitals have seen fewer RSV cases but an increase in flu among children.“We’re just seeing a lot of respiratory viruses right now because we didn’t see them for a couple of years,” Arwady said. “RSV thankfully is very much on the way back down. But in the meantime, some extra care and caution, especially in the holiday season, to limit some of that risk is important.”It’s likely Chicago will move into a high level of COVID-19 community transmission, as defined by the Centers for Disease Control and Prevention. About 600 people are testing positive daily in pharmacies, doctor’s offices, and laboratories, and thousands more are testing positive at home, Arwady said.“We are not out of the woods,” Arwady said Tuesday. “Know that if and when we move to a high level, we will be asking you to put those masks back on.”Chicago Public Schools opened this fall with fewer mitigations, including a mask optional policy. Despite an initial uptick in cases, the district has seen fewer laboratory confirmed cases compared to schools reopening last fall in August 2021. On Tuesday, Arwady and Martinez said the school district would follow the health department’s lead in implementing a mask requirement. However, students will be on break starting Friday and classes are not scheduled to resume until January 9. Last winter, a surge in COVID-19 cases raised concerns among teachers over the district’s safety measures. The Chicago Teachers Union voted to teach remote, prompting a weeklong standoff and canceled classes.Martinez said the district continues to “heavily encourage masking” and provides masks to “every single school, every single classroom.” He also urged parents to keep sick children home. “If your child feels sick, please just let them stay home,” Martinez said. “It’s an excused absence.”Arwady encouraged families to take at-home rapid tests before gathering to celebrate the holidays. Martinez said the district continues to offer at-home tests at schools. The federal government is again offering four free at-home tests per household. Become a Chalkbeat sponsorMauricio Peña is a reporter for Chalkbeat Chicago covering K-12 schools. Contact Mauricio at mpena@chalkbeat.org. Becky Vevea is the bureau chief for Chalkbeat Chicago. Contact Becky at bvevea@chalkbeat.org. The Latest Chicago mayor’s office bumps deadline for $500 grants to help families of children with disabilitiesThe grants, funded by federal COVID relief money, are meant to provide some relief for low-income families of children with disabilities By Reema Amin | November 11I grew up visiting my mom in prison. Here’s what I wish my school understood about kids like me.One in 14 U.S. kids has had an incarcerated parent, but the experience can be surprisingly lonely.By Anna Tovchigrechko | November 11Rita Joseph, NYC Council’s ed committee chair, talks school budgets, curriculum mandates, and moreSince taking office in 2022, the Brooklyn council member and former teacher has visited nearly 100 schools across the five boroughs.By Julian Shen-BerroandMichael Elsen-Rooney | November 11Adams 14 tax request election results: Late results show 4A and 4B pulling aheadThe district asked voters to approve two school funding measures.By Yesenia Robles | November 5How can students secure financial aid after the FAFSA calamity? Indiana leaders have a suggestion.Higher education officials say families should try to get key accounts set up soon so they can be ready to apply for financial aid.By Mitzi S. Morris | November 11Unofficial election results: Colorado voters approved about half of the school funding measuresMany of the measures that were successful did not require a tax increase, according to unofficial election results.By Yesenia Robles | November 8Become a Chalkbeat sponsorEverything you need to know about Chicago's public schools todayThousands of Chicagoans are getting a 3-minute rundown of the city's big education stories and statewide policy changes every weekday morning. Sign up for Chalkbeat Chicago’s free newsletter to join them today.Email (required)By signing up, you agree to our Privacy Notice and European users agree to the data transfer policy. You may also receive occasional messages from sponsors.Sign Me UpIf you value Chalkbeat, consider making a donationChalkbeat is a nonprofit newsroom dedicated to providing the information families and educators need, but this kind of work isn’t possible without your help.DonateConnect with your communityFind upcoming eventsEventsEventsNovember 13Virtual Info Session &#8211; University of Colorado Denver&#8217;s EdD with a concentration in Justice, Equity, and Diverse Identities &#8211; Available OnlineNovember 18Virtual Info Session: Online MA in Innovative Early Childhood EducationBecome a Chalkbeat sponsorWho We AreAbout UsCode of EthicsOur StaffCareers at ChalkbeatAwardsOur SupportersPoliciesRepublishingPrivacy PolicyContactContact UsBecome a SponsorHow to Be a SourceNewslettersCHALKBEAT IS A CIVIC NEWS COMPANY NEWSROOM ©2024clockCST_5 reasons you are catching cold frequently this winter | Health - Hindustan Times Explore Search Tuesday, Nov 12, 2024 New Delhi oC Subscribe Games E-Paper Sign in My Account Start 14 Days Free Trial Subscribe Enjoy unlimited access Subscribe Now! Get features like Ad lite A Minimal Ad Experience HT Premium Articles Expertly crafted articles Quickreads Segment News brief in summary format HT E-paper Access digital news experience Start 14 Days Free Trial Home Assembly Elections 2024 HT Premium HTCity Loan ₹10 Lakh India World Real Estate Powered by Entertainment Trending Astrology Lifestyle Education Business Cities Latest News Games & Puzzles IPL Auction Win iPhone 15 The Taste of Time Photos Web Stories Sports Delhi News Mumbai News Bengaluru News Technology Quickreads Daily Digest Following Games + 5 more Technology Quickreads Daily Digest Following Games 5 reasons you are catching cold frequently this winter ByParmita Uniyal, New Delhi Dec 21, 2022 05:28 PM IST Read this news in brief form Share Via Copy Link There is an increase in the number of patients of influenza-like illnesses not only in India but also in other countries of the world, say experts. Here are reasons why people are catching cold frequently this winter. Amid the rapidly dropping mercury, cases of cold, cough and fever in different parts of the country are on rise. In fact, experts say a trend has been observed across the globe of rise in influenza-like illnesses and this could be attributed to increase in socialisation in recent times amid diminishing Corona scare, people not following social distancing measures apart from missed immunisations due to Covid pandemic. Additionally increase in pollution levels is also giving rise to cases of allergic cough. Stress, not sleeping well at night and reduced immunity due to staying indoors are also some of the reasons that are causing increase in cold and cough cases this winter. (Also read: Ayurvedic home remedies to manage cough, cold and Covid) Reduction in immunization for other disease like influenza due to emphasis on covid vaccination is also one of the reasons of increasing cold and cough cases.(Pixabay) TOP REASONS FOR INCREASE IN COUGH AND COLD CASES"There is an increase in the number of patients of influenza like illnesses not only in India but also in other countries of the world. The reasons could range from lack of behavioural practices like social distancing and masking, increased socialization, travel in most societies; increased pollution levels specially in North India increases the risk of cough and allergic cough and increases risk of superadded infections. Reduction in immunization for other disease like influenza due to emphasis on covid vaccination is also one of the reasons," says Dr Vineeta Taneja - Director - Internal Medicine, Fortis Hospital, Shalimar Bagh. Dr Vikrant Shah, Consulting physician, intensivist, and infectious disease specialist, Zen Multispeciality Hospital Chembur also lists reasons behind the sudden increase in cough and cold cases: REASONS WHY YOU ARE FREQUENTLY CATCHING COUGH AND COLD1. SmokingIf you are one of those who tend to smoke then you need to stop doing that right away. You will be shocked to know that smoking impacts the cells of the immune system which makes one prone to frequent colds. Try to quit smoking and stay healthy. 2. Not maintaining personal hygieneAre you often getting cold and cough? Then, you need to ensure good hand hygiene. It is the need of the hour to cover the mouth while coughing and sneezing, wash your hands with soap and water or sanitize from time to time. Wear a mask and maintain a safe distance from people who are sick. 3. StressStress can not only take a toll on your mental health but even physical well-being. It can steal your peace of mind. Being stressed can lead to weakened immunity and you may be at risk of suffering from a cold. Stress will impact the immune system and may not allow you to fight infections. 4. Insufficient sleepAre you aware? The inability to sleep peacefully will weaken your immune system and increase your susceptibility to the common cold. It is better to get a sound sleep at night and stay in top shape during those colder days. 5. Remaining indoors during the chilly monthsSince the temperature outside is low, there is cold and people tend to spend maximum time indoors. Did you know? Colder temperatures slow down the immune system, and make you sick. The dust and mold at home can invite allergies and the common cold. Follow more stories on Facebook & Twitter Catch every big hit,... See more Catch every big hit, every wicket with Crick-it, a one stop destination for Live Scores, Match Stats, Quizzes, Polls & much more. Explore now!.Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs. News / Lifestyle / Health / 5 reasons you are catching cold frequently this winter SHARE THIS ARTICLE ON Share this article Read this news in brief form Share Via Copy Link Seasonal Influenza Influenza Virus SHARE Copy Whatsapp Twitter Facebook Linkedin [Best Deals] Best air purifier brands for a healthier home: Fight pollution with top picks Best geysers in India: Top 11 energy-saving water heaters you can trust Best top load washing machines: Top 10 efficient, and effective options for you Best serums for sensitive skin: 10 top picks to soothe and nourish your skin Best 5 star geysers for home: Top 10 instant water heaters to choose from View All Join Hindustan Times Create free account and unlock exciting features like Newsletters, Alerts and Recommendations Get personalised news and exciting deals Bookmark the stories you want to read later REGISTER FOR FREE Already have an account? Sign In SKIP Subscribe to our best newsletters HT Daily Capsule Sign Up to Subscribe Newsletter subscribed successfully Latest News World News India News Cricket Live Score Cricket Schedule T20 World Cup Suryakumar Yadav Virat Kohli Yashasvi Jaiswal Axar Patel Hardik Pandya Ravindra Jadeja Shivam Dube Rishabh Pant Sanju Samson Arshdeep Singh Jasprit Bumrah Kuldeep Yadav Mohammed Siraj Yuzvendra Chahal Tim David David Warner Cameron Green Travis Head India vs Sri Lanka India vs South Africa India vs Pakistan India vs Netherlands India vs Ireland India vs England India vs Bangladesh India vs Australia India vs Afghanistan CITY NEWS Bengaluru News Bhopal News Chandigarh News Chennai News Dehradun News Delhi News Gurugram News Hyderabad News Indore News Jaipur News Kolkata News Lucknow News Mumbai News Noida News Patna News Pune News Ranchi News Other Cities Entertainment Bollywood News Hollywood News Music Tamil Cinema Telugu Cinema TV Web Series Entertainment Others Books HT Insight Brand Post Brand Stories Elections Upcoming Elections Income Tax Calculator ASTROLOGY Horoscope Education Admission News Board Exams Competitive Exams Employment News Exam Results Education News LIFESTYLE Art and Culture Brunch Fashion Festivals Health Recipes Relationship Travel Pet Web Stories Trending Business Photos Videos Environment Science Opinion Editorials Car and Bike Technology Sports Badminton Football Hockey Tennis Others Quickreads Covid 19 Assembly Election GAMES Daily Sudoku Daily Crossword Daily Word Jumble TRENDING NEWS CBSE Date Sheet 2025 UP Police Constable Result 2024 Live UGC NET 2024 Live SSC CGL Result 2024 Live India News Live Entertainment News Live World News Live Trending News Live US News Live Bollywood News LIVE Hollywood News Live Horoscope Today LIVE Cricket News Live Sanjiv Khanna Gautam Gambhir Pushpa 2 Trailer Singham Again box office collection IPL 2025 Auction Maharashtra Election 2024 Jharkhand Election 2024 Assembly Election 2024 Cricket Score LIVE Cricket Schedule Gold rate World News TRENDING TOPICS CBSE Date Sheet 2025 UP Police Constable Result 2024 Live UGC NET 2024 Live SSC CGL Result 2024 Live India News Live Entertainment News Live World News Live Trending News Live US News live Bollywood News LIVE Hollywood News Live Horoscope Today LIVE Cricket News Live Sanjiv Khanna Gautam Gambhir Pushpa 2 Trailer Singham Again box office collection Maharashtra Assembly Election 2024 IPL Auction 2025 Jharkhand Assembly Election Assembly Election 2024 Cricket Cricket Match Today India News World News Latest Lifestyle News Mike Waltz, India caucus head and China hawk, picked as Donald Trump's National Security Advisor JD Vance will become president after Donald Trump if Democrats fail to do this Yellowstone season 5 Part 2: How to watch for free; time, TV, live streaming details, date, and more US military strikes 9 Iranian-backed militia targets in Syria in 24 hours Pakistan air pollution: Lahore AQI over 1000, UNICEF warns 11 million kids in Punjab in danger |10 updates Florida boy, 14, beats and sexually assaults 91-year-old woman after breaking into her home: ‘Unimaginable violence’ The best of India in Australia, Part 8: Rahul Dravid's 12-and-a-half-hour epic powers IND to historic win in Adelaide Is Varun Tej's film based on Matka King Ratan Khatri's life? He clarifies ‘Aamir Khan is the reason people in north India know me’, says Suriya 5 rare animals that are on the verge of extinction About Us Contact us Terms of use Privacy policy Weather Today HT Newsletters Subscription Disclaimer Print Ad Rates Code of Ethics Site Map RSS Feeds © 2024 HindustanTimes Click to Top Story Saved Live Score OPEN APP Edit Profile Start 14 Days Free Trial Subscribe Now Your Subscription Plan Renew Subscription Manage Subscription Saved Articles Following My Reads Sign out New Delhi 0C Tuesday, November 12, 2024 Start 14 Days Free Trial Subscribe Now Home HTLS 2023 Astrology India News Lifestyle Entertainment Elections Trending Videos Education Photos Sports Cities Daily Digest Quickreads Opinion Analysis For You Following Web Stories Science HT Games Podcasts Weather Technology Latest News Cricket India vs Sri Lanka Live Cricket Score Cricket Teams Cricket Players ICC Rankings Cricket Schedule Shreyas Iyer Harshit Rana Kusal Mendis Ravi Bishnoi Rinku Singh Riyan Parag Washington Sundar Avishka Fernando Charith Asalanka Dasun Shanaka Khaleel Ahmed Pathum Nissanka World News US News Cities Delhi Mumbai Bengaluru Gurugram Noida Hyderabad Chennai Kolkata Bhopal Chandigarh Dehradun Indore Jaipur Lucknow Patna Pune Ranchi Other Cities Business Income Tax Calculator Petrol Prices UGC NET Answer Key 2024 Live Diesel Prices Gold Rate Silver Rate Lifestyle Fashion Health Relationships Art and Culture Travel Recipes Festivals Pet Brunch Entertainment Bollywood TV Web Series Music Hollywood Telugu Cinema Tamil Cinema Anime Education Study Abroad Board Exams JEE Exam Results Admission News Employment News Competitive Exams BBA Colleges Engineering Colleges Medical Colleges BCA Colleges BBA Exams BCA Exams Medical Exams Engineering Exams Astrology Horoscope Love Horoscope Tarot Chinese Panchang Annual Horoscope Festival Calendar Compatibility Calculator Career Horoscope Manifestation Transits HT Premium E-Paper The Economist Articles HT Insider HT Insight Elections 2024 Lok Sabha States Lok Sabha Parties Lok Sabha Candidates Videos india news infocus HT Insight Explainer Video On The Record HT Weekend Aur Batao Vikram Chandra Daily Wrap Photos Entertainment Photos Lifestyle Photos News Photos Sports Olympics 2024 Olympics Medal Tally Other Sports Sports Football Tennis EPL 2023-24 ISL 2023-24 Hockey Asian Games 2023 HT Insight Public Health Economic Policy International Affairs Climate Change Gender Equality knowledge future tech Governance More from HT HT Epaper Auto HT Tech HT Bangla HT School Quiz HT Friday Finance HT Premium Explore Hindustan Times HT Newsletters Weather Today About Us Contact Us Privacy Policy Terms of Use Disclaimer Print Ad Rates Code of Ethics Sitemap RSS Feeds Subscription - Terms of Use Copyright © HT Digital Streams Ltd. All rights reserved. Follow Us On My Account Sign in Home Cricket Premium Games Sign In // // //Largest bird flu outbreak in Europe, 50 million birds culled in the past one year: Report डाउन टू अर्थPrint EditionSubscribeHealthAgricultureWaterWasteClimateAirAfricaData CentreVideoGalleryYoung EnvironmentalistBookshopNewslettersSubscribeHealthAgricultureWaterWasteClimateAirAfricaData CentreVideoGalleryYoung EnvironmentalistBookshopNewsletters HealthLargest bird flu outbreak in Europe, 50 million birds culled in the past one year: ReportRisk of transmission to humans by exposure to contaminated poultry products is considered negligibleThe report suggested that waterfowl might be responsible for the spread of the HPAI virus into poultry firms. Photo: iStockDTE StaffPublished on: 21 Dec 2022, 3:45 amCopiedEurope has suffered the largest, most devastating epidemic of highly pathogenic avian influenza (HPAI) from October 2021 to September 2022, according to a report brought out by the European Food Safety Authority (EFSA) December 20, 2022.Some 2,520 HPAI outbreaks in poultry, 227 in captive birds and 3,867 in wild birds were recorded in 37 countries on the continent, Avian influenza overview September – December 2022 noted.Some 50 million birds have been culled in the affected establishments.“The unusual persistence of HPAI in wild birds and poultry throughout the summer of 2022 means that for the first time there was no clear separation between the end of the first year of the epidemic and the beginning of this year’s HPAI season, which began in October 2022,” a statement on the EFSA website stated.The risk of transmission to humans by exposure to contaminated poultry products is considered negligible.The report suggested that waterfowl might be responsible for the spread of the HPAI virus into poultry farms as their habitat was more likely to overlap with the location of poultry establishments than seabird colony sites.Steps taken to arrest the spread of the virus have not been effective so far. The assessment warned that “sustained and increasing infection pressure on poultry establishments will further challenge the effectiveness of the applied biosecurity measures” in the months to come.It warned that avian influenza could further spread between establishments, primarily in areas with high poultry densities.This was because of the persistent presence of HPAI A(H5) viruses in wild birds and in the environment; the continuous occurrence of primary outbreaks in several countries and the possible reduction of biosecurity compliance.The document urged identifying and implementing short-term preparedness and medium- and long-term prevention strategies. This should primarily be done in densely populated poultry areas and poultry production systems that are highly susceptible to avian influenza exposure, it said.Testing for avian influenza virus in wild and farmed mammals showing neurological and respiratory symptoms; documentation of wild birds that were ill or died due to bird flu and surveillance of animals and humans that could be potentially exposed to infected birds were some of the other response options suggested in the report.Read more: Bird flu: UK is seeing its largest ever outbreak – which may prove particularly deadly for wild birds Ebola rears head again in DRC; China, US report new strains of bird flu WorldHealthEuropebird fluBirdsBird cullingMigratory BirdsShow CommentsRelated StoriesNo stories found. Follow UsSubscribeHealthClimateAfricaNewsVideoData CentreBookshopNewsletterIn-depthBlogs© Copyright Down To Earth 2024. All rights reserved.Powered by Quintype Down To Earth www.downtoearth.org.in INSTALL APPHow to Stay Healthy When Everyone in Your House Is Sick Skip to main content Skip to header navigation Icon Link Plus Icon Icon Link Plus Icon Icon Link Plus Icon Icon Link Plus Icon Icon Link Plus Icon SheKnows Plus Icon Click to expand the Mega Menu Plus Icon Click to Expand Search Input optional screen reader Parenting Entertainment Health Food Shopping Digital Issues Newsletters Plus Icon Click to expand the Mega Menu Menu optional screen reader Parenting Entertainment Health Food Shopping Digital Issues Newsletters SheKnows Plus Icon Click to Expand Search Input optional screen reader Health & Wellness Mind & Body How to Stay Healthy When Everyone in Your House Is Sick by Brianne Hogan Plus Icon Brianne Hogan Plus Icon https://www.twitter.com/briannehogan Follow optional screen reader Brianne's Most Recent Stories Vitamix’s ‘Versatile’ Blender Is My Most Favorite Appliance in My Kitchen — Here’s Why It’s Worth Snagging Before Prime Day Ends Are You in a Toxic Relationship? Look Out for These 8 Signs 8 Vitamins & Supplements You Should Not Take Together, According to Experts View All December 22, 2022 at 3:12pm EST Share Share on Flipboard Plus Icon Share on Pinterest Plus Icon Share on Facebook Plus Icon Share on Twitter Plus Icon Plus Icon If everyone's getting sick, here's what you need to do to beef up your health game. yavdat/Adobe Stock The Things You Need in Your Coronavirus First Aid Kit 11 Images It is officially well into cold and flu season (and we’re seeing with new COVID variants and RSV another wave of illness) — which means everyone around you is at risk of getting sick. Ugh. While you might be able to avoid coughing and sneezing at work by avoiding those who are infected, what happens when you’re the only healthy one in a house filled with sickos? Fortunately you don’t have to move out. There are some tips and remedies that you and your housemates/family/friends can do that will help save you from catching the phlegm-infested fate that’s overcome them. Get a flu & COVID-19 vaccination No one likes needles but sometimes it’s your best defense when it comes to avoiding getting ill (or bringing sickness into your house in the first place). Related story This Surprisingly Chic, Award-Winning Humidifier Is a Must for Cold & Flu Season – & It’s on Sale “If your household members are sick because of the flu then chances are higher of you getting affected with the virus as well,” Dr. Ashish Sharma, an Internal Medicine Physician at Yuma Regional Medical Center. “The most important aspect of prevention is to get a flu vaccine every year.” And receiving one is always better late than never. “Even if someone in the house has already been diagnosed with the flu, it’s not too late to get vaccinated,” Dr. Elizabeth Wang, MD an Infectious Diseases Physician at the University of Maryland St. Joseph Medical Center tells SheKnows. “However someone with a weakened immune system and at high risk for influenza complications has already been exposed to a household member with the flu—in addition to practicing the precautions listed above–it’s wise to talk with your health care provider about taking Tamiflu as a precaution.” Wang says people with the flu should take Tamiflu to decrease the chances of spreading the virus and to shorten the duration of symptoms. Related story This Surprisingly Chic, Award-Winning Humidifier Is a Must for Cold & Flu Season – & It’s on Sale The same can be said for your COVID-19 vaccine and boosters — if you aren’t sure if it’s a right fit for you, just talk with your doctor. I promise they’ll have thoughts. Wash your hands, and then wash them again Germs are everywhere and how do they spread super fast? Through touch. “Relentless hand washing is crucial for staying healthy,” says Wang. “Think about when you wash your hands, too — after using the bathroom, of course, but also after blowing or wiping your nose, after touching common surfaces like doorknobs, light switches, phones/cellphones, countertops, keys, computer mouses, etc. — as we inadvertently expose ourselves to illness-causing germs and bacteria when we touch these things.” Wang says it’s also important to be thorough about how you wash your hands. She advises using soap and warm water and lathering for at least two full choruses of “Happy Birthday” or the Jeopardy! theme song, which sounds pretty fun, at least peppy. If soap and water aren’t available, she advises using an alcohol-based hand gel and letting it dry thoroughly before touching anything else. “Be mindful of cleaning your entire hand—including under the nails and underneath rings—to ensure that you’re killing as many harmful germs as possible,” she says. “It’s certainly an added risk when you’re directly caring for someone who’s sick, as you’re doing things like picking up their used cups or mugs or tissues, giving them medicine, taking their temperature, so the best thing you can do to protect yourself is to practice good hand hygiene.” Wipe everything clean “The influenza virus can stay for eight hours on different articles and objects, such as on a remote control, door knob, cups, plates, clothes etc. that’s been touched by sick family members,” says Sharma. “It also makes it easy to disinfect these objects with alcohol, hydrogen peroxide, iodine or bleach based disinfectant after one recovers from illness.” Smartphones are also a big source of germs, which is why Wang recommends keeping bleach wipes handy and wipe down your cellphone as needed. “Avoid placing it on common household or public surfaces, and try not to let anyone in your home who’s sick touch your phone or your charging cords,” she says. “Our phones are in our hands and near our eyes, noses and mouths—all areas in which harmful germs and bacteria can easily enter the body and make us sick.” Wear masks You might feel a little silly doing but Wang says “don’t underestimate the power of the surgical mask.” She suggests going with the majority rule to determine who should wear it. “If one family member has the flu, and all others are healthy, it’s helpful for the sick person to wear the mask. If several people in the household are down with the flu, the healthy minority should wear masks to protect themselves.” If no mask is available, Sharma says that the sickies should cough into their elbow or use tissues and must wash hands after discarding tissues in trash. Create a “sick room” To prevent the virus spreading to other parts of the house, Sharma suggests creating a sick room with a separate bathroom where the sick family member can stay until he or she recovers is a good idea if you have enough space availability. Wang agrees, adding that if it’s possible, “quarantine any people with illness in one bathroom so that you have a ‘sick’ and a ‘well’ bathroom. Use rubber gloves to clean, and keep plenty of bleach wipes on hand to wipe down counters, doorknobs, light switches, faucet, toilet and shower handles as needed.” She says it’s also a good idea to keep your “healthy” toothbrush well away from that of anyone who’s sick, and to use separate tubes of toothpaste. Before you go, check out our favorite all-natural cold and flu remedies for kids: Leave a comment Sign Up optional screen reader Tags cold flu season sick days Leave a Comment More Stories from Health & Wellness Mind & Body The Golden Bachelorette’s Michael Gave an Update on His Cancer Diagnosis & Surprising Reveal 7 hrs ago by Maggie Ryan Mind & Body James Van Der Beek Reveals the Early Symptom of Colorectal Cancer That Pushed Him To See a Doctor November 8, 2024 by Maggie Ryan Children’s Health Teens Get Seasonal Depression Too. Here’s How To Help Them Cope November 7, 2024 by Zuania Capó, MHC-LP Mind & Body A Guide To Coping With the Crushing Election Grief You Feel Right Now November 6, 2024 by Maggie Ryan Reproductive Health Abortion Is Officially Protected in 7 More States Thanks to These Key Ballot Measures November 6, 2024 by Maggie Ryan More Stories Sign Up Never Miss a Thing The stories you care about, delivered daily. Email Address Subscribe Sign Up By providing your information, you agree to our Terms of Use and our Privacy Policy. We use vendors that may also process your information to help provide our services. // This site is protected by reCAPTCHA Enterprise and the Google Privacy Policy and Terms of Service apply. Newswire HollywoodLife ‘Outer Banks’ Season 5: Release Date, Plot & Everything We Know StyleCaster Here’s the Style of House Each Zodiac Sign Would Love to Call Home FootwearNews Knicks’ Josh Hart Recalls ‘Shaking Like A Stripper’ When Nervously Introducing Kith’s Ronnie Fieg at the 2023 FNAAs Rolling Stone Dwayne Johnson Says He’s Now Open to ‘Deeper’ Films: ‘I’ve Evolved’ optional screen reader SheKnows About Us Careers Accessibility SheKnows Baby Names Connect with us Icon Link Plus Icon Icon Link Plus Icon Icon Link Plus Icon Icon Link Plus Icon Icon Link Plus Icon optional screen reader Legal Privacy Policy Terms of Use California Privacy Rights AdChoices Your Privacy Choices Privacy Preferences Newsletter Signup Your Email Subscribe Sign Up By providing your information, you agree to our Terms of Use and our Privacy Policy. We use vendors that may also process your information to help provide our services. // This site is protected by reCAPTCHA Enterprise and the Google Privacy Policy and Terms of Service apply. optional screen reader SheKnows Family: She Media StyleCaster Soaps BlogHer Icon Link Plus Icon SheKnows is a part of Penske Media Corporation. © 2024 SheMedia, LLC. All Rights Reserved. Powered by WordPress.com VIP optional screen reader Our Sites Art in America Artforum Artnews ATX TV ATX TV Festival BGR Billboard BlogHer Deadline Flow Space Footwear News GoldDerby IndieWire LA3C Life is Beautiful Robb Report Rolling Stone SheKnows Soaps Sourcing Journal Sportico Spy StyleCaster The Hollywood Reporter TVLine Variety Vibe WWD SheKnows Close the menu Parenting Expand the sub menu Parenting News Kids Baby Names Motherhood What to Buy Health Expand the sub menu Health News Reproductive Health Children’s Health Love & Sex Nutrition & Fitness Food & Recipes Expand the sub menu Recipes Cooking Tips & Trends Entertaining Living Expand the sub menu Home & Garden Beauty & Style Entertainment Expand the sub menu Entertainment News Celebrities Culture TV & Movies Books & Music Special Series Expand the sub menu Edward Jones Presents: Women, Wealth, and Wellbeing Digital Issues Mamá y Más The Black Maternal Health Crisis Black Mind & Body SK Conversations Shopping Expand the sub menu Shopping Guides Ultimate Gift Guide Presented by Walmart Videos Expand the sub menu Follow Us Follow us on Pintrest Follow us on Instagram Follow us on Facebook Follow us on Twitter Follow us on Flipboard Alerts & Newsletters Your Email Sign Up Sign Up By providing your information, you agree to our Terms of Use and our Privacy Policy. We use vendors that may also process your information to help provide our services. // This site is protected by reCAPTCHA Enterprise and the Google Privacy Policy and Terms of Service apply. optional screen reader Contact Us Advertise AdChoices Accessibility Careers Privacy Policy EU Privacy Preferences Terms of Use Icon Link Plus Icon SheKnows is a part of Penske Media Corporation. © 2024 SheMedia, LLC. All Rights Reserved. adBird Flu on the Move Worldwide, Kerala Orders Culling of Thousands of Birds + For the best experience, open m.thewire.in on your mobile browser or Download our App. Profile News Letters Logout Home #Elections 2024 Politics Economy World Security Law Science Society Culture Editor's Pick Opinion × Home Politics Economy World Security Law Science Society Culture Editor's Pick Opinion Next Trending Journalist Mahesh Langa Booked Again by Gujarat Police for Possessing Official Documents; 'Unacceptable' Says 'The Hindu' Editor On a Hidden Struggle: Unpacking Internalised Ableism US Sends Back Indians Who Entered Country Illegally Code Dependence Has a Human Cost and Is Fuelling Technofeudalism Why Is There No Experience Like 99 Runs for Bowlers in Cricket? The Battle That Ensured Kashmir Was a Part of India KYC-Led Freezing of Bank Accounts Leaves Jharkhand Adivasis Without Access to Own Money: Survey Backstory: If Some Media Outlets Call Muslim Citizens 'Outsiders,' Others Should Defeat That Project 'Implement Every Possible Sanction': Over 2,700 Israelis Call for Global Pressure on Israel For a Ceasefire Israel Strikes Iran, Says Retaliation 'Complete'; Tehran Says 'Limited Damage' We need your support. Know More You are reading an older article which was published on Dec 22, 2022 health Bird Flu on the Move Worldwide, Kerala Orders Culling of Thousands of Birds Aathira Perinchery Dec 22, 2022 Bird flu, or avian influenza, is a zoonotic disease that tends to peak during winter. Representative image of a poultry farm. Photo: Reuters Advertisement Support Free & Independent Journalism Good morning, we need your help! Since 2015, The Wire has fearlessly delivered independent journalism, holding truth to power.Despite lawsuits and intimidation tactics, we persist with your support. Contribute as little as ₹ 200 a month and become a champion of free press in India. Yes, I want to contribute Kochi: Bird flu has reared its head again in Kerala. Last week, authorities ordered the culling of at least 8,000 birds, including poultry and ducks, in the district of Kottayam. Worldwide too, cases of bird flu have surged over the past few months. The US and UK witnessed their worst-ever outbreaks of bird flu in October-November this year. The zoonotic disease is spreading rapidly in France too. Poultry exports, including India’s, are beginning to take a hit. Bird flu, or avian influenza, is a zoonotic disease that affects wild and domestic birds and can spill over to humans as well. Bird flu in Kerala Almost a week ago, two panchayats in Kerala’s Kottayam district – Arpookara and Thalayazham – reported a bird flu outbreak. Authorities have ordered the culling of around 8,000 ducks, hens and other domestic birds within a kilometre radius of the affected areas, reported India Today. The district administration also ordered a ban on the sale and import of chicken, duck, quail, and other poultry eggs and meat for three days from December 13 within 10 km of the epicentre of bird flu. The ban has now been lifted. As per district authorities, tests conducted at the National Institute of High-Security Animal Diseases (NIHSAD) in Bhopal confirmed it to be the H5N1 strain of the virus, reported Livemint. The H5N1 strain is the most prevalent one now across the world. Kerala had already reported cases of bird flu in October this year and around 1,500 birds died, reported The Hindu. Authorities had prepared to cull around 20,000 birds then. The Nilgiris district administration in Tamil Nadu also temporarily suspended the transport of poultry products from Kerala in November. The impacts of bird flu are beginning to tell on poultry exports too. There is a reduction in poultry exports due to the bird flu, which has resulted in reduced demand from major importing countries, the Indian government said recently. Bird flu cases surge worldwide Advertisement Worldwide, the cases of bird flu have surged over the past months. As of November 2022, 97 million birds have died globally, as per one estimate, and experts have warned that infections could rise even higher over the winter. The US witnessed around 47 million birds dying either due to infections or culling – almost a record – as a result of bird flu. As per reports, this was caused by a different form of the virus (a subtype of the H5N1 strain) than usually seen in the area. This in turn infected more wild birds that then transmit the disease, officials said. Advertisement Bird flu is rife across Europe as well. Fifty million birds have been culled in Europe alone, reported Down to Earth. The United Kingdom witnessed its worst-ever outbreak of avian influenza last month. Authorities closed down the renowned Berlin Zoo temporarily last month due to an outbreak. Bird flu has also spread quickly over the past weeks in France, the country’s farm ministry said on Wednesday. According to the ministry, 217 bird flu outbreaks were detected on French farms by December 20, up from 100 on December 2, and the number of cases has also risen sharply in wildlife, reported Reuters. France is the European Union’s second-largest poultry producer, and the sudden spike in bird flu cases raises concerns about shortages. Advertisement What is bird flu? Bird flu, or avian influenza, refers to a variety of influenza type A viruses and is a zoonotic disease that affects wild and domestic bird populations. The disease makes its presence felt particularly during winter in most of India and other parts of the globe, as wintering migratory birds arrive and bring pathogens with them. Temperature is also a factor: the virus thrives better in cooler climes, thus enabling its spread during winter. Bird flu is a concern because the virus can spread quickly among domestic birds, causing drastic economic losses. It can also spill over to people, and poses a significant public health risk. Strains of avian influenza differ in their impacts and some such as the H5N1 strain have caused human deaths worldwide too. Globally, from January 2003 to November 11 this year, there have been 868 cases of human infection with the H5N1 strain of the virus, across 21 countries according to a report by the World Health Organisation. Of these, 457 were fatal. Bird flu affects wild bird populations drastically as well. The highly contagious H5N1 strain of the virus killed around 13,000 pelicans, blue-footed boobies and other seabirds in Peru last month, according to biologists. This year’s outbreaks have been particularly hard on wild bird populations: it has killed more wild birds than ever before and sea birds have been especially affected, reported the BBC. Culling infected domestic bird populations is one of the measures that can be taken to tackle such outbreaks. Some countries, such as China, also vaccinate their birds; others such as the Netherlands have begun vaccine trials to control outbreaks. Surveillance of domestic and wild birds is another measure that is used to detect an outbreak early so that control measures can be taken immediately to minimise spread. Advertisement Make a contribution to Independent Journalism More in Top Stories : World Mauritius: With PM Conceding and Before Full Results Out, Modi Congratulates Ramgoolam on Victory View More Videos Editor's Pick Trending Get the latest news, top headlines, opinions, analysis and much more from India and World including current news headlines on elections, politics, economy, business, science, culture on The Wire. - Powered By -PAN seeks compensation for farmers with Avian Influenza-ravaged farms - Tribune Online HomeNewsColumnsEditorialVIDEOSEntertainmentPoliticsHealthOpinionsSPORTING TRIBUNE No Result View All ResultHomeNewsColumnsEditorialVIDEOSEntertainmentPoliticsHealthOpinionsSPORTING TRIBUNE No Result View All Result No Result View All ResultPAN seeks compensation for farmers with Avian Influenza-ravaged farms by Nurudeen Alimi December 20, 2022 in Agriculture Reading Time: 2 mins read A A A A ResetFILE PHOTO POULTRY farmers under the aegis of the Poultry Association of Nigeria (PAN) has called on the Federal Government to urgently compensate poultry farmers whose farms were ravaged by the outbreak of avian influenza, popularly known as bird flu.South-West Chairman of PAN, Gideon Oluleye, made the call during this year’s Nigeria Poultry show in Abeokuta, Ogun State. He said the urgent compensation is necessary so that the farmers will remain in business as lot of them have been out of business since the incidence, stressing that the compensation is necessary for the farmers, to alleviate their sufferings and save the poultry industry from imminent collapse.Related Posts Fueling the future: Nigeria’s CNG revolution Security sector: Olagunju, Dare, nepotism in appointments Prioritise students’ feedback in teacher evaluations, expert urges tertiary institutions Oluleye while lamenting the huge losses recorded by farmers during the outbreak, noted that hundreds of farmers lost their means of livelihood while several millions of naira were also lost.ALSO READ FROM NIGERIAN TRIBUNE Eight Months Withheld Salaries: ASUU May Consider Legal Action Against FGKogi: Agbakoba Tackles EFCC Over N20bn BailoutAtiku To APC: Lift Veil On Your Flag-Bearer’s IdentityKidnappers Kill Businessman After Ransom Payment In OndoCampaign Finances: How We Will Checkmate Political Parties — INECEDITORIAL: FG’s Lamentation On Nigeria’s Yam DilemmaTo help farmers grow their businesses and also contribute to the Gross Domestic Product (GDP) of the country, Oluleye called on the Federal Government, through the Ministry of Agriculture and the Central Bank of Nigeria (CBN) to make more funds available for farmers. “The poultry industry is a subsector of the Nigerian economy that provides direct and indirect employment to over 25 million people. As a result of this, we are urging the Nigerian government, through the Federal Ministry of Agriculture and other levels of government and the CBN to give more funding to the sector, as the sector can generate huge employment opportunities for the jobless youths and earn foreign exchange for the country.”While speaking further, the PAN Southwest Chairman added, “Other reasons why the government must fund this sector the most are; the current built-in-inflation within the economy that has pushed up the cost of inputs, climate change, dwindling economy, internal security; and the Ukraine-Russian war, which has further taken its toll on the poultry subsector of the country.“All levels of government and the CBN should therefore budget more funding to the sector and subsidise the major inputs – maize and soya much more than they have been doing before and grant more loans in the long term to farmers in order to protect the sector from imminent collapse.” Get real-time news updates from Tribune Online! Follow us on WhatsApp for breaking news, exclusive stories and interviews, and much more. Join our WhatsApp Channel now ShareTweetSendShareShare Previous PostElection can’t hold in 40 LGs, 2023 poll in danger — Falana Next PostProtests rock Abuja over alleged plan to charge Emefiele with terrorism Most Read 10 most powerful passports in the World 2024 10 weakest passports in the World 2024 Drinking water in the morning How Baltasar Engonga betrayed me after dating for four years, lady in sextape reveals Baltasar Engonga: Sacked Equatorial Guinea’s anti-graft boss remanded in prison Full lyrics of new national anthem ‘Nigeria, We Hail thee’ UPDATED: Truck accident claims five lives in Epe market Lagos: Three dead, others injured as truck rams into vehicles, building at Ayetoro market How personal losses ‘pushed’ AY, Basketmouth to reconcile after 18-year rift Equatorial Guinea’s ANIF boss enmeshed in s3x scandal with multiple women Subscribe to e-Paper Frontpage Today EDITORIAL Editorial Opinion Letters News Extra BUSINESS Capital Market Money Market Economy ENTERTAINMENT Friday Treat Entertainment RazzmattazREGIONS South West Niger Delta Arewa RELIGION Tribune Church Church News Muslim Sermon Eye of Islam Islamic NewsCOLUMNS Anike's Diary Aplomb Ask The Doctor Autoclinic With The Mechanic Awo's Thought Borderless Crucial Moment Empowered For Life Festus Adebayo's Flickers Financewise Gibbers Intimacy Language & Style Leaders' Forum Leadership & Management Lynx Eye Monday Lines Mum & Child Natural Health Notes from Atlanta with Farooq Kperogi On The Lord's Day PENtagon Political Panorama Veritatem With Obadiah Mailafia Voice of Courage Whatsapp Conversation You and Eye Your Life Counts WOMEN Xquisite Xquisite Food Xquisite Style Wondrous World of WomenMORE Business Coach Education Event Digest Crime & Court Do It Yourself Ecoscope Property & Environment Energy Maritime Aviation Brands & Marketing Agriculture Info Tech Labour Leadership & Management Achievers Arewa Live Arts & Culture Arts & Reviews Campus Beat Politics Health NewsAbout UsContact usDisclaimerPrivacyAdvertise © 2023 Tribune Online - an online publication of African Newspapers of Nigeria Plc. All rights reserved Welcome Back!Login to your account below Remember Me Forgotten Password?Retrieve your passwordPlease enter your username or email address to reset your password. Log In Add New Playlist - Select Visibility -PublicPrivate No Result View All ResultHomeNewsColumnsEditorialVIDEOSEntertainmentPoliticsHealthOpinionsSPORTING TRIBUNE © 2023 Tribune Online - an online publication of African Newspapers of Nigeria Plc. All rights reservedWelsh pharmacies deliver more than 150,000 flu vaccines in three months NewsAnalysisPodcastsLearningCommunityOpens in new windowJobsOpens in new windowAwards NewsDataOpens in new windowSearchSearchNewsFundingRegulationBusinessClinicalProduct NewsPoliticsLocumsIndependentsMultiplesEducationCoronavirusAnalysisExplainersOpinionSalary SurveyInvestigationsCrimes in pharmaciesCase StudiesPartnered ContentPodcastsLearningCommunityJobsFind a jobOpens in new windowPost a jobOpens in new windowAwards NewsAwards 2024Opens in new windowDataLoginOpens in new windowData servicesOpens in new windowPharmacy subscriptions MoreAbout usAdvertise with usContact usHelpHomeWelsh pharmacies deliver more than 150,000 flu vaccines in three months19 Dec 2022 • By Eoghan O'DonnellCommunity pharmacies in Wales have vaccinated more than 150,000 people so far this season against flu, Community Pharmacy Wales (CPW) has announced.Additional TopicsFluVaccinationServicesLatest from NewsMore from ClinicalFacebook pageTwitter feedRSS feedRSS feedDiscover MoreC+D DataOpens in new windowC+D CommunityOpens in new windowC+D JobsOpens in new windowC+D has been informing, supporting and championing community pharmacy since 1859 and is proud to be at the forefront of providing the latest news to everyone working in the sector.Terms and ConditionsOpens in new windowPrivacy PolicyOpens in new windowCommunity PrinciplesCopyright © 2024 Citeline, a Norstella Company. Chemist+Druggist is a trading division of Citeline, a Norstella company and operates as part of C&D Intelligence U.K. Limited. C&D Intelligence U.K. Limited is a company registered in England and Wales (Registration number 13793264) with its registered office at 3 More London Riverside, London SE1 2AQ.